Product overview
Methods
| Technology | Parameter | Substrate | Species | Calibration | Ig Class | Format | Order No. |
|---|---|---|---|---|---|---|---|
| ChLIA | IDS human Growth Hormone (hGH) | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-37001 | ||
| ChLIA | IDS Insulin-like Growth Factor-I (IGF-I) | Streptavidin-coated magnetic particles |
quantitative |
01 x 01 |
IS-39001 | ||
| ChLIA | IDS Insulin-like Growth Factor-I (IGF-I) Control Set | 3 x 1.0 ml Control 1/2/3 | Insulin-like Growth Factor-I (IGF-I) |
3 concentrations |
IS-39301 | ||
| ChLIA | IDS Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-44001 | ||
| ChLIA | IDS Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Control Set | 3 x 1.0 ml Control 1/2/3 | Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) |
3 concentration levels |
IS-44301 | ||
| ELISA |
Leptin ELISA |
antibody-coated microplate wells | 0/1/5/10/20/50/100 ng/ml |
96 x 01 |
EQ 6444-9601 | ||
| ELISA |
Adiponectin ELISA |
antibody-coated microplate wells | 0/2/5/10/25/50 ng/ml |
96 x 01 |
EQ 6446-9601 | ||
| IIFT | adrenal cortex | adrenal gland | monkey | IgG |
10 x 05 10 x 05 |
FA 1050-1005 FB 1050-1005 |
|
| ChLIA | IDS Cortisol | Antibody-coated magnetic particles |
quantitative |
100 x 01 |
IS-46001 | ||
| ChLIA | IDS Cortisol Calibrator Set | 1 x 1.0 ml Calibrator 1/2/3/4/5/6 | Cortisol |
6 concentration levels |
IS-46201 | ||
| ChLIA | IDS Cortisol Control Set | 3 x 1.0 ml Control 1/2 | Cortisol |
2 concentration levels |
IS-46301 | ||
| ELISA |
17-OH-Progesterone ELISA |
antibody-coated microplate wells | 0/0.15/0.5/1.5/3/7.5/20 ng/ml |
96 x 01 |
EQ 6163-9601 | ||
| ChLIA | IDS 17-OH Progesterone | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-51001 | ||
| ChLIA | IDS 17-OH Progesterone Control Set | 2 x 1.0 ml Control 1/2/3 | 17-OH Progesterone |
3 concentration levels |
IS-51301 | ||
| ELISA |
Cortisol Saliva ELISA |
antibody-coated microplate wells |
Cortisol, in saliva |
0/0.3/1/3/10/30 ng/ml |
96 x 01 |
EQ 6141-9601 S | |
| ChLIA | IDS ACTH II | Antibody-coated magnetic particles |
quantitative |
100 x 01 |
IS-4500NG1 | ||
| ChLIA | IDS ACTH II Calibrator Set | 2 x 1.0 ml Calibrator 1/2/3/4/5 | Adrenocorticotropic hormone (ACTH) |
5 concentration levels |
IS-4520NG1 | ||
| ChLIA | IDS ACTH II Control Set | 6 x 1.0 ml Control 1/2 | Adrenocorticotropic hormone (ACTH) |
2 concentration levels |
IS-4530NG1 | ||
| ChLIA | IDS Salivary Cortisol | Antibody-coated magnetic particles |
100 x 01 |
IS-49001 | |||
| ChLIA | IDS Salivary Cortisol Control Set | 4 x 2.0 ml Control 1/2/3 | Cortisol |
3 concentration levels |
IS-49301 | ||
| ChLIA | IDS Urinary Cortisol |
Antibody-coated magnetic particles |
quantitative |
100 determinations |
IS-58001 | ||
| ChLIA | IDS Urinary Cortisol Calibrator Set | 1 x 1.0 ml Calibrator 1/2/3/4/5/6 | Cortisol |
6 concentration levels |
IS-58201 | ||
| ChLIA | IDS Urinary Cortisol Control Set | 3 x 1.0 ml Control 1/2 | Cortisol |
2 concentration levels |
IS-58301 | ||
| ELISA |
Aldosterone ELISA |
antibody-coated microplate wells | 0/15/50/200/500/1000 pg/ml |
96 x 01 |
EQ 6143-9601 | ||
| ChLIA | IDS Aldosterone | Antibody-coated magnetic particles |
quantitative |
100 x 01 |
IS-33001 | ||
| ChLIA | IDS Aldosterone Control Set | 6 x 1.0 ml Control 1/2/3 | Aldosterone |
3 concentration levels |
IS-33301 | ||
| ChLIA | IDS Direct Renin | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-34001 | ||
| ChLIA | IDS Direct Renin Control Set | 6 x 1.0 ml Control 1/2/3 | Renin |
3 concentration levels |
IS-34301 | ||
| NUL | anti-CCD absorbent |
01 x 01 01 x 04 |
ZD 3001-0101-2 ZD 3001-0104-2 |
||||
| ChLIA | Control set Anti-Gliadin (GAF-3X) ChLIA (IgG) | 2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 3011-20210 G | ||
| ChLIA |
IDS Positive Specific IgE Control (F003) Cod 2 x 1.2 ml Control 1 |
2 x 1.2 ml Control 1 |
1 concentration |
IS-1F003-301 | |||
| ChLIA |
IDS Positive Specific IgE Control (G006) Timothy Grass 2 x 1.2 ml Control 1 |
2 x 1.2 ml Control 1 |
1 concentration |
IS-1G006-301 | |||
| ChLIA |
IDS Negative Specific IgE Control (F003/G006) Cod/Timothy Grass 2 x 1.2 ml Control 1 |
2 x 1.2 ml Control 1 |
1 concentration |
IS-1SIGE9301 | |||
| ChLIA | IDS Total / Specific IgE Reagent Kit | magnetic particles |
quantitative |
50 x 01 |
IS-1TIGE9001 | ||
| ChLIA |
IDS Total IgE Control Set 1 x 1.2 ml Control 1/2/3 |
1 x 1.2 ml Control 1/2/3 |
3 concentrations |
IS-1TIGE9301 | |||
| ELISA | Total IgE ELISA |
antigen-coated microplate wells |
anti-human IgE | 0/10/100/500 IU/ml | IgE |
96 x 01 |
EV 3840-9601 E |
| EUROLINE |
EUROLINE DPA-Dx Milk 1 (IgE) (f2, f76, f77, f78, f334, e204, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3510-1601-1 E | ||
| EUROLINE |
EUROLINE DPA-Dx Peanut 1 (IgE) (t215, f422, f423, f424, f429, f445, f444, f427, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3511-1601-1 E | ||
| ChLIA | IDS Specific IgE (F076) Alpha-lactalbumin | allergen |
quantitative |
50 x 01 |
IS-1F0761 | ||
| ChLIA | IDS Specific IgE (F077) Beta-lactoglobulin | allergen |
quantitative |
50 x 01 |
IS-1F0771 | ||
| ChLIA | IDS Specific IgE (F078) Casein | allergen |
quantitative |
50 x 01 |
IS-1F0781 | ||
| ChLIA | IDS Specific IgE (F233) nGal d 1 | allergen |
quantitative |
20 x 01 |
IS-1F2331 | ||
| ChLIA | IDS Specific IgE (F351) rPen a 1 | allergen |
quantitative |
20 x 01 |
IS-1F3511 | ||
| ChLIA | IDS Specific IgE (F423) rAra h 2 | allergen |
quantitative |
20 x 01 |
IS-1F4231 | ||
| ChLIA | IDS Specific IgE (F427) rAra h 9 | allergen |
quantitative |
20 x 01 |
IS-1F4271 | ||
| ChLIA | IDS Specific IgE (F428) rCor a 1 | allergen |
quantitative |
20 x 01 |
IS-1F4281 | ||
| ChLIA | IDS Specific IgE (F434) rMal d 1 | allergen |
quantitative |
20 x 01 |
IS-1F4341 | ||
| EUROLINE |
EUROLINE DPA-Dx Pollen 1 (IgE) (t3, g6, t215, t216, t220, t225, g205, g215, g210, g212, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3210-1601-1 E | ||
| EUROLINE |
EUROLINE DPA-Dx Pollen Southern Europe 1 (IgE) (t3, t9, t23, g6, w21, m6, t215, t226, w211, g205, g215, g210, g212, t224, t231, t235, m229, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3211-1601-1 E | ||
| EUROASSAY |
EUROASSAY DPA-Dx Pollen 1 (IgE) (t3, g6, t215, t216, t220, t225, g205, g215, g210, g212, CCD) |
EUROASSAY strip with allergens |
IgE | DE 3210-0501-1 E | |||
| ChLIA | IDS Specific IgE (D202) rDer p 1 | allergen |
quantitative |
20 x 01 |
IS-1D2021 | ||
| ChLIA | IDS Specific IgE (D203) rDer p 2 | allergen |
quantitative |
20 x 01 |
IS-1D2031 | ||
| ChLIA | IDS Specific IgE (D205) rDer p 10 | allergen |
quantitative |
20 x 01 |
IS-1D2051 | ||
| ChLIA | IDS Specific IgE (E094) nFel d 1 | allergen |
quantitative |
20 x 01 |
IS-1E0941 | ||
| ChLIA | IDS Specific IgE (E101) nCan f 1 | allergen |
quantitative |
20 x 01 |
IS-1E1011 | ||
| ChLIA | IDS Specific IgE (G205) rPhl p 1 | allergen |
quantitative |
20 x 01 |
IS-1G2051 | ||
| ChLIA | IDS Specific IgE (G213) rPhl p 1, rPhl p 5b | allergen |
quantitative |
20 x 01 |
IS-1G2131 | ||
| ChLIA | IDS Specific IgE (G215) rPhl p 5b | allergen |
quantitative |
20 x 01 |
IS-1G2151 | ||
| ChLIA | IDS Specific IgE (M229) rAlt a 1 | allergen |
quantitative |
20 x 01 |
IS-1M2291 | ||
| ChLIA | IDS Specific IgE (T215) rBet v 1 | allergen |
quantitative |
20 x 01 |
IS-1T2151 | ||
| ChLIA | IDS Specific IgE (T216) rBet v 2 | allergen |
quantitative |
20 x 01 |
IS-1T2161 | ||
| ChLIA | IDS Specific IgE (T224) rOle e 1 | allergen |
quantitative |
20 x 01 |
IS-1T2241 | ||
| ChLIA | IDS Specific IgE (W230) nAmb a 1 | allergen |
quantitative |
20 x 01 |
IS-1W2301 | ||
| ChLIA | IDS Specific IgE (W231) nArt v 1 | allergen |
quantitative |
20 x 01 |
IS-1W2311 | ||
| EUROLINE |
EUROLINE DPA-Dx Insect venoms 3 (IgE) (i1, i3, i75, i208, i213, i216, i209, i211, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3850-1601-3 E | ||
| EUROLINE |
EUROLINE DPA-Dx Insect venoms "Southern Europe 1" (IgE) (i1, i3, i75, i77, i208, i213, i216, i210, i209, i220, i211, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3851-1601-1 E | ||
| EUROASSAY |
EUROASSAY DPA-Dx Insect venoms 3 (IgE) (i1, i3, i75, i208, i213, i216, i209, i211, CCD) |
EUROASSAY strip with allergens |
IgE | DE 3850-0501-3 E | |||
| EUROLINE |
EUROLINE DPA-Dx Pediatrics 1 (IgE) (t215, f76, f77, f78, f334, e204, f232, f233, f323, f356, f422, f423, f424, f427, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3812-1601-1 E | ||
| EUROLINE |
EUROLINE DPA-Dx Pediatrics 2 (IgE) (f76, f77, f78, f334, e204, f232, f233, f323, f356, f422, f423, f424, f429, f445, f444, f427, t215, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3812-1601-2 E | ||
| EUROLINE |
EUROLINE Food (IgE) (f1, f75, f2, f45, f4, f5, f9, f13, f14, f17, f20, f49, f84, f237, f25, f31, f35, f85, f3, f23, CCD) |
membrane strip with allergens (EUROLINE) |
IgE IgE |
16 x 01 64 x 01 |
DP 3410-1601 E DP 3410-6401 E |
||
| EUROLINE |
EUROLINE Food 2 (IgE) (f1, f75, f2, f78, f4, f5, f14, f10, f13, f17, f20, f49, f84, f95, f25, f31, f35, f85, f3, f23, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3410-1601-1 E | ||
| EUROLINE |
EUROLINE Food 3 (IgE) (f13, f17, f20, f158, f12, f14, f89, f96, f25, f47, f48, f85, f49, f84, f92, f95, f26, f27, f83, f3, f23, f24, f40, f4, f8, f9, f10, f45, f2, f78, f218, f1, f75, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3410-1601-3 E | ||
| EUROLINE |
EUROLINE Food 6 (IgE) (f245, f2, f31, f49, f3, f24, f4, f14, f13, f17, CCD) |
membrane strip with allergens (EUROLINE) |
IgE IgE |
16 x 01 64 x 01 |
DP 3410-1601-6 E DP 3410-6401-6 E |
||
| EUROLINE |
EUROLINE Food South East Asia 1 (IgE) (f1, f75, f2, f4, f9, f10, f14, f13, f17, f63, f64, f83, fs10, fs14, f23, f24, f80, f234, f105, f336, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3411-1601 E | ||
| EUROLINE |
EUROLINE Food (China 2) (IgE) (f1, f2, f13, f14, f23, f24, fs33, fs34, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3414-1601-2 E | ||
| EUROLINE |
EUROLINE Food Gulf (IgE) (f1, f75, f2, f4, f14, f45, fs36, f13, f33, f44, f92, f93, f25, f31, f48, f83, f88, f3, f24, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3416-1601 E | ||
| EUROLINE |
EUROLINE Food "Turkey 1" (IgE) (f1, f75, f2, f169, f78, f4, f79, f9, f14, f10, f13, f17, f144, u87, f222, f33, f44, f49, f92, f84, f146, f328, f25, f31, f35, f48, f95, f97, f122, f132, fs14, fs10, fs43, f83, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3420-1601-11 E | ||
| EUROLINE |
EUROLINE Food India (IgE) (f1, f2, f360, f75, f4, f9, f14, f13, f36, f49, f50, f35, f38, f48, f244, f83, f89, f240, f23, f24, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3421-1601 E | ||
| EUROLINE |
EUROLINE Food "India 2" (IgE) (f1, f75, f2, f360, f4, f79, f7, f8, f9, f14, f13, f20, fs32, f33, f36, f49, f50, f12, f25, f35, f38, f47, f48, f159, f244, f262, f370, f364, f27, f83, f88, f89, f240, fs81, f3, f23, f24, f371, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3421-1601-2 E | ||
| EUROLINE |
EUROLINE Food "Lebanon 3" (IgE) (f23, f24, f40, f41, fs79, f45, f1, f2, f76, f77, f78, e204, f4, f9, f10, f12, f13, f14, f20, fs39, f44, f49, f84, f95, fs80, f25, f31, f35, f47, f48, f86, f96, f159, f292, fs78, f27, f83, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3423-1601-3 E | ||
| EUROLINE |
EUROLINE Food "Screen South Africa" (IgE) (f1, f2, f4, f13, f14, fs36, f3, fs12, fs58, fs53, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3424-1601 E | ||
| EUROLINE |
EUROLINE Food "Mexico" (IgE) (f1, f75, f2, f78, f95, f96, f44, fs32, f4, f7, f9, f45, f13, f14, f20, fs35, f12, f15, f49, f292, f25, f31, f35, f92, f216, f191, f263, f284, f83, f26, f27, fs27, f24, f40, fs12, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3425-1601 E | ||
| EUROLINE |
EUROLINE Food Dairy and Nuts (IgE) (f1, f2, f75, f78, f13, f17, f20, f144, f158, f256, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3427-1601 E | ||
| EUROLINE |
EUROLINE Food Flour and Meat (IgE) (f4, f5, f7, f9, f26, f27, f83, f79, f3, f24, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3428-1601 E | ||
| EUROLINE |
EUROLINE Food Vegetables (IgE) (f10, f14, f86, f25, f31, f35, f85, f46, f244, f292, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3429-1601 E | ||
| EUROLINE |
EUROLINE Food Fruits (IgE) (f44, f49, f84, f92, f95, f97, f122, f237, f329, fs32, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3430-1601 E | ||
| EUROLINE |
EUROLINE Food "Maghreb" (IgE) (f1, f75, f2, f78, f4, f9, f10, f12, f13, f14, f17, f20, f33, f44, f49, f92, f25, f35, f47, f48, f85, f45, f27, f83, f3, f40, f41, f23, f24, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3431-1601 E | ||
| EUROLINE |
EUROLINE Food 4 (IgE) (f1, f75, f2, f78, f4, f5, f9, fs13, f10, f13, f14, f17, f20, f144, f256, f79, f44, f49, f50, f84, f92, f93, f95, f97, f87, fs32, f25, f35, f46, f47, f85, f262, f83, fs28, f24, fs12, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3432-1601-1 E | ||
| EUROLINE |
EUROLINE Food "Venezuela 1" (IgE) (f1, f232, f233, f75, f2, f76, f77, f78, f105, f4, f5, f6, f7, f9, f14, f292, f79, f13, f17, f20, f256, f3, f24, f37, f40, f41, f308, f155, f45, f25, f31, f35, f32, f33, f44, f49, f72, f92, f26, f27, f83, f81, f205, f218, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3433-1601-1 E | ||
| EUROASSAY |
EUROASSAY Food (IgE) (f1, f75, f2, f78, f45, f4, f5, f9, f14, f10, f13, f17, f20, f84, f95, f237, f25, f31, f35, f85, f3, f23, f49, CCD) |
EUROASSAY strip with allergens |
IgE | DE 3410-1001 E | |||
| ChLIA | IDS Specific IgE (F001) Egg white | allergen |
quantitative |
50 x 01 |
IS-1F0011 | ||
| ChLIA | IDS Specific IgE (F002) Cow's Milk | allergen |
quantitative |
50 x 01 |
IS-1F0021 | ||
| ChLIA | IDS Specific IgE (F003) Fish (cod) | allergen |
quantitative |
50 x 01 |
IS-1F0031 | ||
| ChLIA | IDS Specific IgE (F013) Peanut | allergen |
quantitative |
50 x 01 |
IS-1F0131 | ||
| ChLIA | IDS Specific IgE (F014) Soybean | allergen |
quantitative |
50 x 01 |
IS-1F0141 | ||
| ChLIA | IDS Specific IgE (F017) Hazelnut | allergen |
quantitative |
50 x 01 |
IS-1F0171 | ||
| ChLIA | IDS Specific IgE (F020) Almond | allergen |
quantitative |
50 x 01 |
IS-1F0201 | ||
| ChLIA | IDS Specific IgE (F037) Mussel | allergen |
quantitative |
50 x 01 |
IS-1F0371 | ||
| ChLIA | IDS Specific IgE (F075) Egg yolk | allergen |
quantitative |
50 x 01 |
IS-1F0751 | ||
| ChLIA | IDS Specific IgE (F084) Kiwi | allergen |
quantitative |
50 x 01 |
IS-1F0841 | ||
| ChLIA | IDS Specific IgE (F202) Cashew nut | allergen |
quantitative |
50 x 01 |
IS-1F2021 | ||
| ChLIA | IDS Specific IgE (F203) Pistachio | allergen |
quantitative |
50 x 01 |
IS-1F2031 | ||
| ChLIA | IDS Specific IgE (F245) Hen's Egg | allergen |
quantitative |
50 x 01 |
IS-1F2451 | ||
| ChLIA | IDS Specific IgE (F256) Walnut | allergen |
quantitative |
50 x 01 |
IS-1F2561 | ||
| EUROLINE |
EUROLINE Inhalation (IgE) (g1, g3, g6, g12, t2, t3, t4, t7, w1, w6, w9, d1, d2, e1, e2, e3, m1, m2, m3, m6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE IgE |
16 x 01 64 x 01 |
DP 3110-1601 E DP 3110-6401 E |
||
| EUROLINE |
EUROLINE Inhalation 3 (IgE) (t3, t4, t7, t9, t11, t15, t23, g2, g3, g6, g8, g12, g101, u85, w1, w6, w9, w21, e1, e5, e3, e82, m3, m5, m6, i6, d1, d2, d70, d201, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3110-1601-3 E | ||
| EUROLINE |
EUROLINE Inhalation 6 (IgE) (e1, e2, ds1, gs12, g12, m6, w6, t2, t3, t4, CCD) |
membrane strip with allergens (EUROLINE) |
IgE IgE |
16 x 01 64 x 01 |
DP 3110-1601-6 E DP 3110-6401-6 E |
||
| EUROLINE |
EUROLINE Pediatric Inhalation (IgE) (g6, g12, t2, t3, t4, w6, w8, w9, d1, d2, e1, e2, e3, e6, e82, e84, m1, m2, m3, m6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3111-1601 E | ||
| EUROLINE |
EUROLINE Mediterranean Inhalation (IgE) (g2, g6, t3, t4, t9, t11, t23, t210, w1, w6, w9, w19, d1, d2, d70, e1, e2, e3, m2, m6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3112-1601 E | ||
| EUROLINE |
EUROLINE Mediterranean Inhalation 2 (IgE) (d1, d2, d70, d71, d201, e1, e2, e3, m2, m3, m6, i6, g2, g3, g5, g6, g8, g12, t2, t3, t4, t9, t11, t23, w1, w6, w9, w10, w11, w19, w21, u85, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3112-1601-2 E | ||
| EUROLINE |
EUROLINE Inhalation South East Asia (IgE) (ts19, t19, t223, u85, gs1, ds1, i6, u134, e1, e2, es172, e6, e71, e82, e84, ms1, ms4, m5, m12, m45, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3113-1601 E | ||
| EUROLINE |
EUROLINE Inhalation (China 2) (IgE) (ds1, h1, i6, e1, e2, ms1, ts20, u80, w1, w6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3116-1601-2 E | ||
| EUROLINE |
EUROLINE Inhalation Gulf (IgE) (g6, g12, w1, w6, t2, t3, t7, t9, d1, d2, i6, e1, e2, e3, m1, m2, m3, m5, m6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3118-1601 E | ||
| EUROLINE |
EUROLINE Inhalation "Turkey 1" (IgE) (gs12, gs15, gs21, g12, ts23, ts24, t9, t70, ws19, ws20, d1, d2, i6, es2, es173, e1, e2, e3, e4, e80, e81, e84, m1, m2, m3, m6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3119-1601-11 E | ||
| EUROLINE |
EUROLINE Inhalation India (IgE) (g6, g12, g20, t18, w4, w8, w12, w29, d1, d2, i6, e1, e2, e4, e11, e85, m3, m37, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3120-1601 E | ||
| EUROLINE |
EUROLINE Inhalation "India 2" (IgE) (g2, g6, g10, g12, g20, t18, t20, w6, w7, w8, w10, w12, w13, w14, w29, d1, d2, i6, m1, m2, m3, m4, m5, m6, m37, e1, e2, e11, e85, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3120-1601-2 E | ||
| EUROLINE |
EUROLINE Inhalation "Lebanon 2" (IgE) (g2, g6, g12, g101, w7, w19, w21, ws24, t2, t3, t7, t9, t16, t23, ts32, m1, m2, m3, m5, m6, d1, d2, e1, e2, e3, e85, es170, es173, u85, i1, i3, i6, i71, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3123-1601-2 E | ||
| EUROLINE |
EUROLINE Inhalation "Screen South Africa" (IgE) (ts19, ts29, gs1, ws21, e1, e2, hs12, ms1, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3124-1601 E | ||
| EUROLINE |
EUROLINE Inhalation "Mexico" (IgE) (g2, g5, g6, g10, g14, t3, t7, t19, t210, t20, t14, t15, w1, w4, w6, w8, w10, w11, w14, w15, w100, d1, d2, h1, i6, e1, e2, es4, m1, m2, m3, m5, m6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3126-1601 E | ||
| EUROLINE |
EUROLINE Inhalation "Ukraine 1" (IgE) (d1, d2, e1, e2, e3, e6, e82, e84, t2, t3, t4, t7, g6, g12, w6, w9, m1, m2, m3, m6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3127-1601-1 E | ||
| EUROLINE |
EUROLINE Inhalation Trees (IgE) (t1, t2, t3, t4, t5, t7, t15, t12, t14, t16, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3128-1601 E | ||
| EUROLINE |
EUROLINE Inhalation Grass and Weeds (IgE) (g1, g3, g6, g12, w1, w6, w9, w10, w103, w203, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3129-1601 E | ||
| EUROLINE |
EUROLINE Inhalation Animals (IgE) (e1, e2, e3, e6, e71, e73, e82, e84, es7, es173, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3130-1601 E | ||
| EUROLINE |
EUROLINE Inhalation Indoor allergens (IgE) (ds1, es2, i6, e7, m1, m2, m3, m5, m6, m37, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3131-1601 E | ||
| EUROLINE |
EUROLINE Inhalation "Maghreb" (IgE) (g2, g3, g6, g8, g12, t3, t5, t7, t9, t11, t15, t18, t19, t23, w1, w4, w6, w7, w9, w10, w21, d1, d2, i6, e1, e2, e3, m3, m5, m6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3132-1601 E | ||
| EUROASSAY |
EUROASSAY Inhalation (IgE) (g1, g3, g6, g12, t2, t3, t4, t7, w1, w8, w6, w9, d1, d2, es4, e2, e3, e6, e1, e82, e84, m1, m2, m3, m6, CCD) |
EUROASSAY strip with allergens |
IgE | DE 3110-1001 E | |||
| EUROASSAY |
EUROASSAY Inhalation 2 (IgE) (t3, t4, t15, t2, gx2, g12, d1, w6, w1, d2, e1, e2, m6, m2, t7, t11, t23, g6, i6, d70, w21, w9, d71, e3, u85, d72, m3, m1, CCD) |
EUROASSAY strip with allergens |
IgE | DE 3110-1001-2 E | |||
| ChLIA | IDS Specific IgE (D001) House dust mite | allergen |
quantitative |
50 x 01 |
IS-1D0011 | ||
| ChLIA | IDS Specific IgE (D002) House dust mite | allergen |
quantitative |
50 x 01 |
IS-1D0021 | ||
| ChLIA | IDS Specific IgE (E001) Cat dander | allergen |
quantitative |
50 x 01 |
IS-1E0011 | ||
| ChLIA | IDS Specific IgE (E003) Horse dander | allergen |
quantitative |
50 x 01 |
IS-1E0031 | ||
| ChLIA | IDS Specific IgE (E005) Dog dander | allergen |
quantitative |
50 x 01 |
IS-1E0051 | ||
| ChLIA | IDS Specific IgE (G002) Bermuda grass | allergen |
quantitative |
50 x 01 |
IS-1G0021 | ||
| ChLIA | IDS Specific IgE (G003) Cocksfoot | allergen |
quantitative |
50 x 01 |
IS-1G0031 | ||
| ChLIA | IDS Specific IgE (G004) Meadow fescue | allergen |
quantitative |
50 x 01 |
IS-1G0041 | ||
| ChLIA | IDS Specific IgE (G005) Rye-grass | allergen |
quantitative |
50 x 01 |
IS-1G0051 | ||
| ChLIA | IDS Specific IgE (G006) Timothy grass | allergen |
quantitative |
50 x 01 |
IS-1G0061 | ||
| ChLIA | IDS Specific IgE (G007) Common reed | allergen |
quantitative |
50 x 01 |
IS-1G0071 | ||
| ChLIA | IDS Specific IgE (G008) Meadow grass | allergen |
quantitative |
50 x 01 |
IS-1G0081 | ||
| ChLIA | IDS Specific IgE (G012) Cultivated rye | allergen |
quantitative |
50 x 01 |
IS-1G0121 | ||
| ChLIA | IDS Specific IgE (G013) Velvet grass | allergen |
quantitative |
50 x 01 |
IS-1G0131 | ||
| ChLIA | IDS Specific IgE (G014) Cultivated oat | allergen |
quantitative |
50 x 01 |
IS-1G0141 | ||
| ChLIA | IDS Specific IgE (G015) Cultivated wheat | allergen |
quantitative |
50 x 01 |
IS-1G0151 | ||
| ChLIA | IDS Specific IgE (G201) Barley | allergen |
quantitative |
50 x 01 |
IS-1G2011 | ||
| ChLIA | IDS Specific IgE (GX03) Grass mix 3 | allergen |
quantitative |
50 x 01 |
IS-1GX031 | ||
| ChLIA | IDS Specific IgE (M003) Aspergillus fumigatus | allergen |
quantitative |
50 x 01 |
IS-1M0031 | ||
| ChLIA | IDS Specific IgE (M006) Alternaria alternata | allergen |
quantitative |
50 x 01 |
IS-1M0061 | ||
| ChLIA | IDS Specific IgE (T002) Alder | allergen |
quantitative |
50 x 01 |
IS-1T0021 | ||
| ChLIA | IDS Specific IgE (T003) Common silver birch | allergen |
quantitative |
50 x 01 |
IS-1T0031 | ||
| ChLIA | IDS Specific IgE (T004) Hazel | allergen |
quantitative |
50 x 01 |
IS-1T0041 | ||
| ChLIA | IDS Specific IgE (T009) Olive | allergen |
quantitative |
50 x 01 |
IS-1T0091 | ||
| ChLIA | IDS Specific IgE (T025) European ash | allergen |
quantitative |
50 x 01 |
IS-1T0251 | ||
| ChLIA | IDS Specific IgE (W001) Common ragweed | allergen |
quantitative |
50 x 01 |
IS-1W0011 | ||
| ChLIA | IDS Specific IgE (W006) Mugwort | allergen |
quantitative |
50 x 01 |
IS-1W0061 | ||
| ChLIA | IDS Specific IgE (W009) Plantain | allergen |
quantitative |
50 x 01 |
IS-1W0091 | ||
| ChLIA | IDS Specific IgE (I001) Honey bee | allergen |
quantitative |
50 x 01 |
IS-1I0011 | ||
| ChLIA | IDS Specific IgE (I003) Wasp | allergen |
quantitative |
50 x 01 |
IS-1I0031 | ||
| EUROLINE |
EUROLINE Atopy "Chile 1" (IgE) (d1, d2, e1, e2, es2, g2, g4, g5, m2, m3, m6, t11, t14, t15, t19, w9, w100, f1, f75, f78, f2, f40, f41, fs12, f4, f9, f13, f14, f25, f33, f49, f92, f83, f96, f292,CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3702-1601-1 E | ||
| EUROLINE |
EUROLINE Atopy "Chile 2" (IgE) (d1, d2, e1, e2, es2, gs2, m5, i6, t1, t7, t11, t14, t19, ts30, ws23, f1, f2, f4, f6, f7, f13, f17, f36, f256, f14, f74, f105, f292, f26, f27, f83, f88, f3, f40, f41, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3702-1601-2 E | ||
| EUROLINE |
EUROLINE Atopy "Venezuela 1" (IgE) (f1, f75, f3, f24, f40, f308, f4, f5, f6, f7, f9, f14, f292, f79, f13, f17, f20, f2, f76, f77, f78, f105, f218, f25, f32, f33, f44, f49, f72, f26, f27, f83, f155, f45, u85, d1, d2, d201, e1, e2, e85, m1, m2, m3, m5, m6, g2, w8, i1, i3, i70, i71, i100, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3704-1601-1 E | ||
| EUROLINE |
EUROLINE Atopy "Caribbean 1" (IgE) (g6, g12, t3, t20, w6, e1, e2, e3, d1, m2, m6, f1, f2, f26, f79, f4, f9, f14, f13, f31, f35, f292, f49, f3, f24, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3706-1601-1 E | ||
| EUROLINE |
EUROLINE Atopy "Indonesia 1" (IgE) (g2, g6, gs1, t19, t223, u85, d1, d2, d4, d72, d73, d201, e1, e2, e3, e204, es2, u134, i1, i6, m5, ms1, f4, f79, f13, f14, f17, f20, f45, f336, f1, f2, f76, f77, f78, fs10, f3, f40, f41, f23, f24, f80, f157, f63, f64, f83, f88, f81, f25, f47, f44, f84, f74, f105, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3707-1601-1 E | ||
| EUROLINE |
EUROLINE Atopy "Thailand 1" (IgE) (g2, g6, g10, e1, e2, e84, d1, d2, i6, i100, m2, m3, m6, u85, f1, f75, f2, f3, f23, f24, f41, f177, f234, f258, f232, f233, f76, f77, f78, f4, f79, f13, f423, f427, f14, f36, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3709-1601-1 E | ||
| EUROLINE |
EUROLINE Atopy "Thailand 2" (IgE) (d1, d2, e1, e2, e71, e82, e84, e85, e86, u81, u85, g2, g6, g10, t18, t19, i6, i100, m1, m2, m3, m6, f1, f75, f2, f4, f10, f13, f14, f20, f158, f31, f35, f45, f336, f23, f24, f234, f40, f41, f3, f436, f324, f37, f258, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3709-1601-2 E | ||
| EUROLINE |
EUROLINE Atopy (IgE) (g6, g12, t3, w6, d1, e1, e2, e3, m2, m6, f1, f2, f3, f4, f9, f14, f17, f31, f35, f49, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3710-1601 E | ||
| EUROLINE |
EUROLINE Atopy 4 (IgE) (f13, f17, f12, f14, f4, f85, f96, f26, f3, f24, f1, f2, f49, f84, f95, t3, t7, t9, t11, t15, t23, g6, w1, w6, w9, w21, e1, e5, m3, m6, d1, d2, i6, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3710-1601-4 E | ||
| EUROLINE |
EUROLINE Pediatrics (IgE) (gx, t3, w6, d1, d2, e1, e2, e3, m2, m3, m6, f1, f75, f2, f3, f76, f77, f78, e204, f4, f9, f14, f13, f17, f31, f35, f49, CCD) |
membrane strip with allergens (EUROLINE) |
IgE IgE |
16 x 01 64 x 01 |
DP 3712-1601 E DP 3712-6401 E |
||
| EUROLINE |
EUROLINE Atopy China (IgE) (ts20, w1, w6, ds1, h1, e1, e2, i6, ms1, u80, f1, f2, f13, f14, f27, f88, fs33, f24, f23, CCD) |
membrane strip with allergens (EUROLINE) |
IgE IgE |
16 x 01 64 x 01 |
DP 3713-1601 E DP 3713-6401 E |
||
| EUROLINE |
EUROLINE Atopy (China 5) (IgE) (ds1, h1, i6, e1, e2, ms1, w1, w6, f1, f2, f13, f14, f23, f24, fs33, u80, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3713-1601-5 E | ||
| EUROLINE |
EUROLINE Atopy (Peru) (IgE) (e1, e2, e3, e11, e82, e84, es173, i1, i3, i6, m1, m2, m3, m6, t18, u85, w29, d1, d2, f75, f79, f1, f2, f23, f206, f13, f14, f104, f26, fs32, f44, f49, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3716-1601 E | ||
| EUROLINE |
EUROLINE Atopy "Lithuania" (IgE) (w6, w9, w103, w203, t3, t4, t11, g6, gs21, e1, e2, e3, e4, e82, es2, ds1, ms1, m5, f245, f2, f81, f13, f14, f17, f256, f4, f12, f15, f44, fs32, f26, f27, f83, f49, f3, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3718-1601 E | ||
| EUROLINE |
EUROLINE Atopy "Latin America 1" (IgE) (d1, d2, d201, h1, i71, i100, m1, m2, m3, m5, m6, g2, g6, t3, ts26, ws23, e1, e2, e3, f4, f6, f7, f9, f104, f1, f75, f3, f40, f41, f2, f78, f77, f76, f23, f24, f25, f31, f35, f96, f14, f13, f256, f26, f27, f83, f33, f44, f49, f72, f84, f92, f93, f95, f329, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3725-1601-1 E | ||
| EUROLINE |
EUROLINE Atopy Screen (IgE) (d1, d2, i1, i3, i6, h1, e1, e2, e3, m1, m2, m3, m6, g1, g3, g6, g12, t2, t3, t4, t7, t23, w1, w6, w9, u85, f25, f31, f35, f85, f1, f75, f2, f3, f23, f24, e204, f76, f77, f78, f27, f88, f45, f4, f5, f9, f14, f10, f13, f17, f20, f49, f84, f237, CCD) |
membrane strip with allergens (EUROLINE) |
IgE |
16 x 01 |
DP 3790-1601 E | ||
| EUROASSAY |
EUROASSAY Pediatrics / Atopy (IgE) (g6, g12, t3, w6, d1, d2, e1, e2, e3, m2, m3, m6, f1, f75, f3, f2, f76, f77, f78, e204, f4, f9, f14, f13, f17, f31, f35, f49, CCD) |
EUROASSAY strip with allergens |
IgE | DE 3712-1001 E | |||
| EUROASSAY |
EUROASSAY Pediatrics / Atopy 2 (IgE) (t3, t4, t15, t2, gx2, g12, d1, w6, w1, d2, e1, e2, m6, m2, f1, f13, f5, f2, f14, f4, f25, f85, f31, f33, f92, f49, f17, f3, CCD) |
EUROASSAY strip with allergens |
IgE | DE 3712-1001-2 E | |||
| ChLIA | IDS Specific IgE (K082) Latex | allergen |
quantitative |
50 x 01 |
IS-1K0821 | ||
| ELISA |
beta-amyloid (1-40) determination in CSF |
human | 0-900 pg/ml |
96 x 01 |
EQ 6511-9601-L | ||
| ELISA |
beta-amyloid (1-42) determination in CSF |
human | 0-1800 pg/ml |
96 x 01 |
EQ 6521-9601-L | ||
| ELISA |
total tau determination in CSF |
human | 0-1500 pg/ml |
96 x 01 |
EQ 6531-9601-L | ||
| ELISA |
pTau(181) determination in CSF |
human | 0-200 pg/ml |
96 x 01 |
EQ 6591-9601-L | ||
| ChLIA |
Beta-Amyloid (1-40) ChLIA Sample type: CSF |
Antibody-coated magnetic particles | human |
quantitative |
100 x 1 |
LQ 6511-10010-L | |
| ChLIA |
Beta-Amyloid (1-42) ChLIA Sample type: CSF |
Antibody-coated magnetic particles | human |
quantitative |
100 x 1 |
LQ 6521-10010-L | |
| ChLIA |
Total-tau ChLIA Sample type: CSF |
Antibody-coated magnetic particles | total tau protein |
quantitative |
100 x 1 |
LQ 6531-10010-L | |
| ChLIA |
pTau(181) ChLIA Sample type: CSF |
Antibody-coated magnetic particles | phosphorylated tau protein |
quantitative |
100 x 1 |
LQ 6591-10010-L | |
| ChLIA | Control set Beta-Amyloid (1-40) ChLIA | 2 x 0.5 ml control 1/2 | human |
02 x 02 |
LR 6511-20210-L | ||
| ChLIA | Control set Beta-Amyloid (1-42) ChLIA | 2 x 0.5 ml control 1/2 | human |
02 x 02 |
LR 6521-20210-L | ||
| ChLIA | Control set Total-tau ChLIA | 2 x 0.5 ml control 1/2 |
02 x 02 |
LR 6531-20210-L | |||
| ChLIA | Control set pTau(181) ChLIA | 2 x 0.5 ml control 1/2 |
02 x 02 |
LR 6591-20210-L | |||
| ELISA |
beta-amyloid (1-40) determination in plasma |
human | 0-75 pg/ml |
96 x 01 |
EQ 6511-9601* | ||
| ELISA |
beta-amyloid (1-42) determination in plasma |
human | 0-40 pg/ml |
96 x 01 |
EQ 6521-9601* | ||
| ELISA |
BACE-1 determination in CSF |
human | 0-12000 pg/ml |
96 x 01 |
EQ 6541-9601-L* | ||
| ELISA |
alpha-synuclein determination in CSF |
human | 0-6000 pg/ml |
96 x 01 |
EQ 6545-9601-L* | ||
| ELISA |
neurogranin determination in CSF |
human | 0-1300 pg/ml |
96 x 01 |
EQ 6551-9601-L* | ||
| ELISA |
Neurofilament Light (NfL) determination in CSF |
antibody-coated microplate wells |
neurofilament light chain |
10.8 pg/ml – 12,000 pg/ml (lot dependent) |
96 x 01 |
EQ 6563-9601-L | |
| ELISA |
neurofilament (pNf-H) determination in CSF and serum |
human | 0/0,125/0,5/2/5/10 ng/ml |
96 x 01 |
EQ 6561-9601 | ||
| ELISA |
neurofilament (pNf-H) highly sensitive determination in serum and plasma |
human | 0/20/50/200/500/1000 pg/ml |
96 x 01 |
EQ 6562-9601 | ||
| ChLIA | IDS ACE | enzymatic FAPGG assay |
quantitative |
100 x 01 |
IS-59001 | ||
| IIFT |
renal glomeruli (GBM) and renal tubuli |
kidney | monkey | IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1250-1005 FA 1250-1010 FB 1250-1005 FB 1250-1010 |
|
| IIFT |
EUROPLUS kidney glomeruli and tubuli glomerular basement membrane (GBM) |
2 BIOCHIPs per field: kidney GBM BIOCHIPs |
monkey |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1250-1005-1 FA 1250-1010-1 FB 1250-1005-1 FB 1250-1010-1 |
|
| IIFT |
Nephrology Screen (KM) EUROPattern renal glomeruli (GBM) |
kidney |
monkey |
IgG |
20 x 05 |
FC 1250-2005 | |
| IIFT |
EUROPLUS Nephrology Screen 1 EUROPattern Renal glomeruli (GBM) glomerular basement membrane (GBM) |
2 BIOCHIPs per field kidney GBM-EUROPLUS |
monkey |
IgG |
20 x 05 |
FC 1250-2005-1 | |
| ELISA |
Anti-GBM ELISA (IgG) glomerular basement membrane |
antigen-coated microplate wells |
alpha-3 chain of type IV collagen, incl. NC1 domain, from bovine kidney |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1251-9601 G |
| ChLIA | IDS GBM | antigenic coated magnetic particles | NC1?3(IV) |
quantitative |
50 x 01 |
IS-AI17031 | |
| ChLIA | Anti-GBM ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
100 x 1 |
LA 1251-10010 G | |
| ChLIA | Control set Anti-GBM ChLIA (IgG) | 2 x 0.4 ml control 1/2 | IgG |
02 x 02 |
LR 1251-20210 G | ||
| EUROLINE |
EUROLINE Anti-MPO, -PR3 and -GBM (IgG) myeloperoxidase proteinase 3 (PR3) glomerular basement membrane |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1200-1601-3 G DL 1200-6401-3 G |
||
| ChLIA | IDS ANCA/GBM Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI17301 | ||
| ELISA | Anti-Cardiolipin ELISA (IgA) |
antigen-coated microplate wells |
native, bovine heart |
2/12/120 PL IgA U/ml |
IgA |
96 x 01 |
EA 1621-9601 A |
| ELISA | Anti-Cardiolipin ELISA (IgG) |
antigen-coated microplate wells |
native, bovine heart |
2/12/120 PL IgG U/ml |
IgG |
96 x 01 |
EA 1621-9601 G |
| ELISA | Anti-Cardiolipin ELISA (IgM) |
antigen-coated microplate wells |
native, bovine heart |
2/12/120 PL IgM U/ml |
IgM |
96 x 01 |
EA 1621-9601 M |
| ELISA | Anti-Cardiolipin ELISA (IgAGM) |
antigen-coated microplate wells |
native, bovine heart |
2/12/120 RU/ml | IgAGM |
96 x 01 |
EA 1621-9601 P |
| ELISA | Anti-Phosphatidylserine ELISA (IgA) |
antigen-coated microplate wells |
native, bovine brain |
2/12/120 RU/ml | IgA |
96 x 01 |
EA 162a-9601 A |
| ELISA | Anti-Phosphatidylserine ELISA (IgG) |
antigen-coated microplate wells |
native, bovine brain |
2/12/120 RU/ml | IgG |
96 x 01 |
EA 162a-9601 G |
| ELISA | Anti-Phosphatidylserine ELISA (IgM) |
antigen-coated microplate wells |
native, bovine brain |
2/12/120 RU/ml | IgM |
96 x 01 |
EA 162a-9601 M |
| ELISA | Anti-Phosphatidylserine ELISA (IgAGM) |
antigen-coated microplate wells |
native, bovine brain |
2/12/120 RU/ml | IgAGM |
96 x 01 |
EA 162a-9601 P |
| ELISA | Anti-ß2-Glycoprotein 1 ELISA (IgA) |
antigen-coated microplate wells |
native, human serum |
2/20/200 RU/ml | IgA |
96 x 01 |
EA 1632-9601 A |
| ELISA | Anti-ß2-Glycoprotein 1 ELISA (IgG) |
antigen-coated microplate wells |
native, human serum |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1632-9601 G |
| ELISA | Anti-ß2-Glycoprotein 1 ELISA (IgM) |
antigen-coated microplate wells |
native, human serum |
2/20/200 RU/ml | IgM |
96 x 01 |
EA 1632-9601 M |
| ELISA | Anti-ß2-Glycoprotein 1 ELISA (IgAGM) |
antigen-coated microplate wells |
native, human serum |
2/20/200 RU/ml | IgAGM |
96 x 01 |
EA 1632-9601 P |
| ChLIA | IDS Cardiolipin IgG | antigenic coated magnetic particles | Cardiolipin/ß2-Glycoprotein I complex |
quantitative |
100 x 01 |
IS-AI15011 | |
| ChLIA | IDS B2-Glycoprotein I IgG | antigenic coated magnetic particles | ß2-glycoprotein I |
quantitative |
100 x 01 |
IS-AI15021 | |
| ChLIA | IDS APS IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI15301 | ||
| ChLIA | IDS Cardiolipin IgM | antigenic coated magnetic particles | Cardiolipin/ß2-Glycoprotein I complex |
quantitative |
100 x 01 |
IS-AI16011 | |
| ChLIA | IDS B2-Glycoprotein I IgM | antigenic coated magnetic particles | ß2-glycoprotein I |
quantitative |
100 x 01 |
IS-AI16021 | |
| ChLIA | IDS APS IgM Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI16301 | ||
| IIFT | laminin 332 (LAM332) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG+IgG4 |
10 x 05 |
FA 150b-1005-50 | |
| IIFT |
antibodies against epidermis: desmosomes (pemphigus vulgaris control) |
IgG |
05 x 02 |
CA 1501-0502 | |||
| IIFT |
antibodies against epidermis: basement membrane (bullous pemphigoid control) |
IgG |
05 x 02 |
CA 1502-0502 | |||
| IIFT |
epidermis: prickle cell desmosomes epidermal basement membrane |
oesophagus | monkey | IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1501-1005 FA 1501-1010 FA 1501-2005 FB 1501-1005 FB 1501-1010 FB 1501-2005 |
|
| IIFT |
Dermatology Mosaic 20 epidermis pemphigoid antigens |
2 BIOCHIPs per field: oesophagus salt-split skin |
monkey monkey |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 |
FA 1501-1005-20 FA 1501-1010-20 FA 1501-2005-20 FB 1501-1005-20 FB 1501-1010-20 |
|
| IIFT |
Dermatology Mosaic 7 epidermis pemphigoid antigens BP230gC desmoglein 1 desmoglein 3 BP180-NC16A-4X |
6 BIOCHIPs per field: oesophagus salt-split skin transfected cells transfected cells transfected cells BP180-NC16A-4X BIOCHIPs |
monkey monkey EU 90 EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1501-1005-7 FA 1501-1010-7 FB 1501-1005-7 FB 1501-1010-7 |
|
| IIFT |
Dermatology Screen (EM) EUROPattern epidermis: prickle cell desmosomes epidermal basement membrane |
oesophagus |
monkey |
IgG+IgG4 IgG+IgG4 IgG+IgG4 |
10 x 05 10 x 10 20 x 05 |
FC 1501-1005 FC 1501-1010 FC 1501-2005 |
|
| IIFT |
EUROPLUS Dermatology Mosaic 7 EUROPattern epidermis pemphigoid antigens BP230gC desmoglein 1 desmoglein 3 BP180-NC16A-4X |
6 BIOCHIPs per field: oesophagus salt-split skin transfected cells transfected cells transfected cells BP180-NC16A-4X EUROPLUS |
monkey monkey EU 90 EU 90 EU 90 |
IgG+IgG4 IgG+IgG4 IgG+IgG4 IgG+IgG4 |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1501-1005-7 FC 1501-1010-7 FC 1501-2005-7 FC 1501-2010-7 |
|
| IIFT |
Dermatology Mosaic 20 EUROPattern epidermis pemphigoid antigens |
2 BIOCHIPs per field: oesophagus salt-split skin |
monkey monkey |
IgG+IgG4 IgG+IgG4 IgG+IgG4 |
10 x 10 20 x 05 20 x 10 |
FC 1501-1010-20 FC 1501-2005-20 FC 1501-2010-20 |
|
| ELISA |
Dermatology Profile ELISA (IgG) (DerBP180-NC16A-4X, BP230-CF, desmoglein 1, desmoglein 3, envoplakin, collagen type VII separately) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
12 x 08 |
EA 1490-1208-1 G |
| ELISA | Anti-Envoplakin ELISA (IgG) |
antigen-coated microplate wells |
recombinant, expression in E. coli |
semi-quantitative | IgG |
48 x 01 |
EA 1491-4801 G |
| ELISA | Anti-Desmoglein 1 ELISA (IgG) |
antigen-coated microplate wells |
recombinant, expression in mammalian cells, extracellular domain |
2/20/200 RU/ml | IgG |
48 x 01 |
EA 1495-4801 G |
| ELISA | Anti-Desmoglein 1 ELISA 2.0 (IgG) | semi-quantitative | IgG |
96 x 01 |
EA 1495-9601-2 G | ||
| ELISA | Anti-Desmoglein 3 ELISA (IgG) |
antigen-coated microplate wells |
recombinant, expression in mammalian cells, extracellular domain |
2/20/200 RU/ml | IgG |
48 x 01 |
EA 1496-4801 G |
| ELISA | Anti-Desmoglein 3 ELISA 2.0 (IgG) | semi-quantitative | IgG |
96 x 01 |
EA 1496-9601-2 G | ||
| ELISA | Anti-BP230-CF ELISA (IgG) |
antigen-coated microplate wells |
recombinant, expression in E. coli | 2/20/200 RU/ml | IgG |
48 x 01 |
EA 1502-4801-1 G |
| ELISA | Anti-BP180-NC16A-4X ELISA (IgG) |
antigen-coated microplate wells |
recombinant, expression in E. coli, tetramer of the NC16A domain |
2/20/200 RU/ml | IgG |
48 x 01 |
EA 1502-4801-2 G |
| ELISA | Anti-BP230-CF ELISA 2.0 (IgG) | semi-quantitative | IgG |
96 x 01 |
EA 1502-9601-5 G | ||
| ELISA | Anti-BP180-NC16A-4X ELISA 2.0 (IgG) | semi-quantitative | IgG |
96 x 01 |
EA 1502-9601-6 G | ||
| ELISA | Anti-Collagen type VII ELISA (IgG) |
antigen-coated microplate wells |
recombinant collagen type VII, human c-DNA expressed in human cell line |
2/20/200 RU/ml | IgG |
48 x 01 |
EA 1947-4801 G |
| IIFT |
antibodies against pancreas islets (islet cell ab control) |
IgG |
05 x 02 |
CA 1021-0502 | |||
| IIFT | pancreas islets | pancreas | monkey | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1020-1005 FA 1020-1010 FA 1020-2005 FA 1020-2010 FB 1020-1005 FB 1020-1010 FB 1020-2005 FB 1020-2010 |
|
| IIFT |
pancreas islets, GAD (brain: grey matter) |
pancreas cerebellum (2 BIOCHIPs per field) |
monkey monkey |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1020-1005-3 FA 1020-1010-3 FA 1020-2005-3 FA 1020-2010-3 |
|
| IIFT |
islet cells antibodies (PM) EUROPattern pancreas islets |
1 BIOCHIP per field: pancreas |
monkey |
IgG IgG |
20 x 05 20 x 10 |
FC 1020-2005 FC 1020-2010 |
|
| ELISA | Anti-IA2 ELISA |
antigen-coated microplate wells |
96 x 01 |
EA 1023-9601-2 | |||
| ELISA | Anti-Zinc Transporter 8 ELISA | antigen-coated microplate wells | 10/20/75/500/2000 RU/ml |
96 x 01 |
EA 1027-9601 | ||
| ELISA | Anti-GAD ELISA |
antigen-coated microplate wells |
96 x 01 |
EA 1022-9601-2 | |||
| IIFT | antibodies against glutamate receptor (type NMDA) | IgG |
05 x 02 |
CA 112d-0502 | |||
| IIFT | antibodies against GABA B receptor | IgG |
05 x 02 |
CA 112l-0502 | |||
| IIFT |
antibodies against dipeptidyl aminopeptidase-like protein 6 (DPPX ab control) |
IgG |
05 x 02 |
CA 112m-0502 | |||
| IIFT |
RC-IIFT Neurology Mosaic 14A glutamate receptor (type NMDA) contactin-associated protein 2 (CASPR2) IgLON family member 5 (IgLON5) dipeptidyl aminopeptidase-like protein 6 (DPPX) leucine-rich glioma-inactivated protein 1 (LGI1) GABA B receptor |
6 BIOCHIPs per field: transfected cells transfected cells transfected cells transfected cells transfected cells transfected cells |
EU 90 EU 90 EU 90 EU 90 EU 90 EU 90 |
IgG |
10 x 05 |
FA 112d-1005-14 | |
| IIFT | glutamate receptor (type NMDA) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 112d-1005-51 FA 112d-1010-51 FB 112d-1005-51 FB 112d-1010-51 |
|
| IIFT |
Autoimmune Encephalitis Mosaic 6 glutamate receptor (type NMDA) contactin-associated protein 2 (CASPR2) glutamate receptors (type AMPA1/2) leucine-rich glioma-inactivated protein 1 (LGI1) dipeptidyl aminopeptidase-like protein 6 (DPPX) GABA B receptor |
6 BIOCHIPs per field: transfected cells transfected cells transfected cells transfected cells transfected cells transfected cells |
EU 90 EU 90 EU 90 EU 90 EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 10 x 05 |
FA 112d-1005-6 FA 112d-1010-6 FB 112d-1005-6 |
|
| IIFT | Glutamate Receptor (Type AMPA1/2) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 05 |
FA 112k-1005-53 | |
| IIFT | GABA B receptor |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 05 10 x 05 |
FA 112l-1005-50 FB 112l-1005-50 |
|
| IIFT |
dipeptidyl aminopeptidase-like protein 6 (DPPX) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 05 |
FA 112m-1005-50 | |
| IIFT | glutamate receptor (type NMDA) EUROPattern |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 |
FC 112d-1005-51 FC 112d-1010-51 FC 112d-12010-51 FC 112d-2005-51 FC 112d-2010-51 |
|
| IIFT |
Autoimmune Encephalitis Mosaic 6 EUROPattern glutamate receptor (type NMDA) contactin-associated protein 2 (CASPR2) glutamate receptors (type AMPA1/2) leucine-rich glioma-inactivated protein 1 (LGI1) dipeptidyl aminopeptidase-like protein 6 (DPPX) GABA B receptor |
6 BIOCHIPs per field: transfected cells transfected cells transfected cells transfected cells transfected cells transfected cells |
EU 90 EU 90 EU 90 EU 90 EU 90 EU 90 |
IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 112d-1005-6 FC 112d-1010-6 FC 112d-2005-6 FC 112d-2010-6 |
|
| IIFT |
dipeptidyl aminopeptidase-like protein 6 (DPPX) EUROPattern |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG PI |
20 x 05 |
FC 112m-2005-50 | |
| IIFT |
antibodies against IgLON family member 5 (IgLON5) |
IgG |
05 x 02 |
CA 1151-0502 | |||
| IIFT |
antibodies against leucine-rich glioma-inactivated protein 1 (LGI1 ab control) |
IgG |
05 x 02 |
CA 1439-0502-1 | |||
| IIFT |
antibodies against contactin-associated protein 2 (CASPR2 ab control) |
IgG |
05 x 02 |
CA 1439-0502-2 | |||
| IIFT | IgLON family member 5 (IgLON5) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 05 |
FA 1151-1005-50 | |
| IIFT |
Anti-VGKC-Ass. Proteins Mosaic 1 leucine-rich glioma-inact. prot. 1 (LGI1) contactin-associated protein 2 (CASPR2) |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG |
10 x 05 10 x 05 |
FA 1439-1005-1 FB 1439-1005-1 |
|
| IIFT | contactin-associated protein 2 (CASPR2) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 05 |
FA 1439-1005-50 | |
| IIFT | leucine-rich glioma-inactivated protein 1 (LGI1) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 05 |
FA 1439-1005-51 | |
| IIFT |
Anti-VGKC-Ass. Proteins Mosaic 1 EUROPattern leucine-rich glioma-inact. prot. 1 (LGI1) contactin-associated protein 2 (CASPR2) |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG PI IgG PI |
10 x 05 120 x 10 |
FC 1439-1005-1 FC 1439-12010-1 |
|
| EUROLINE |
EUROLINE Autoimmune Gastrointestinal Diseases (IgA) (tissue transglutaminase (endomysium), gliadin-analogue fusion peptide (GAF-3X), mannan (ASCA)) |
EUROLINE | IgA IgA IgA |
05 x 10 16 x 01 64 x 01 |
DL 1360-0510 A DL 1360-1601 A DL 1360-6401 A |
||
| EUROLINE |
EUROLINE Autoimmune Gastrointestinal Diseases (IgG) (tissue transglutaminase (endomysium), gliadin-analogue fusion peptide (GAF-3X), parietal cell antigen (PCA) separately Intrinsic factor, mannan (ASCA)) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1360-1601 G DL 1360-5001 G DL 1360-6401 G |
||
| IIFT |
antibodies against parietal cells (PCA control) |
IgG |
05 x 02 |
CA 1361-0502 | |||
| IIFT |
antibodies against parietal cells + intrinsic factor (PCA + intrinsic factor ab control) |
IgG |
05 x 02 |
CA 1363-0502 | |||
| IIFT |
parietal cells (PCA) |
stomach | monkey | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1360-1005 FA 1360-1010 FA 1360-2005 FA 1360-2010 FB 1360-1005 FB 1360-1010 FB 1360-2005 FB 1360-2010 |
|
| IIFT | intrinsic factor | intrinsic factor BIOCHIPs | IgG |
10 x 05 10 x 05 |
FA 1362-1005 FB 1362-1005 |
||
| IIFT |
EUROPLUS parietal cells (PCA) intrinsic factor |
2 BIOCHIPs per field: stomach intrinsic factor BIOCHIPs |
monkey |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1362-1005-1 FA 1362-1010-1 FA 1362-2005-1 FB 1362-1005-1 FB 1362-1010-1 FB 1362-2005-1 |
|
| IIFT | Anti-Parietal cells (SM) IIFT EUROPattern | stomach | monkey | IgG IgG |
20 x 05 20 x 10 |
FC 1360-2005 FC 1360-2010 |
|
| ELISA |
Anti-PCA ELISA (IgG) parietal cells |
antigen-coated microplate wells |
native, H+/K+ ATPase, porcine gastric mucosa |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1361-9601 G |
| ELISA | Anti-ATP4B ELISA (IgG) |
antigen-coated microplate wells |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1361-9601-1 G | |
| ELISA | Anti-Intrinsic Factor ELISA (IgG) |
antigen-coated microplate wells |
native, porcine gastric mucosa |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1362-9601 G |
| IIFT | cell nuclei (ANA) |
HEp-2 cells (1 BIOCHIP per field) |
human | IgG IgG IgG IgG |
10 x 50 120 x 10 20 x 05 20 x 10 |
FA 1520-1050-R FA 1520-12010-R FA 1520-2005-R FA 1520-2010-R |
|
| IIFT | cell nuclei (ANA) |
HEp-20-10 cells (1 BIOCHIP per field) |
human | IgG IgG IgG IgG |
10 x 50 120 x 10 20 x 05 20 x 10 |
FA 1522-1050-R FA 1522-12010-R FA 1522-2005-R FA 1522-2010-R |
|
| IIFT |
antibodies against liver-kidney microsomes (LKM ab control) |
IgG |
05 x 02 |
CA 1320-0502 | |||
| IIFT | antibodies against F-actin | IgG |
05 x 02 |
CA 1651-0502 | |||
| IIFT |
antibodies against smooth muscles (ASMA control) |
IgG |
05 x 02 |
CA 1710-0502 | |||
| IIFT |
soluble liver antigen/ liver-pancreas antigen (SLA/LP) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 |
FA 1302-1005-50 FA 1302-1010-50 |
|
| IIFT | F-actin | VSM47 | rat | IgG IgG |
10 x 05 10 x 10 |
FA 1651-1005 FA 1651-1010 |
|
| IIFT |
smooth muscles (ASMA) |
stomach | rat | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1710-1005 FA 1710-1010 FA 1710-2005 FA 1710-2010 FB 1710-1005 FB 1710-1010 FB 1710-2005 FB 1710-2010 |
|
| IIFT |
smooth muscles (ASMA) F-actin |
stomach VSM47 (2 BIOCHIPs per field) |
rat rat |
IgG IgG |
10 x 05 20 x 10 10 x 05 |
FA 1710-1005-1 FA 1710-2010-1 FB 1710-1005-1 |
|
| IIFT | F-actin EUROPattern | VSM47 | rat | IgG PI IgG PI |
10 x 05 10 x 10 |
FC 1651-1005 FC 1651-1010 |
|
| ELISA |
Anti-SLA/LP ELISA (IgG) soluble liver antigen/ liver-pancreas antigen |
antigen-coated microplate wells |
recombinant SLA/LP expression in E. coli |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1302-9601 G |
| ELISA |
Anti-LC-1 ELISA (IgG) cytosolic liver antigen type 1 |
antigen-coated microplate wells |
recombinant formiminotransferase cyclodeaminase, expression with baculovirus vector in insect cells |
semi-quantitative | IgG |
96 x 01 |
EA 1307-9601 G |
| ELISA |
Anti-LKM-1 ELISA (IgG) liver-kidney microsomes |
antigen-coated microplate wells |
recombinant cytochrome P450 IID6 |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1321-9601 G |
| IIFT |
Liver Mosaic 1 liver-kidney microsomes (LKM), ANA mitochondria (AMA), LKM |
2 BIOCHIPs per field: liver kidney |
rat rat |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1300-1005-1 FA 1300-1010-1 FA 1300-2005-1 FB 1300-1005-1 FB 1300-1010-1 FB 1300-2005-1 |
|
| IIFT |
Liver Screen 1 mitochondria (AMA), LKM soluble liver antigen/ liver-pancreas antigen (SLA/LP) LKM, ANA smooth muscles (ASMA) |
4 BIOCHIPs per field: kidney transfected cells liver stomach |
rat EU 90 rat rat |
IgG IgG |
10 x 05 10 x 10 |
FA 1300-1005-21 FA 1300-1010-21 |
|
| IIFT |
Liver Mosaic 8 liver antigens, cell nuclei (ANA) F-actin cell nuclei (ANA) LKM, ANA mitochondria (AMA), LKM smooth muscles (ASMA) |
6 BIOCHIPs per field: liver VSM47 HEp-2 cells liver kidney stomach |
monkey rat human rat rat rat |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1300-1005-8 FA 1300-1010-8 FA 1300-2005-8 FB 1300-1005-8 FB 1300-1010-8 FB 1300-2005-8 |
|
| IIFT |
Liver Mosaic 9 mitochondria (AMA), LKM LKM, ANA smooth muscles (ASMA) F-actin |
4 BIOCHIPs per field: kidney liver stomach VSM47 |
rat rat rat rat |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1300-1005-9 FA 1300-1010-9 FB 1300-1005-9 FB 1300-1010-9 |
|
| IIFT |
Autoimmune liver diseases Screen 9 EUROPattern mitochondria (AMA), LKM LKM, ANA smooth muscles (ASMA) F-actin |
4 BIOCHIPs per field: kidney liver stomach VSM47 |
rat rat rat rat |
IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1300-1005-9 FC 1300-1010-9 FC 1300-2005-9 FC 1300-2010-9 |
|
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1300-X G |
IgG |
05 x 07 |
CL 1300-0507 G | |||
| EUROLINE |
EUROLINE Liver Profile 2 (IgG) (AMA M2, M2-3E, LKM-1, LC-1, SLA/LP separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1300-1601-2 G DL 1300-6401-2 G |
||
| EUROLINE |
EUROLINE Liver Profile (IgG) (AMA M2, LKM-1, LC-1, SLA/LP separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1300-1601-3 G DL 1300-6401-3 G |
||
| EUROLINE |
EUROLINE Autoimmune Liver Diseases (IgG) (AMA M2, M2-3E, Sp100, PML, gp210, LKM-1, LC-1, SLA/LP, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1300-1601-4 G DL 1300-5001-4 G DL 1300-6401-4 G |
||
| EUROLINE |
EUROLINE Autoimmune Liver Diseases 14 Ag (IgG) (AMA-M2, M2-3E, Sp100, PML, gp210, LKM-1, LC-1, SLA/LP, SS-A, Ro-52, Scl-70, CENP A, CENP B, PGDH separately) |
EUROLINE | IgG IgG |
16 x 01 50 x 01 |
DL 1300-1601-5 G DL 1300-5001-5 G |
||
| EUROLINE |
EUROLINE Autoimmune Liver Diseases 9 Ag plus F-Actin (IgG) (AMA-M2, M2-3E, Sp100, PML, gp210, LKM-1, LC-1, SLA/LP, F-Aktin und Ro-52) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1300-1601-9 G DL 1300-5001-9 G DL 1300-6401-9 G |
||
| EUROASSAY | EUROASSAY AMA-M2, LKM-1, SLA/LP (IgG) |
EUROASSAY strip with antigens |
IgG | DA 1300-1003 G | |||
| EUROASSAY |
EUROASSAY Liver Profile (IgG) AMA M2, LKM-1, LC-1, SLA/LP |
EUROASSAY strip with antigens |
IgG | DA 1300-1003-3 G | |||
| ChLIA | IDS LKM-1 | antigenic coated magnetic particles | LKM-1 |
quantitative |
50 x 01 |
IS-AI18021 | |
| ChLIA |
IDS AMA (M2) MIT3 |
antigenic coated magnetic particles | MIT3 |
quantitative |
50 x 01 |
IS-AI18011 | |
| ChLIA | IDS Liver Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI18301 | ||
| IIFT |
Mosaic Basic Profile 1 cell nuclei (ANA) mitochondria (AMA) smooth muscles (ASMA) |
3 BIOCHIPs per field: HEp-2 cells kidney stomach |
human rat rat |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1800-1005-1 FA 1800-1010-1 FA 1800-2005-1 FB 1800-1005-1 FB 1800-1010-1 FB 1800-2005-1 |
|
| IIFT |
Mosaic Basic Profile 2 cell nuclei (ANA), LKM mitochondria (AMA), LKM smooth muscles (ASMA) |
3 BIOCHIPs per field: liver kidney stomach |
rat rat rat |
IgG IgG IgG IgG IgG |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1800-1005-2 FA 1800-1010-2 FA 1800-12010-2 FA 1800-2005-2 FA 1800-2010-2 FB 1800-1005-2 FB 1800-1010-2 FB 1800-2005-2 FB 1800-2010-2 |
|
| IIFT |
Mosaic Basic Profile 3 cell nuclei (ANA) cell nuclei (ANA) mitochondria (AMA) smooth muscles (ASMA) |
4 BIOCHIPs per field: HEp-2 cells liver kidney stomach |
human monkey rat rat |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1800-1005-3 FA 1800-1010-3 FA 1800-2005-3 FB 1800-1005-3 FB 1800-1010-3 FB 1800-2005-3 |
|
| IIFT |
Mosaic Basic Profile 3A cell nuclei (ANA) cell nuclei (ANA) mitochondria (AMA) smooth muscles (ASMA) |
4 BIOCHIPs per field: HEp-20-10 cells liver kidney stomach |
human monkey rat rat |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1802-1005-3 FA 1802-1010-3 FA 1802-2005-3 FA 1802-2010-3 FB 1802-1005-3 FB 1802-1010-3 FB 1802-2005-3 FB 1802-2010-3 |
|
| IIFT |
Mosaic Basic Profile 3C cell nuclei (ANA) cell nuclei (ANA), LKM mitochondria (AMA), LKM smooth muscles (ASMA) |
4 BIOCHIPs per field: HEp-20-10 cells liver kidney stomach |
human rat rat rat |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 |
FA 1812-1005-3 FA 1812-1010-3 FA 1812-2005-3 FA 1812-2010-3 FB 1812-1005-3 FB 1812-1010-3 FB 1812-2005-3 |
|
| IIFT |
Mosaic Basic Profile 2 EUROPattern cell nuclei (ANA), LKM mitochondria (AMA), LKM smooth muscles (ASMA) |
3 BIOCHIPs per field: liver kidney stomach |
rat rat rat |
IgG IgG IgG IgG |
10 x 10 120 x 10 20 x 05 20 x 10 |
FC 1800-1010-2 FC 1800-12010-2 FC 1800-2005-2 FC 1800-2010-2 |
|
| IIFT |
Mosaic Basic Profile 3A EUROPattern cell nuclei (ANA) EUROPattern cell nuclei (ANA) mitochondria (AMA) smooth muscles (ASMA) |
4 BIOCHIPs per field: HEp-20-10 cells liver kidney stomach |
human monkey rat rat |
IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1802-1005-3 FC 1802-1010-3 FC 1802-2005-3 FC 1802-2010-3 |
|
| IIFT |
Mosaic Basic Profile 3C EUROPattern cell nuclei (ANA), EUROPattern cell nuclei (ANA), LKM mitochondria (AMA), LKM smooth muscles (ASMA) |
4 BIOCHIPs per field: HEp-20-10 cells liver kidney stomach |
human rat rat rat |
IgG PI IgG PI IgG PI |
10 x 05 10 x 10 20 x 05 |
FC 1812-1005-3 FC 1812-1010-3 FC 1812-2005-3 |
|
| ChLIA | IDS Thyroid Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI19301 | ||
| IIFT |
thyroid gland (Mab) |
thyroid gland | monkey | IgG |
10 x 05 |
FA 1010-1005 | |
| IIFT |
EUROPLUS thyroid gland (MAb) thyroglobulin (TG) |
2 BIOCHIPs per field: thyroid gland TG BIOCHIPs |
monkey human |
IgG IgG |
10 x 05 10 x 10 |
FA 1010-1005-3 FA 1010-1010-3 |
|
| ELISA | Anti-TPO ELISA (IgG) | antigen-coated microplate wells |
recombinant, expression with Baculovirus vector in insect cells |
10/50/500 IU/ml | IgG |
96 x 01 |
EA 1012-9601 G |
| ELISA | Anti-TG ELISA (IgG) | antigen-coated microplate wells |
native, human thyroid gland |
20/100/1000 IU/ml | IgG |
96 x 01 |
EA 1013-9601 G |
| ELISA | Anti-TSH Receptor ELISA (IgG) | antigen-coated microplate wells |
native, porcine thyrocytes |
0/1/2/8/40 IU/l | IgG |
96 x 01 |
EA 1015-9601 G |
| ELISA | Anti-TSH Receptor (TRAb) Fast ELISA (IgG) | antigen-coated microplate wells |
native, porcine thyrocytes |
0.1/1/2/8/40 IU/l | IgG |
96 x 01 |
EA 1015-9601-1 G |
| ChLIA | IDS Anti-TG | antigenic coated magnetic particles | Thyroglobulin (TG) |
quantitative |
100 x 01 |
IS-AI19011 | |
| ChLIA | IDS Anti-TPO | antigenic coated magnetic particles | Thyroid peroxidase (TPO) |
quantitative |
100 x 01 |
IS-AI19021 | |
| ELISA |
Calcitonin ELISA |
antibody-coated microplate wells |
Synthetic human calcitonin |
0-500 pg/ml |
96 x 01 |
EQ 6431-9601 | |
| ELISA |
Reverse triiodothyronine (RT3) ELISA |
antibody-coated microplate wells | 0/0.02/0.1/0.4/1/2 ng/ml |
96 x 01 |
EQ 1016-9601-9 | ||
| IIFT |
autoantibody-free control (aab negative) |
IgA, IgG, IgM IgA, IgG, IgM |
05 x 02 05 x 10 |
CA 1000-0502 CA 1000-0510 |
|||
| IIFT |
hippocampus antigens cerebellum antigens |
hippocampus cerebellum (2 BIOCHIPs per field) |
rat rat |
IgG IgG |
10 x 05 10 x 10 |
FA 111a-1005-3 FA 111a-1010-3 |
|
| IIFT |
hippocampus antigens cerebellum antigens glutamate receptor (type NMDA) |
hippocampus cerebellum transfected cells control transfection (4 BIOCHIPs per field) |
rat rat EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 111m-1005-3 FA 111m-1010-3 FB 111m-1005-3 FB 111m-1010-3 |
|
| IIFT | skeletal muscle | musculus iliopsoas | monkey | IgG |
10 x 05 10 x 05 |
FA 1430-1005 FB 1430-1005 |
|
| IIFT |
Mosaic Heart Muscle/Skeletal Muscle heart muscle skeletal muscle |
2 BIOCHIPs per field: heart musculus iliopsoas |
monkey monkey |
IgG |
10 x 05 10 x 05 |
FA 1430-1005-1 FB 1430-1005-1 |
|
| IIFT | heart muscle | heart | monkey | IgG IgG |
10 x 05 20 x 05 10 x 05 20 x 05 |
FA 1461-1005 FA 1461-2005 FB 1461-1005 FB 1461-2005 |
|
| IIFT |
Myasthenia gravis Screen (SMM) EUROPattern skeletal muscle |
1 BIOCHIP per field: musculus iliopsoas |
monkey |
IgG |
20 x 05 |
FC 1430-2005 | |
| EUROLINE |
autoantibody-free control (aab negative) |
IgA, IgG, IgM |
05 x 01 |
CL 1000-0501 Z | |||
| NUL | IDS Top Cap Set |
01 x 01 |
IS-CAP3001 | ||||
| IIFT |
antibodies against pancreas acini (CUZD1 control; associated with Crohn's disease) |
IgG |
05 x 02 |
CA 1391-0502 | |||
| IIFT |
CIBD Screen 3 pancreas ag rPAg1(CUZD1) / rPAg2(GP2) intestinal goblet cells |
3 BIOCHIPs per field: transfected cells goblet cells control transfection |
EU 90 EU 80 EU 90 |
IgA/G |
10 x 05 10 x 05 |
FA 1391-1005-3 FB 1391-1005-3 |
|
| IIFT |
CIBD Profile 7 upper row: pancreas ag rPAg1(CUZD1) / rPAg2(GP2) intestinal goblet cells pANCA bottom row: Saccharomyces cerevisiae |
transfected cells goblet cells granulocytes (EOH) control transfection fungal smear |
EU 90 EU 80 human EU 90 S. cerevisiae |
IgA/G |
10 x 05 10 x 05 |
FA 1391-1005-7 FB 1391-1005-7 |
|
| ChLIA |
IDS Calprotectin Sample type: Stool |
Antibody-coated magnetic particles | Calprotectin |
quantitative |
100 x 01 |
IS-AI260001 | |
| ChLIA | IDS Calprotectin Calibrator Set | 2 x 0.5 ml calibrator 1/2/3/4/5 | Calprotectin |
5 concentration levels |
IS-AI260201 | ||
| ChLIA | IDS Calprotectin Control Set | 3 x 0.5 ml control 1/2 | Calprotectin |
2 concentration levels |
IS-AI260301 | ||
| IIFT |
antibodies against endomysium (EMA IgA control) |
IgA |
05 x 02 |
CA 1910-0502 A | |||
| IIFT |
antibodies against endomysium (EMA IgG control) |
IgG |
05 x 02 |
CA 1910-0502 G | |||
| IIFT |
antibodies against endomysium plus gliadin (GAF-3X) (EMA plus gliadin GAF-3X IgA control) |
IgA |
05 x 02 |
CA 1913-0502 A | |||
| IIFT |
antibodies against endomysium plus gliadin (GAF-3X) (EMA plus gliadin GAF-3X IgG control) |
IgG |
05 x 02 |
CA 1913-0502 G | |||
| IIFT | endomysium | small intestine | monkey | IgA IgA IgA IgA IgA IgA |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1913-1005 A FA 1913-1010 A FA 1913-2005 A FB 1913-1005 A FB 1913-1010 A FB 1913-2005 A |
|
| IIFT |
EUROPLUS endomysium gliadin (GAF-3X) |
2 BIOCHIPs per field: small intestine gliadin (GAF-3X) BIOCHIPs |
monkey |
IgA IgA IgA IgA IgA IgA |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1913-1005-1 A FA 1913-1010-1 A FA 1913-2005-1 A FB 1913-1005-1 A FB 1913-1010-1 A FB 1913-2005-1 A |
|
| IIFT | endomysium | liver | monkey | IgA IgGpa IgA IgGpa IgA IgGpa IgA IgGpa IgA IgA IgGpa IgA IgGpa IgA IgGpa IgA |
10 x 05 10 x 05 10 x 10 10 x 10 120 x 10 120 x 10 20 x 05 20 x 05 20 x 10 10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 20 x 10 |
FA 1914-1005 A FA 1914-1005 G FA 1914-1010 A FA 1914-1010 G FA 1914-12010 A FA 1914-12010 G FA 1914-2005 A FA 1914-2005 G FA 1914-2010 A FB 1914-1005 A FB 1914-1005 G FB 1914-1010 A FB 1914-1010 G FB 1914-2005 A FB 1914-2005 G FB 1914-2010 A |
|
| IIFT |
EUROPLUS endomysium gliadin (GAF-3X) |
2 BIOCHIPs per field: liver gliadin (GAF-3X) BIOCHIPs |
monkey |
IgA IgGpa IgA IgGpa IgA IgGpa IgA IgGpa IgA IgGpa IgA IgGpa |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 |
FA 1914-1005-1 A FA 1914-1005-1 G FA 1914-1010-1 A FA 1914-1010-1 G FA 1914-2005-1 A FA 1914-2005-1 G FB 1914-1005-1 A FB 1914-1005-1 G FB 1914-1010-1 A FB 1914-1010-1 G FB 1914-2005-1 A FB 1914-2005-1 G |
|
| IIFT |
endomysium endomysium |
liver small intestine (2 BIOCHIPs per field) |
monkey monkey |
IgA IgA IgA IgA IgA IgA |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1914-1005-2 A FA 1914-1010-2 A FA 1914-2005-2 A FB 1914-1005-2 A FB 1914-1010-2 A FB 1914-2005-2 A |
|
| IIFT |
Coeliac Disease Screen (LM) EUROPattern endomysium |
liver | monkey | IgA IgGpa IgA IgGpa IgA IgGpa IgA IgGpa |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 20 x 10 20 x 10 |
FC 1914-1005 A FC 1914-1005 G FC 1914-1010 A FC 1914-1010 G FC 1914-2005 A FC 1914-2005 G FC 1914-2010 A FC 1914-2010 G |
|
| ELISA |
Anti-tissue Transglutaminase ELISA (IgA) (endomysium) |
antigen-coated microplate wells |
recombinant, expression with baculovirus vector in insect cells |
2/20/200 RU/ml | IgA |
96 x 01 |
EA 1910-9601 A |
| ELISA |
Anti-tissue Transglutaminase ELISA (IgG) (endomysium) |
antigen-coated microplate wells |
recombinant, expression with baculovirus vector in insect cells |
semi-quantitative | IgG |
96 x 01 |
EA 1910-9601 G |
| EUROLINE |
positive control serum: IgA, human, 100x concentrated for DL 1910 A |
IgA |
05 x 07 |
CL 1910-0507 A | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1910 G |
IgG |
05 x 07 |
CL 1910-0507 G | |||
| EUROLINE |
EUROLINE Coeliac Disease Profile (IgA) (tissue transglutaminase (endomysium), gliadin-analogue fusion peptide (GAF-3X) separately) |
EUROLINE | IgA |
16 x 01 |
DL 1910-1601 A | ||
| EUROLINE |
EUROLINE Coeliac Disease Profile (IgG) (tissue transglutaminase (endomysium), gliadin-analogue fusion peptide (GAF-3X) separately) |
EUROLINE | IgG |
16 x 01 |
DL 1910-1601 G | ||
| ChLIA | IDS Deamidated Gliadin IgA | antigenic coated magnetic particles | Gliadin |
quantitative |
100 x 01 |
IS-AI13011 | |
| ChLIA | IDS Deamidated Gliadin IgG | antigenic coated magnetic particles | Gliadin |
quantitative |
100 x 01 |
IS-AI13021 | |
| ChLIA | IDS t-TG IgA | antigenic coated magnetic particles | Tissue transglutaminase |
quantitative |
100 x 01 |
IS-AI13031 | |
| ChLIA | IDS CELIAC Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI13301 | ||
| ChLIA | IDS t-TG IgG | antigenic coated magnetic particles | Tissue transglutaminase |
quantitative |
50 x 01 |
IS-AI14011 | |
| ChLIA | IDS t-TG IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI14301 | ||
| ChLIA | Anti-Gliadin (GAF-3X) ChLIA (IgA) | Antigen-coated magnetic particles | quantitative | IgA |
100 x 1 |
LV 3011-10010 A | |
| ChLIA | Anti-Gliadin (GAF-3X) ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
100 x 1 |
LV 3011-10010 G | |
| EUROArray | EUROArray HLA-DQ2/DQ8-h Direct |
MN 5320-0505-V MN 5320-0803-V MN 5320-1005-V MN 5320-2005-V |
|||||
| EUROArray | EUROArray HLA-DQ2/DQ8 Direct |
MN 5321-0505-V MN 5321-0803-V MN 5321-1005-V MN 5321-2005-V |
|||||
| ELISA | Anti-PM-Scl-ELISA (IgG) |
antigen-coated microplate wells |
recombinant, expression in E. coli |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1584-9601 G |
| ELISA | Anti-nRNP/Sm ELISA (IgG) |
antigen-coated microplate wells |
native, U1-nRNP, incl. 70K, A, C, B, B', D, E, F, G, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1591-9601 G |
| ELISA | Anti-Jo-1 ELISA (IgG) |
antigen-coated microplate wells |
native, histidyl-tRNA synthetase, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1661-9601 G |
| ELISA |
Anti-cN-1A ELISA (IgG) Mup44, NT5C1A |
antigen-coated microplate wells |
recombinant, expression in E. coli | semi-quantitative | IgG |
48 x 01 |
EA 1675-4801 G |
| EUROLINE |
EUROLINE Myositis Antigens Profile (IgG) (Mi-2, Ku, PM-Scl, Jo-1, PL-7, PL-12, Ro-52 separately) |
EUROLINE | IgG |
16 x 01 |
DL 1530-1601 G | ||
| EUROLINE |
EUROLINE Myositis Antigens Profile 3 (IgG) (Mi-2, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1530-1601-3 G DL 1530-5001-3 G DL 1530-6401-3 G |
||
| EUROLINE |
EUROLINE Autoimmune Inflammatory Myopathies 16 Ag (IgG) (Mi-2 alpha, Mi-2 beta, TIF1g, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1530-1601-4 G DL 1530-5001-4 G DL 1530-6401-4 G |
||
| EUROLINE |
EUROLINE Autoimmune Inflammatory Myopathies 16 Ag et cN-1A (IgG) (Mi-2 alpha, Mi-2 beta, TIF1g, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52, cN-1A separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1530-1601-7 G DL 1530-5001-7 G DL 1530-6401-7 G |
||
| EUROLINE |
EUROLINE Autoimmune Inflammatory Myopathies 20 Ag (IgG) ( Mi-2 alpha, Mi-2 beta, TIF1g, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52, cN-1A, Ha, Ks, Zo) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1530-1601-9 G DL 1530-5001-9 G DL 1530-6401-9 G |
||
| ChLIA | IDS Jo-1 | antigenic coated magnetic particles | Jo-1 |
quantitative |
50 x 01 |
IS-AI11091 | |
| ChLIA | IDS SS-A/Ro 52 kDa | antigenic coated magnetic particles | SS-A/Ro 52 kDa |
quantitative |
50 x 01 |
IS-AI11031 | |
| ChLIA | CRP | immunoturbidimetric assay |
quantitative |
01 x 190 |
CPTXL-H00/IDS1 | ||
| ELISA |
Anti-ssDNA ELISA (IgG) single-stranded DNA |
antigen-coated microplate wells |
heat-denatured ssDNA | 2/20/200 RU/ml | IgG |
96 x 01 |
EA 1576-9601 G |
| ELISA |
Anti-ENA ProfilePlus 1 ELISA (IgG) (nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1 separately) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
12 x 08 |
EA 1590-1208-1 G |
| ELISA |
Anti-ENA PoolPlus ELISA (IgG) (antigen mixture: nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-7 G |
| ELISA |
Anti-SS-A ELISA (IgG) Ro |
antigen-coated microplate wells |
native, SS-A-specific proteins (60 kDa), calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1595-9601 G |
| ELISA |
Anti-SS-B ELISA (IgG) La |
antigen-coated microplate wells |
native, SS-B-specific protein (48 kDa), calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1597-9601 G |
| ELISA | Anti-Scl-70 ELISA (IgG) |
antigen-coated microplate wells |
native, DNA topoisomerase I, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1599-9601 G |
| ELISA | Anti-DFS70 ELISA (IgG) |
antigen-coated microplate wells |
DFS70 recombinant |
semi-quantitative | IgG |
96 x 01 |
EA 159z-9601 G |
| ELISA | Anti-Centromeres ELISA (IgG) |
antigen-coated microplate wells |
recombinant centromere protein B, expression with baculovirus vector in insect cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1611-9601 G |
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1530-X G |
IgG |
05 x 07 |
CL 1530-0507 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1532 G |
IgG |
05 x 07 |
CL 1532-0507 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1590-X G |
IgG |
05 x 07 |
CL 1590-0507 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1590-35 G |
IgG |
05 x 07 |
CL 1590-0507-35 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 159z-X G |
IgG |
05 x 07 |
CL 159z-0507 G | |||
| EUROLINE |
EUROLINE Systemic sclerosis (Nucleoli) profile (IgG) (Scl-70, CENP A, CENP B, RP11, RP155, fibrillarin, NOR90, Th/To, PM-Scl100, PM-Scl75, Ku, PDGFR, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1532-1601 G DL 1532-5001 G DL 1532-6401 G |
||
| EUROLINE |
EUROLINE Systemic Sclerosis Profile 2 (IgG) (Scl-70, CenpA, Cenp B, RP11, RP155, Fibrillarin, NOR90, Th/To, PM-Scl100, PM-Scl75, Ku, NVL und Ro-52) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1532-1601-2 G DL 1532-5001-2 G DL 1532-6401-2 G |
||
| EUROLINE |
EUROLINE Anti-ENA ProfilePlus 1 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1 separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1590-1601-1 G DL 1590-6401-1 G |
||
| EUROLINE |
EUROLINE Anti-ENA ProfilePlus 2 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1, ribosomal P-proteins separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1590-1601-2 G DL 1590-6401-2 G |
||
| EUROLINE | EUROLINE Anti-dsDNA, -Nucleosomes, -Histones, -DFS70 (IgG) | EUROLINE | IgG IgG |
16 x 01 50 x 01 |
DL 1590-1601-32 G DL 1590-5001-32 G |
||
| EUROLINE |
EUROLINE Cytoplasm profile (IgG) (AMA M2, M2-3E, ribosomal P-proteins, Jo-1 SRP, PL-7, PL-12, EJ, OJ, Ro-52 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-35 G DL 1590-5001-35 G DL 1590-6401-35 G |
||
| EUROLINE |
EUROLINE Cytoplasm profile 13 Ag (IgG) (CAMA-M2, M2-3E, ribosomal P-Proteins, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52, Ha, Ks, Zo separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-37 G DL 1590-5001-37 G DL 1590-6401-37 G |
||
| EUROLINE | EUROLINE Anti-DFS70 (IgG) | EUROLINE | IgG IgG |
16 x 01 50 x 01 |
DL 159z-1601 G DL 159z-5001 G |
||
| EUROASSAY |
EUROASSAY Anti-ENA ProfilePlus (IgG) (nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1 separately) |
EUROASSAY strip with antigens |
IgG IgG |
DA 1590-1003-1 G DA 1590-1005-1 G |
|||
| ChLIA | IDS Scl-70 | antigenic coated magnetic particles | Scl-70 |
quantitative |
50 x 01 |
IS-AI11081 | |
| ChLIA | IDS Centromere B | antigenic coated magnetic particles | Centromere B |
quantitative |
50 x 01 |
IS-AI11101 | |
| IIFT |
antibodies against cell nuclei (ANA control), homogeneous pattern |
IgG |
05 x 02 |
CA 1570-0502 | |||
| IIFT |
antibodies against dsDNA (dsDNA ab control) |
IgG |
05 x 02 |
CA 1572-0502 | |||
| IIFT |
cell nuclei (ANA global test) |
HEp-2 cells liver (2 BIOCHIPs per field) |
human monkey |
IgG IgG IgG IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FA 1510-1005-1 FA 1510-1010-1 FA 1510-1050-1 FA 1510-12010-1 FA 1510-2005-1 FA 1510-2010-1 FA 1510-2450-1 FB 1510-1005-1 FB 1510-1010-1 FB 1510-1050-1 FB 1510-2005-1 FB 1510-2010-1 |
|
| IIFT |
cell nuclei (ANA) mitochondria (AMA) |
HEp-2 cells kidney (2 BIOCHIPs per field) |
human rat |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1510-1005-2 FA 1510-1010-2 FB 1510-1005-2 FB 1510-1010-2 |
|
| IIFT |
cell nuclei (ANA global test) |
HEp-20-10 cells liver (2 BIOCHIPs per field) |
human monkey |
IgG IgG IgG IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FA 1512-1005-1 FA 1512-1010-1 FA 1512-1050-1 FA 1512-12010-1 FA 1512-2005-1 FA 1512-2010-1 FA 1512-2450-1 FB 1512-1005-1 FB 1512-1010-1 FB 1512-1050-1 FB 1512-2005-1 FB 1512-2010-1 |
|
| IIFT |
cell nuclei (ANA) mitochondria (AMA) |
HEp-20-10 cells kidney (2 BIOCHIPs per field) |
human rat |
IgG IgG IgG |
10 x 05 10 x 10 10 x 50 10 x 05 10 x 10 10 x 50 |
FA 1512-1005-2 FA 1512-1010-2 FA 1512-1050-2 FB 1512-1005-2 FB 1512-1010-2 FB 1512-1050-2 |
|
| IIFT | cell nuclei (ANA) | HEp-2 cells | human | IgG IgG IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FA 1520-1005 FA 1520-1010 FA 1520-1050 FA 1520-12010 FA 1520-2005 FA 1520-2010 FB 1520-1005 FB 1520-1010 FB 1520-1050 FB 1520-2005 FB 1520-2010 |
|
| IIFT | cell nuclei (ANA) | HEp-20-10 cells | human | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1522-1005 FA 1522-1010 FA 1522-2005 FA 1522-2010 FB 1522-1005 FB 1522-1010 FB 1522-2005 FB 1522-2010 |
|
| IIFT | dsDNA | flagellates | Crithidia luciliae | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1572-1005 FA 1572-1010 FA 1572-2005 FA 1572-2010 FB 1572-1005 FB 1572-1010 FB 1572-2005 FB 1572-2010 |
|
| IIFT | dsDNA (sensitive) | flagellates | Crithidia luciliae | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1572-1005-1 FA 1572-1010-1 FA 1572-2005-1 FA 1572-2010-1 |
|
| IIFT |
cell nuclei (ANA) EUROPattern cell nuclei (ANA) |
HEp-2 cells liver (2 BIOCHIPs per field) |
human monkey |
IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 24 x 50 10 x 50 20 x 10 |
FC 1510-1005-1 FC 1510-1010-1 FC 1510-12010-1 FC 1510-2005-1 FC 1510-2010-1 FC 1510-2450-1 FW 1510-1050-1 FW 1510-2010-1 |
|
| IIFT |
cell nuclei (ANA) EUROPattern cell nuclei (ANA) |
HEp-20-10 cells liver (2 BIOCHIPs per field) |
human monkey |
IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 10 x 10 10 x 50 20 x 10 |
FC 1512-1005-1 FC 1512-1010-1 FC 1512-1050-1 FC 1512-12010-1 FC 1512-2005-1 FC 1512-2010-1 FC 1512-2450-1 FW 1512-1005-1 FW 1512-1010-1 FW 1512-1050-1 FW 1512-2010-1 |
|
| IIFT |
cell nuclei (ANA) EUROPattern mitochondria (AMA) |
HEp-20-10 cells kidney (2 BIOCHIPs per field) |
human rat |
IgG PI IgG PI IgG PI |
10 x 05 120 x 10 |
FC 1512-1005-2 FC 1512-12010-2 FC 1512-2450-2 |
|
| IIFT |
cell nuclei (ANA) EUROPattern |
HEp-2 cells | human | IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FC 1520-1005 FC 1520-1010 FC 1520-1050 FC 1520-12010 FC 1520-2005 FC 1520-2010 FC 1520-2450 FW 1520-1005 FW 1520-1010 FW 1520-1050 FW 1520-2005 FW 1520-2010 |
|
| IIFT |
cell nuclei (ANA) EUROPattern |
HEp-20-10 cells | human | IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 10 x 05 20 x 05 20 x 10 |
FC 1522-1005 FC 1522-1010 FC 1522-1050 FC 1522-12010 FC 1522-2005 FC 1522-2010 FW 1522-1005 FW 1522-2005 FW 1522-2010 |
|
| IIFT |
dsDNA EUROPattern |
flagellates | Crithidia luciliae | IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1572-1005 FC 1572-1010 FC 1572-2005 FC 1572-2010 |
|
| IIFT |
dsDNA (sensitive) EUROPattern |
flagellates | Crithidia luciliae | IgG EB IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 |
FC 1572-1005-1 FC 1572-1010-1 FC 1572-12010-1 FC 1572-2005-1 FC 1572-2010-1 |
|
| ELISA | Anti-Histones ELISA (IgG) |
antigen-coated microplate wells |
native, highly purified histones, bovine thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1560-9601 G |
| ELISA |
Anti-dsDNA ELISA (IgG) double-stranded DNA |
antigen-coated microplate wells |
highly purified genomic double-stranded DNA |
10/100/800 IU/ml | IgG |
96 x 01 |
EA 1571-9601 G |
| ELISA | Anti-dsDNA-NcX ELISA (IgG) |
antigen-coated microplate wells |
highly purified genomic double-stranded DNA, complexed with nucleosomes |
10/100/800 IU/ml | IgG |
96 x 01 |
EA 1572-9601 G |
| ELISA | Anti-Nucleosomes ELISA (IgG) |
antigen-coated microplate wells |
native, nucleosomes, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1574-9601 G |
| ELISA |
Anti-ENA SLE Profile 2-ELISA (IgG) (dsDNA, histones, nucleosomes, nRNP/Sm, Sm, SS-A, SS-B, Scl-70 separately) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
12 x 08 |
EA 1590-1208-12 G |
| ELISA |
Anti-ENA ProfilePlus 2 ELISA (IgG) (ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1, centromeres, separately) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
12 x 08 |
EA 1590-1208-2 G |
| ELISA |
ANA Screen 11 ELISA (IgG) (antigen mixture: PCNA, PM-Scl, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1, centromeres) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-11 G |
| ELISA |
ANA Screen 9 ELISA (IgG) (antigen mixture: PCNA, PM-Scl, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-14 G |
| ELISA |
ANA Screen ELISA (IgG) (antigen mixture: dsDNA, histones, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1, centromeres) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-8 G |
| ELISA |
Anti-ENA Pool ELISA (IgG) (antigen mixture: nRNP/Sm, Sm, SS-A, SS-B, Scl-70, ribosomal P-proteins, Ro-52) |
antigen-coated microplate wells |
see individual ELISA | semi-quantitative | IgG |
96 x 01 |
EA 1590-9601-9 G |
| ELISA | Anti-Sm ELISA (IgG) |
antigen-coated microplate wells |
native, U2-, U4-, U5-, U6-nRNP, incl. B, B', D, E, F, G, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1593-9601 G |
| EUROLINE |
EUROLINE ANA Profile 23 (IgG) (nucleosomes, dsDNA, histones, SS-A, Ro-52, SS-B, nRNP/Sm, Sm, Mi-2 alpha, Mi-2 beta, Ku, CENP A, CENP B, Sp100, PML, Scl-70, PM-Scl100, PM-Scl75, RP11, RP155, gp210, PCNA, DFS70 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-23 G DL 1590-5001-23 G DL 1590-6401-23 G |
||
| EUROLINE |
EUROLINE ANA Profile 3 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-3 G DL 1590-5001-3 G DL 1590-6401-3 G |
||
| EUROLINE |
EUROLINE ANA Profile 3 plus DFS70 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2, DFS70 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-30 G DL 1590-5001-30 G DL 1590-6401-30 G |
||
| EUROLINE |
EUROLINE ANA Profile et Mi-2 et Ku (IgG) (Mi-2, Ku, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2 separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1590-1601-31 G DL 1590-6401-31 G |
||
| EUROLINE |
EUROLINE ANA Profile et Mi-2, Ku, DFS70 (IgG) (Mi-2, Ku, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl100, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2, DFS70 separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-33 G DL 1590-5001-33 G DL 1590-6401-33 G |
||
| EUROLINE |
EUROLINE ANA Profile 5 (IgG) (nRNP/Sm, Sm, RNP70, RNPA, RNPC, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones, ribosomal P-proteins, AMA M2 separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1590-1601-5 G DL 1590-6401-5 G |
||
| EUROLINE |
EUROLINE ANA-Profile 1 (IgG) (nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1, CENP B, dsDNA, nucleosomes, histones, ribosomal P-proteins separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1590-1601-8 G DL 1590-5001-8 G DL 1590-6401-8 G |
||
| ChLIA | IDS ANA Screen | antigenic coated magnetic particles | dsDNA, Centromere B, SS-A/Ro (60 kDa and 52 kDa), SS-B/La, Sm, U1-snRNP (70 kDa, A and C), Scl-70, Jo-1 |
qualitative |
100 x 01 |
IS-AI10011 | |
| ChLIA | IDS ENA Screen | antigenic coated magnetic particles | SS-A/Ro (60 kDa and 52 kDa), SS-B/La, Sm, U1-snRNP (70 kDa, A and C), Scl-70, Jo-1 |
qualitative |
100 x 01 |
IS-AI10021 | |
| ChLIA | IDS ANA Screen Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI10301 | ||
| ChLIA | IDS dsDNA IgG | antigenic coated magnetic particles | dsDNA |
quantitative |
100 x 01 |
IS-AI11011 | |
| ChLIA | IDS SS-A/Ro | antigenic coated magnetic particles | SS-A/Ro |
quantitative |
50 x 01 |
IS-AI11021 | |
| ChLIA | IDS SS-A/Ro 60 kDa | antigenic coated magnetic particles | SS-A/Ro 60 kDa |
quantitative |
50 x 01 |
IS-AI11041 | |
| ChLIA | IDS SS-B/La | antigenic coated magnetic particles | SS-B/La |
quantitative |
50 x 01 |
IS-AI11051 | |
| ChLIA | IDS Sm | antigenic coated magnetic particles | Sm |
quantitative |
50 x 01 |
IS-AI11061 | |
| ChLIA | IDS U1-snRNP | antigenic coated magnetic particles | U1-snRNP (70 kDa, A, C) |
quantitative |
50 x 01 |
IS-AI11071 | |
| ChLIA | IDS ANA Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI11301 | ||
| ELISA | Anti-ribosomal P Proteins ELISA (IgG) |
antigen-coated microplate wells |
native, P0/P1/P2 of the 60S ribosomal subunit, calf thymus |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1641-9601 G |
| IIFT |
RC-IIFT: Dermal Binder Mosaic 1 Laminin 332 (LAM332) control transfection Laminin subunit beta 4 (LAMB4) Collagen type VII NC1 |
(4 BIOCHIPs per field) transfected cells control transfection transfected cells transfected cells |
EU 90 EU 90 EU 90 EU 90 |
IgG+IgG4 |
10 x 05 |
FA 150b-1005-1* | |
| IIFT | Laminin Subunit Beta 4 (LAMB4) |
transfected cells control transfection |
EU 90 EU 90 |
IgG+IgG4 |
10 x 05 |
FA 150b-1005-51* | |
| IIFT |
Endocrinology Screen (AM) EUROPattern adrenal cortex |
1 BIOCHIP per field: adrenal gland |
monkey |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1050-1005 FC 1050-1010 FC 1050-2005 FC 1050-2010 |
|
| IIFT |
antibodies against adrenal cortex (adrenal cortex ab control) |
IgG |
05 x 02 |
CA 1051-0502 | |||
| IIFT |
antibodies against ovary: theca cells (ovary ab control) |
IgG |
05 x 02 |
CA 1061-0502 | |||
| IIFT | spermatozoa | smear | human | IgAGM IgAGM |
10 x 05 10 x 10 10 x 05 10 x 10 |
FB 1086-1005 FB 1086-1010 FA 1086-1005 FA 1086-1010 |
|
| IIFT |
antibodies against mitochondria (AMA M2 control; associated with PBC) |
IgG |
05 x 02 |
CA 1622-0502 | |||
| IIFT | mitochondria (AMA) | kidney | rat | IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1620-1005 FA 1620-1010 FA 1620-2005 FA 1620-2010 FB 1620-1005 FB 1620-1010 FB 1620-2005 FB 1620-2010 |
|
| IIFT |
mitochondria (AMA) smooth muscles (ASMA) |
kidney stomach (2 BIOCHIPs per field) |
rat rat |
IgG IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FA 1620-1005-1 FA 1620-1010-1 FA 1620-1050-1 FA 1620-2005-1 FA 1620-2010-1 FB 1620-1005-1 FB 1620-1010-1 FB 1620-1050-1 FB 1620-2005-1 FB 1620-2010-1 |
|
| IIFT |
EUROPLUS mitochondria (AMA) smooth muscles (ASMA) cell nuclei (ANA) M2 antigen |
4 BIOCHIPs per field: kidney stomach HEp-2 cells M2 BIOCHIPs |
rat rat human |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1620-1005-5 FA 1620-1010-5 FB 1620-1005-5 FB 1620-1010-5 |
|
| IIFT |
AMA/ASMA IIFT (KR/SR) EUROPattern mitochondria (AMA) smooth muscles (ASMA) |
2 BIOCHIPs per field: kidney stomach |
rat rat |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1620-1005-1 FC 1620-1010-1 FC 1620-2005-1 FC 1620-2010-1 |
|
| ELISA | Anti-M2-3E ELISA (IgG) |
antigen-coated microplate wells |
native, pyruvate dehydrogenase complex, bovine heart plus recombinant M2 fusion antigen (BPO) |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1622-9601 G |
| EUROASSAY |
EUROASSAY AMA Profile (IgGM) (AMA M2, M4, M9 separately) |
EUROASSAY strip with antigens |
IgGM | DA 1620-1003-1 O | |||
| IIFT |
antibodies against striated muscles (myasthenia gravis control) |
IgG |
05 x 02 |
CA 1431-0502 | |||
| IIFT | Muscle-specific Kinase (MuSK) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 |
FA 1434-1005-90 FA 1434-1010-90 |
|
| IIFT | Muscle-specific Kinase (MuSK) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
20 x 05 20 x 10 |
FA 1434-2005-90-R FA 1434-2010-90-R |
|
| EUROLINE | EUROLINE Anti-SOX1, -Titin (IgG) | EUROLINE | IgG |
16 x 01 |
DL 1111-1601-6 G | ||
| IIFT |
Myasthenia gravis Mosaic 2 adult acetylcholine receptor (AChR-E) fetal acetylcholine receptor (AChR-G) Muscle-specific Kinase (MuSK) |
4 BIOCHIPs per field: transfected cells transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 |
FA 1435-1005-2 FA 1435-1010-2 |
|
| IIFT |
Anti-Acetylcholine Receptor (AChR) IIFT adulter Acetylcholinrezeptor (AChR-E) fetaler Acetylcholinrezeptor (AChR-G) --- |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 |
FA 1435-1005-90 FA 1435-1010-90 |
|
| IIFT |
Myasthenia Gravis Mosaic 2 adult acetylcholine receptor (AChR-E) foetal acetylcholine receptor (AChR-G) muscle-specific kinase (MuSK) |
4 BIOCHIPs per field: transfected cells transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 EU 90 |
IgG IgG IgG |
120 x 10 20 x 05 20 x 10 |
FA 1435-12010-2-R FA 1435-2005-2-R FA 1435-2010-2-R |
|
| IIFT |
adult acetylcholine receptor (AChR-E) foetal acetylcholine receptor (AChR-G) |
transfected cells transfected cells control transfection (3 BIOCHIPs per field) |
EU 90 EU 90 EU 90 |
IgG IgG |
20 x 05 20 x 10 |
FA 1435-2005-90-R FA 1435-2010-90-R |
|
| ELISA | Anti-Acetylcholine Receptor ELISA (IgG) |
antigen-coated microplate wells |
recombinant, expression in HEK cells |
0/0.25/0.75/2.5/ 8 nmol/l |
IgG |
96 x 01 |
EA 1435-9601 G |
| IIFT |
antibodies against renal glomeruli (Goodpasture syndrome; GBM ab control) |
IgG |
05 x 02 |
CA 1251-0502 | |||
| IIFT |
antibodies against phospholipase A2 receptor (PLA2R ab control) |
IgG |
05 x 02 |
CA 1254-0502 | |||
| IIFT |
Membranous Nephropathy Mosaic 1 phospholipase A2 receptor (PLA2R) Thrombospondin type-1 domain-containing protein 7A (THSD7A) |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1254-1005-1 FA 1254-1010-1 FB 1254-1005-1 FB 1254-1010-1 |
|
| IIFT | phospholipase A2 receptor (PLA2R) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG IgG |
10 x 05 10 x 10 20 x 10 10 x 05 10 x 10 |
FA 1254-1005-50 FA 1254-1010-50 FA 1254-2010-50 FB 1254-1005-50 FB 1254-1010-50 |
|
| IIFT |
Thrombospondin type-1 domain- containing protein 7A (THSD7A) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
10 x 05 20 x 05 |
FA 1254-1005-51 FA 1254-2005-51 |
|
| IIFT |
Membranous Nephropathy Mosaic 1 phospholipase A2 receptor (PLA2R) Thrombospondin type-1 domain-containing protein 7A (THSD7A) |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG IgG |
20 x 05 20 x 10 |
FA 1254-2005-1-R FA 1254-2010-1-R |
|
| IIFT | phospholipase A2 receptor (PLA2R) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
20 x 05 |
FA 1254-2005-50-R | |
| IIFT | Thrombospondin type-1 domain- containing protein 7A (THSD7A) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
20 x 05 20 x 10 |
FA 1254-2005-51-R FA 1254-2010-51-R |
|
| IIFT | phospholipase A2 receptor (PLA2R) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
20 x 10 |
FA 1254-2010-50-R | |
| IIFT |
phospholipase A2 receptor (PLA2R) EUROPattern |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1254-1005-50 FC 1254-1010-50 FC 1254-2005-50 FC 1254-2010-50 |
|
| ELISA |
Anti-PLA2R ELISA (IgG) phospholipase A2 receptor |
antigen-coated microplate wells |
recombinant, human c-DNA expressed in human cell line |
2/20/100/500/ 1500 RU/ml |
IgG |
96 x 01 |
EA 1254-9601 G |
| ChLIA | Anti-PLA2R ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
100 x 1 |
LA 1254-10010 G | |
| ChLIA | Control set Anti-PLA2R ChLIA (IgG) | 2 x 0.4 ml control 1/2 | IgG |
02 x 02 |
LR 1254-20210 G | ||
| IIFT |
Membranous Nephropathy Mosaic 2 phospholipase A2 receptor (PLA2R) Thrombospondin type-1 domain-containing protein 7A (THSD7A) Neural epidermal growth factor-like 1 protein (Nell1) |
4 BIOCHIPs per field: transfected cells control transfection transfected cells transfected cells |
EU 90 EU 90 EU 90 EU 90 |
IgG |
10 x 05 |
FA 1254-1005-2* | |
| IIFT | Neural epidermal growth factor-like 1 protein (NELL1) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 05 |
FA 1254-1005-52* | |
| ELISA | Anti-Nephrin ELISA RUO |
antigen-coated microplate wells |
96 x 01 |
EA 1253-9601-2-N* | |||
| IIFT |
antibodies against myelin-associated glycoprotein (MAG ab control) |
IgM |
05 X 02 |
CA 1123-0502 M | |||
| IIFT |
antibodies against aquaporin-4 (neuromyelitis optica control) |
IgG |
05 X 02 |
CA 1128-0502 | |||
| IIFT |
antibodies against myelin oligodendrocytes glycoprotein (MOG CBA control) |
IgG |
05 x 02 |
CA 1156-0502 | |||
| IIFT | medullated nerves | nerves | monkey | IgAGM |
10 x 05 10 x 05 |
FA 1120-1005 FB 1120-1005 |
|
| IIFT | Myelin-associated glycoprotein (MAG/HNK-1) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgM IgM |
20 x 05 20 x 10 |
FA 1123-2005-50-R FA 1123-2010-50-R |
|
| IIFT |
NMOSD Screen 1 aquaporin-4 (AQP-4) Myelin-oligodendrocyte glycoprotein (MOG) |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 |
FA 1128-1005-1 FA 1128-1010-1 |
|
| IIFT | aquaporin-4 |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1128-1005-50 FA 1128-1010-50 FB 1128-1005-50 FB 1128-1010-50 |
|
| IIFT |
NMOSD Mosaic 1 aquaporin-4 (AQP4) Myelin-oligodendrocyte glycoprotein (MOG) |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG IgG |
20 x 05 20 x 10 |
FA 1128-2005-1-R FA 1128-2010-1-R |
|
| IIFT | aquaporin-4 (AQP4) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
20 x 05 20 x 10 |
FA 1128-2005-50-R FA 1128-2010-50-R |
|
| IIFT | Myelin-oligodendrocyte glycoprotein (MOG) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 |
FA 1156-1005-50 FA 1156-1010-50 |
|
| IIFT | Myelin-oligodendrocyte glycoprotein (MOG) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
20 x 05 20 x 10 |
FA 1156-2005-50-R FA 1156-2010-50-R |
|
| IIFT | aquaporin-4 EUROPattern |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG PI IgG PI IgG PI IgG PI |
10 x 05 10 x 10 20 x 05 20 x 10 |
FC 1128-1005-50 FC 1128-1010-50 FC 1128-2005-50 FC 1128-2010-50 |
|
| IIFT |
NMOSD Screen 1 EUROPattern aquaporin-4 (AQP-4) Myelin-oligodendrocyte glycoprotein (MOG) |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG PI |
20 x 05 |
FC 1128-2005-1 | |
| IIFT |
Myelin-Oligodendrocyte-Glycoprotein (MOG) EUROPattern |
transfected cells control transfection |
EU 90 EU 90 |
IgG PI |
20 x 05 |
FC 1156-2005-50 | |
| EUROLINE |
Positive control serum: IgG, human, 50x concentrated for DL 1130-X G |
IgG |
05 x 07 |
CL 1130-0507 G | |||
| EUROLINE |
Positive control serum: IgM, human, 50x concentrated for DL 1130-X M |
IgM |
05 x 07 |
CL 1130-0507 M | |||
| EUROLINE |
EUROLINE Anti-Gangliosides Profile 1 (IgG) (GM1, GD1b, GQ1b separately) |
EUROLINE | IgG |
16 x 01 |
DL 1130-1601-1 G | ||
| EUROLINE |
EUROLINE Anti-Gangliosides Profile 1 (IgM) (GM1, GD1b, GQ1b separately) |
EUROLINE | IgM |
16 x 01 |
DL 1130-1601-1 M | ||
| EUROLINE |
EUROLINE Anti-Gangliosides Profile 2 (IgG) (GM1, GM2, GM3, GD1a, GD1b, GT1b, GQ1b separately) |
EUROLINE | IgG |
16 x 01 |
DL 1130-1601-2 G | ||
| EUROLINE |
EUROLINE Anti-Gangliosides Profile 2 (IgM) (GM1, GM2, GM3, GD1a, GD1b, GT1b, GQ1b separately) |
EUROLINE | IgM |
16 x 01 |
DL 1130-1601-2 M | ||
| IIFT |
brain: grey and white matter, Purkinje cell cytoplasm (Yo), Hu and Ri antigen CV2, Ma, amphiphysin |
cerebellum | monkey | IgAGM IgAGM |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1111-1005 FA 1111-1010 FB 1111-1005 FB 1111-1010 |
|
| IIFT |
Neurology Mosaic 1 Yo, Hu, Ri, CV2, Ma, amphiphysin medullated nerves non-medullated nerves |
3 BIOCHIPs per field: cerebellum nerves intestinal tissue |
monkey monkey monkey |
IgAGM IgAGM |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1111-1005-1 FA 1111-1010-1 FB 1111-1005-1 FB 1111-1010-1 |
|
| IIFT |
Neurology Mosaic14 cerebellum antigens non-medullated nerves |
2 BIOCHIPs per field: cerebellum intestinal tissue |
monkey monkey |
IgAGM IgAGM |
10 x 05 10 x 10 |
FA 1111-1005-14 FA 1111-1010-14 |
|
| IIFT |
Yo, Hu, Ri, CV2, Ma, amphiphysin medullated nerves non-medullated nerves cell nuclei (ANA) |
cerebellum nerves intestinal tissue HEp-2 cells (4 BIOCHIPs per field) |
monkey monkey monkey human |
IgAGM IgAGM |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1111-1005-16 FA 1111-1010-16 FB 1111-1005-16 FB 1111-1010-16 |
|
| IIFT |
Neurology Mosaic 17 Yo, Hu, Ri, CV2, Ma, amphiphysin, NMO cerebrum antigens, NMO NMO, optic nerve antigens aquaporin-4 |
5 BIOCHIPs per field cerebellum cerebrum optic nerve transfected cells control transfection |
monkey monkey monkey EU 90 EU 90 |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1111-1005-17 FA 1111-1010-17 FA 1111-2005-17 FB 1111-1005-17 FB 1111-1010-17 FB 1111-2005-17 |
|
| IIFT |
Neurology Mosaic 2 Yo, Hu, Ri, CV2, Ma, amphiphysin medullated nerves |
2 BIOCHIPs per field: cerebellum nerves |
monkey monkey |
IgAGM IgAGM |
10 x 05 10 x 10 |
FA 1111-1005-2 FA 1111-1010-2 |
|
| IIFT |
Neurology Mosaic 8 Yo, Hu, Ri, CV2, Ma, amphiphysin medullated nerves non-medullated nerves pancreas islets |
4 BIOCHIPs per field cerebellum nerves intestinal tissue pancreas |
monkey monkey monkey monkey |
IgAGM IgAGM |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1111-1005-8 FA 1111-1010-8 FB 1111-1005-8 FB 1111-1010-8 |
|
| IIFT |
Neurology Mosaic14 cerebellum antigens non-medullated nerves |
2 BIOCHIPs per field: cerebellum non-medullated nerves |
monkey monkey |
10 x 05 10 x 10 |
FB 1111-1005-14 FB 1111-1010-14 |
||
| IIFT |
Neurology Mosaic 1 EUROPattern Yo, Hu, Ri, CV2, Ma, amphiphysin medullated nerves non-medullated nerves |
3 BIOCHIPs per field: cerebellum nerves intestinal tissue |
monkey monkey monkey |
IgG IgG |
10 x 05 10 x 10 |
FC 1111-1005-1 FC 1111-1010-1 |
|
| IIFT |
Neurology Mosaic 8 EUROPattern Yo, Hu, Ri, CV2, Ma, amphiphysin medullated nerves non-medullated nerves pancreas islets |
4 BIOCHIPs per field: cerebellum nerves intestinal tissue pancreas |
monkey monkey monkey monkey |
IgG IgG |
10 x 05 10 x 10 |
FC 1111-1005-8 FC 1111-1010-8 |
|
| IIFT |
Neurology Mosaic 14 EUROPattern cerebellum antigens medullated nerves |
2 BIOCHIPs per field cerebellum intestinal tissue |
monkey monkey |
IgG IgG |
120 x 10 20 x 10 |
FC 1111-12010-14 FC 1111-2010-14 |
|
| EUROLINE |
EUROLINE Paraneoplastic Neurologic Syndromes 12 Ag (IgG) (amphiphysin, CV2, PNMA2 (Ma-2/Ta), Ri, Yo, Hu, recoverin, SOX1, titin, Zic4, GAD65, Tr (DNER) separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DL 1111-1601-7 G DL 1111-5001-7 G DL 1111-6401-7 G |
||
| IIFT |
antibodies against neuronal nuclei: Hu antigen (Hu ab control) |
IgG |
05 x 02 |
CA 1116-0502 | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1111-1 G, DL 1111-2 G, DL 1111-4 G and DL 1111-7 G |
IgG |
05 x 07 |
CL 1111-0507 G | |||
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1111-6 G |
IgG |
05 x 07 |
CL 1111-0507-6 G | |||
| EUROLINE |
EUROLINE Neuronal Antigens Profile 2 (IgG) (amphiphysin, CV2, PNMA2 (Ma-2/Ta), Ri, Yo, Hu separately) |
EUROLINE | IgG |
16 x 01 |
DL 1111-1601-2 G | ||
| EUROLINE |
EUROLINE Neuronal Antigens Profile PLUS RST (IgG) (amphiphysin, CV2, PNMA2 (Ma-2/Ta), Ri, Yo, Hu, recoverin, SOX1, titin separately) |
EUROLINE | IgG |
16 x 01 |
DL 1111-1601-4 G | ||
| IIFT |
antibodies against glutamic acid decarboxylase (GAD ab control) |
IgG |
05 x 02 |
CA 1022-0502 | |||
| IIFT |
glutamic acid decarboxylase (GAD) 65 kDa (stiff-person syndrome) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 05 |
FA 1022-1005-50 | |
| EUROLINE |
EUROLINE AMA Profile (IgGM) (separate: AMA-M2, M2-3E, M4, M9) |
EUROLINE | IgGM IgGM |
16 x 01 64 x 01 |
DL 1620-1601-1 O DL 1620-6401-1 O |
||
| IIFT |
Mosaic Basic Profile 13B cell nuclei (ANA) cell nuclei (ANA), LKM mitochondria (AMA), LKM smooth muscles (ASMA) |
4 BIOCHIPs per field: HEp-2 cells liver kidney stomach |
human rat rat rat |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1805-1005-13 FA 1805-1010-13 FA 1805-2005-13 FB 1805-1005-13 FB 1805-1010-13 FB 1805-2005-13 |
|
| IIFT |
Mosaic Basic Profile 13B EUROPattern cell nuclei (ANA), EUROPattern cell nuclei (ANA), LKM mitochondria (AMA), LKM smooth muscles (ASMA) |
4 BIOCHIPs per field: HEp-2 cells liver kidney stomach |
human rat rat rat |
IgG PI IgG PI IgG PI |
10 x 10 20 x 05 20 x 10 |
FC 1805-1010-13 FC 1805-2005-13 FC 1805-2010-13 |
|
| IIFT |
antibodies against granulocyte cytoplasm, cytoplasmic pattern (cANCA control, PR3 ab control) |
IgG |
05 x 02 |
CA 1200-0502 | |||
| IIFT |
antibodies against granulocyte cytoplasm, perinuclear pattern (pANCA control) |
IgG |
05 x 02 |
CA 1210-0502 | |||
| IIFT |
antibodies against granulocyte cytoplasm, perinuclear pattern (pANCA control, MPO ab control) |
IgG |
05 x 02 |
CA 1211-0502 | |||
| IIFT |
cytoplasm of granulocytes (cANCA, pANCA), nuclei of granulocytes (GS-ANA) |
granulocytes, ethanol-fixed |
human | IgG IgG IgG IgG |
10 x 05 10 x 10 180 x 10 20 x 05 10 x 05 10 x 10 20 x 05 |
FA 1200-1005 FA 1200-1010 FA 1200-18010 FA 1200-2005 FB 1200-1005 FB 1200-1010 FB 1200-2005 |
|
| IIFT |
granulocytes (cANCA, pANCA) |
granulocytes, formaldehyde-fixed |
human | IgG IgG |
10 x 05 10 x 10 10 x 05 10 x 10 |
FA 1201-1005 FA 1201-1010 FB 1201-1005 FB 1201-1010 |
|
| IIFT |
Granulocyte Mosaic 13 cANCA, pANCA, GS-ANA cell nuclei (ANA), cANCA, pANCA cANCA, pANCA |
3 BIOCHIPs per field: granulocytes (EOH) HEp-2+granulocytes (EOH) granulocytes (HCHO) |
human human human |
IgG IgG IgG IgG IgG IgG |
10 x 05 10 x 10 10 x 50 120 x 10 20 x 05 20 x 10 10 x 05 10 x 10 10 x 50 20 x 05 20 x 10 |
FA 1201-1005-13 FA 1201-1010-13 FA 1201-1050-13 FA 1201-12010-13 FA 1201-2005-13 FA 1201-2010-13 FB 1201-1005-13 FB 1201-1010-13 FB 1201-1050-13 FB 1201-2005-13 FB 1201-2010-13 |
|
| IIFT |
Granulocyte Mosaic 15 cANCA, pANCA, GS-ANA cell nuclei (ANA), cANCA, pANCA |
2 BIOCHIPs per field: granulocytes (EOH) HEp-2+granulocytes (EOH) |
human human |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1201-1005-15 FA 1201-1010-15 FA 1201-2005-15 FA 1201-2010-15 FB 1201-1005-15 FB 1201-1010-15 FB 1201-2005-15 FB 1201-2010-15 |
|
| IIFT |
Granulocyte Mosaic 2 cANCA, pANCA, GS-ANA cANCA, pANCA |
2 BIOCHIPs per field: granulocytes (EOH) granulocytes (HCHO) |
human human |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1201-1005-2 FA 1201-1010-2 FA 1201-2005-2 FA 1201-2010-2 FB 1201-1005-2 FB 1201-1010-2 FB 1201-2005-2 FB 1201-2010-2 |
|
| IIFT |
EUROPLUS Granulocyte Mosaic 22 cANCA, pANCA, GS-ANA cANCA, pANCA pANCA: myeloperoxidase (MPO) cANCA: proteinase 3 (PR3) |
4 BIOCHIPs per field: granulocytes (EOH) granulocytes (HCHO) MPO BIOCHIPs PR3 BIOCHIPs |
human human |
IgG IgG IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 10 |
FA 1201-1005-22 FA 1201-1010-22 FA 1201-2005-22 FB 1201-1005-22 FB 1201-1010-22 |
|
| IIFT |
EUROPLUS Granulocyte Mosaic 25 cANCA, pANCA, GS-ANA cell nuclei (ANA), cANCA, pANCA cANCA, pANCA glomerular basement membrane (GBM) pANCA: myeloperoxidase (MPO) cANCA: proteinase 3 (PR3) |
6 BIOCHIPs per field: granulocytes (EOH) HEp-2+granulocytes (EOH) granulocytes (HCHO) GBM BIOCHIPs MPO BIOCHIPs PR3 BIOCHIPs |
human human human |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 20 x 05 20 x 10 |
FA 1201-1005-25 FA 1201-1010-25 FA 1201-2005-25 FA 1201-2010-25 FB 1201-1005-25 FB 1201-2005-25 FB 1201-2010-25 |
|
| IIFT |
EUROPLUS Granulocyte Mosaic 32 cANCA, pANCA, GS-ANA cANCA, pANCA cell nuclei (ANA), cANCA, pANCA pANCA: myeloperoxidase (MPO) cANCA: proteinase 3 (PR3) |
5 BIOCHIPs per field: granulocytes (EOH) granulocytes (HCHO) HEp-2+granulocytes (EOH) MPO BIOCHIPs PR3 BIOCHIPs |
human human human |
IgG IgG IgG IgG |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 10 x 10 20 x 05 20 x 10 |
FA 1201-1005-32 FA 1201-1010-32 FA 1201-2005-32 FA 1201-2010-32 FB 1201-1005-32 FB 1201-1010-32 FB 1201-2005-32 FB 1201-2010-32 |
|
| IIFT |
cytoplasm of granulocytes (cANCA, pANCA), nuclei of granulocytes (GS-ANA) EUROPattern |
granulocytes, ethanol-fixed |
human | IgG EB IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 |
FC 1200-1005 FC 1200-1010 FC 1200-12010 FC 1200-2005 FC 1200-2010 |
|
| IIFT |
granulocytes (cANCA, pANCA) EUROPattern |
granulocytes, formaldehyde-fixed |
human | IgG EB IgG EB IgG EB |
10 x 05 10 x 10 20 x 05 |
FC 1201-1005 FC 1201-1010 FC 1201-2005 |
|
| IIFT |
Granulocyte Mosaic 13 EUROPattern cANCA, pANCA, GS-ANA, EUROPattern cell nuclei (ANA), cANCA, pANCA cANCA, pANCA, EUROPattern |
3 BIOCHIPs per field: granulocytes (EOH) HEp-2+granulocytes (EOH) granulocytes (HCHO) |
human human human |
IgG EB IgG EB IgG EB IgG EB IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 24 x 50 10 x 05 20 x 10 |
FC 1201-1005-13 FC 1201-1010-13 FC 1201-12010-13 FC 1201-2005-13 FC 1201-2010-13 FC 1201-2450-13 FW 1201-1005-13 FW 1201-2010-13 |
|
| IIFT |
Granulocyte Mosaic 15 EUROPattern cANCA, pANCA, GS-ANA, EUROPattern cell nuclei (ANA), cANCA, pANCA |
2 BIOCHIPs per field: granulocytes (EOH) HEp-2+granulocytes (EOH) |
human human |
IgG EB IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 10 x 50 20 x 10 10 x 05 |
FC 1201-1005-15 FC 1201-1010-15 FC 1201-1050-15 FC 1201-2010-15 FW 1201-1005-15 |
|
| IIFT |
Granulocyte Mosaic 2 EUROPattern cANCA, pANCA, GS-ANA, EUROPattern cANCA, pANCA, EUROPattern |
2 BIOCHIPs per field: granulocytes (EOH) granulocytes (HCHO) |
human human |
IgG EB IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 |
FC 1201-1005-2 FC 1201-1010-2 FC 1201-12010-2 FC 1201-2005-2 FC 1201-2010-2 |
|
| IIFT |
EUROPLUS Granulocyte Mosaic 22 EUROPattern cANCA, pANCA, GS-ANA, EUROPattern cANCA, pANCA, EUROPattern pANCA: myeloperoxidase (MPO), EUROPattern cANCA: proteinase 3 (PR3), EUROPattern |
4 BIOCHIPs per field: granulocytes (EOH) granulocytes (HCHO) MPO BIOCHIPs PR3 BIOCHIPs |
human human |
IgG EB IgG EB IgG EB |
10 x 05 10 x 10 20 x 10 |
FC 1201-1005-22 FC 1201-1010-22 FC 1201-2010-22 |
|
| IIFT |
EUROPLUS Granulocyte Mosaic 25 EUROPattern cANCA, pANCA, GS-ANA, EUROPattern cell nuclei (ANA), cANCA, pANCA cANCA, pANCA, EUROPattern glom. basement membrane (GBM), EUROPattern pANCA: myeloperoxidase (MPO), EUROPattern cANCA: proteinase 3 (PR3), EUROPattern |
6 BIOCHIPs per field: granulocytes (EOH) HEp-2+granulocytes (EOH) granulocytes (HCHO) GBM BIOCHIPs MPO BIOCHIPs PR3 BIOCHIPs |
human human human |
IgG EB IgG EB IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 20 x 05 20 x 10 10 x 05 20 x 10 |
FC 1201-1005-25 FC 1201-1010-25 FC 1201-2005-25 FC 1201-2010-25 FW 1201-1005-25 FW 1201-2010-25 |
|
| IIFT |
EUROPLUS Granulocyte Mosaic 32 EUROPattern cANCA, pANCA, GS-ANA, EUROPattern cANCA, pANCA, EUROPattern cell nuclei (ANA), cANCA, pANCA pANCA: myeloperoxidase (MPO), EUROPattern cANCA: proteinase 3 (PR3), EUROPattern |
5 BIOCHIPs per field: granulocytes (EOH) granulocytes (HCHO) HEp-2+granulocytes (EOH) MPO BIOCHIPs PR3 BIOCHIPs |
human human human |
IgG EB IgG EB IgG EB IgG EB IgG EB IgG EB IgG EB |
10 x 05 10 x 10 120 x 10 20 x 05 20 x 10 10 x 05 10 x 10 |
FC 1201-1005-32 FC 1201-1010-32 FC 1201-12010-32 FC 1201-2005-32 FC 1201-2010-32 FW 1201-1005-32 FW 1201-1010-32 |
|
| ELISA |
ANCA-Profile ELISA (IgG) (proteinase 3, MPO, elastase, cathepsin G, BPI, lactoferrin separately) |
antigen-coated microplate wells |
native, human neutrophil granulocytes recombinant, human c-DNA expressed in human cell line |
semi-quantitative | IgG |
12 x 08 |
EA 1200-1208-1 G |
| ELISA |
Anti-PR3-hn-hr ELISA (IgG) cANCA: proteinase 3 |
antigen-coated microplate wells |
hn: native, human neutrophil granulocytes hr: recombinant, human c-DNA expressed in human cell line |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1201-9601-2 G |
| ELISA |
Anti-MPO ELISA (IgG) pANCA: myeloperoxidase |
antigen-coated microplate wells |
native, human neutrophil granulocytes |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1211-9601 G |
| EUROLINE |
positive control serum: IgG, human, 100x concentrated for DL 1200-X G |
IgG |
05 x 07 |
CL 1200-0507-2 G | |||
| EUROLINE |
EUROLINE Anti-MPO, -PR3 (IgG) myeloperoxidase proteinase 3 |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DL 1200-1601-2 G DL 1200-6401-2 G |
||
| ChLIA | IDS MPO | antigenic coated magnetic particles | MPO |
quantitative |
50 x 01 |
IS-AI17011 | |
| ChLIA | IDS PR3-II | antigenic coated magnetic particles | PR3 |
quantitative |
50 x 01 |
IS-AI1702II1 | |
| ChLIA | Anti-PR3 ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
100 x 1 |
LA 1201-10010 G | |
| ChLIA | Anti-Myeloperoxidase ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
100 x 1 |
LA 1211-10010 G | |
| ChLIA | Control set Anti-PR3 ChLIA (IgG) | 2 x 0.4 ml control 1/2 | IgG |
02 x 02 |
LR 1201-20210 G | ||
| ChLIA | Control set Anti-Myeloperoxidase ChLIA (IgG) | 2 x 0.4 ml control 1/2 | IgG |
02 x 02 |
LR 1211-20210 G | ||
| ELISA | Anti-Sa ELISA (IgG) |
antigen-coated microplate wells |
citrullinated Sa antigen | 2/20/200 RU/ml | IgG |
48 x 02 |
EA 151a-4802 G |
| ELISA |
Anti-CCP ELISA (IgG) cyclic citrullinated peptides |
antigen-coated microplate wells |
highly purified synthetic CCP (second generation) |
1/5/20/100/ 200 RU/ml |
IgG |
96 x 01 |
EA 1505-9601 G |
| ELISA | Anti-CEP-1 ELISA (IgG) |
antigen-coated microplate wells |
citrullinated alpha-enolase peptide |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 151b-9601 G |
| ELISA |
IgA Rheumatoid Factor ELISA (ab of class IgA against IgG) |
antigen-coated microplate wells |
IgG, human |
2/20/200 RU/ml | IgA |
96 x 01 |
EA 1814-9601 A |
| ELISA |
IgG Rheumatoid Factor ELISA (ab of class IgG against IgG) |
antigen-coated microplate wells |
IgG, goat |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1814-9601 G |
| ELISA |
IgM Rheumatoid Factor ELISA (ab of class IgM against IgG) |
antigen-coated microplate wells |
IgG, human |
2/20/200 RU/ml | IgM |
96 x 01 |
EA 1814-9601 M |
| ELISA |
CIC-C1q ELISA (IgG) circulating immune complexes |
antigen-coated microplate wells |
native, human C1q |
2/20/200 RU/ml | IgG |
96 x 01 |
EA 1818-9601 G |
| ELISA | Circulating Calprotectin ELISA |
antibody-coated microplate wells |
96 x 01 |
EQ 6831-9601 | |||
| ChLIA | CRP Medium Control | 1 x 2.0 ml Control M | C-reactive protein (CRP) |
1 concentration |
CPCON-0021 | ||
| ChLIA | CRP High Control | 1 x 2.0 ml Control H | C-reactive protein (CRP) |
1 concentration |
CPCOX-0021 | ||
| ChLIA | CRP Calibrator Set | 1 x 1.0 ml Calibrator 1/2/3/4/5 | C-reactive protein (CRP) |
5 concentrations |
CPREK-0001 | ||
| ChLIA | IDS CCP | antigenic coated magnetic particles | CCP |
quantitative |
100 x 01 |
IS-AI12011 | |
| ChLIA | IDS CCP Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-AI12301 | ||
| ChLIA | IDS Fluid Calprotectin | Antibody-coated magnetic particles | Calprotectin | quantitative |
100 x 01 |
IS-AI261001 | |
| ChLIA | IDS Fluid Calprotectin Calibrator Set | 2 x 0.5 ml calibrator 1/2/3/4/5 | Calprotectin |
5 concentrations |
IS-AI261201 | ||
| ChLIA | Anti-CCP ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
01 x 00 |
LA 1505-0100 G | |
| ChLIA | Control set Anti-CCP ChLIA (IgG) | 2 x 0.4 ml control 1/2 | IgG |
02 x 02 |
LR 1505-0160 G | ||
| ChLIA | Rheumatoid Factor Control Set | 3 x 1.5 ml Control 1/2 | human Rheumatoid Factor (RF) |
2 concentrations |
RFCOK-000/IDS1 | ||
| ChLIA | Rheumatoid Factor | colloidal gold particles | IgG specific for Rheumatoid Factor |
quantitative |
100 x 01 |
RFCOL-B00/IDS1 | |
| ChLIA | Rheumatoid Factor Control | 1 x 2.0 ml Control 1 | human Rheumatoid Factor (RF) |
1 concentration |
RFCON-002/IDS1 | ||
| ChLIA | Rheumatoid Factor Calibration Set | 1 x 1.5 ml Calibrator 1/2/3/4/5 | human Rheumatoid Factor (RF) |
5 concentrations |
RFREK-000/IDS1 | ||
| ChLIA |
Nu.Q® NETs H3.1 nucleosome |
Antibody-coated magnetic particles | H3.1 nucleosome |
quantitative |
100 x 01 |
2001-02-011 | |
| IIFT | dsDNA (sensitive) EUROPattern |
flagellates (1 BIOCHIP per field) |
Crithidia luciliae | IgG IgG IgG IgG |
24 x 50 120 x 10 20 x 05 20 x 10 |
FC 1572-12010-1-R FC 1572-2005-1-R FC 1572-2010-1-R |
|
| IIFT | dsDNA (sensitive) |
flagellates (1 BIOCHIP per field) |
Crithidia luciliae | IgG IgG |
20 x 05 20 x 10 |
FA 1572-2005-1-R FA 1572-2010-1-R |
|
| IIFT | dsDNA |
flagellates (1 BIOCHIP per field) |
Crithidia luciliae | IgG IgG |
20 x 05 20 x 10 |
FA 1572-2005-R FA 1572-2010-R |
|
| IIFT | dsDNA EUROPattern |
flagellates (1 BIOCHIP per field) |
Crithidia luciliae | IgG IgG |
20 x 05 20 x 10 |
FC 1572-2005-R FC 1572-2010-R |
|
| EUROArray | EUROArray HLA-B27 Direct |
MN 5110-0505-V MN 5110-0803-V MN 5110-1005-V MN 5110-2005-V |
|||||
| ELISA |
Serum CrossLaps® ELISA Beta C-terminal telopeptides of type I collagen |
antibody coated microtiter wells | Beta C-terminal telopeptides of type I collagen |
96 x 01 |
AC-02F11 | ||
| ELISA |
Urine CrossLaps® EIA Beta C-terminal telopeptides of type I collagen, in urine |
antibody coated microtiter wells | Beta C-terminal telopeptides of type I collagen, in urine |
96 x 01 |
AC-03F11 | ||
| ELISA |
Urine Alpha CrossLaps® (CTX-I) EIA Alpha C-terminal telopeptides of type I collagen, in urine |
antibody coated microtiter wells | Alpha C-terminal telopeptides of type I collagen, in urine |
96 x 01 |
AC-04F11 | ||
| ELISA |
Urine BETA CrossLaps® (CTX-I) ELISA Beta C-terminal telopeptides of type I collagen, in urine |
antibody coated microtiter wells | Beta C-terminal telopeptides of type I collagen, in urine |
96 x 01 |
AC-05F11 | ||
| ELISA | N-MID® Osteocalcin ELISA | antibody coated microtiter wells | Osteocalcin |
96 x 01 |
AC-11F11 | ||
| ChLIA | IDS N-MID® Osteocalcin | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-29001 | ||
| ChLIA | IDS N-MID® Osteocalcin Control Set | 4 x 1.0 ml Control 1/2/3 | Osteocalcin |
3 concentration levels |
IS-29301 | ||
| ChLIA | IDS Beta CrossLaps® (CTX-I) | Antibody-coated magnetic particles |
quantitative |
100 x 01 |
IS-3000N1 | ||
| ChLIA | IDS Beta CrossLaps® (CTX-I) Calibrator Set | 1 x 2.0 ml Calibrator 1/2/3/4/5/6 | Cross-linked carboxyterminal telopeptide of type 1 collagen (CTX-I) |
6 concentration levels |
IS-3020N1 | ||
| ChLIA | IDS Beta CrossLaps® (CTX-I) Control Set | 2 x 2.5 ml Control 1/2 | Cross-linked carboxyterminal telopeptide of type 1 collagen (CTX-I) |
2 concentration levels |
IS-3030N1 | ||
| ChLIA | IDS TRAcP 5b (BoneTRAP®) | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-41001 | ||
| ELISA |
Ostase® BAP EIA Bone-specific alkaline phosphatase |
antibody coated microtiter wells | Bone-specific alkaline phosphatase |
96 x 01 |
AC-20F11 | ||
| ELISA |
BoneTRAP® (TRAcP 5b) ELISA Tartrate-resistant acid phosphatase |
antibody coated microtiter wells | Tartrate-resistant acid phosphatase |
96 x 01 |
SB-TR201A1 | ||
| ChLIA | IDS Ostase® BAP | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-28001 | ||
| ChLIA | IDS Ostase® BAP Control Set | 2 x 2.5 ml Control 1/2/3 | Bone alkaline phosphatase (BAP) |
3 concentration levels |
IS-28301 | ||
| ChLIA | IDS Intact PINP | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-40001 | ||
| ChLIA | IDS Intact PINP Control Set | 2 x 1.0 ml Control 1/2/3 | Procollagen type I N-propeptide (PINP) |
3 concentrations |
IS-40301 | ||
| ChLIA | IDS TRAcP 5b (BoneTRAP®) Control Set | 3 x 1.0 ml Control 1/2/3 | Tartrate-resistant acid phosphatase 5b (TRAP 5b) |
3 concentration levels |
IS-41301 | ||
| ELISA |
Urine CartiLaps® (CTX-II) EIA C-terminal telopeptides of type II collagen, in urine |
antibody coated microtiter wells | C-terminal telopeptides of type II collagen, in urine |
96 x 01 |
AC-10F11 | ||
| ELISA |
Human COMP ELISA Cartilage oligomeric matrix protein |
antibody coated microtiter wells | Cartilage oligomeric matrix protein |
96 x 01 |
AC-23F11 | ||
| ChLIA | IDS InaKtif MGP (dp-uc MGP) | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-47001 | ||
| ChLIA | IDS InaKtif MGP (dp-uc MGP) Control Set | 4 x 1.0 ml Control 1/2/3 | dephosphorylated-uncarboxylated matrix Gla protein (dp-uc MGP) |
3 concentration levels |
IS-47301 | ||
| ELISA | 1,25-Dihydroxy Vitamin D EIA | antibody coated microtiter wells | 1,25-(OH)2 vitamin D |
96 x 01 |
AC-62F11 | ||
| ChLIA | IDS 1,25 VitD Xp | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-20001 | ||
| ChLIA | IDS 1,25 VitD Xp Control Set | 6 x 1.2 ml Control 1/2 | 1,25-dihydroxyvitamin D |
2 concentration levels |
IS-20301 | ||
| ChLIA | IDS 1,25-Dihydroxy Vitamin D | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-24001 | ||
| ChLIA | IDS 1,25-Dihydroxy Vitamin D Control Set | 3 x 1.2 ml Control 1/2 | 1,25-dihydroxyvitamin D |
2 concentration levels |
IS-24301 | ||
| ELISA |
25-Hydroxy Vitamin D S EIA (D2 and D3) |
antibody coated microtiter wells | 25-OH vitamin D (D2 and D3) |
96 x 01 |
AC-57SF11 | ||
| ELISA |
25-OH-Vitamin D ELISA |
antibody-coated microplate wells | 25-OH vitamin D (D2 and D3) | 0/4/10/25/60/120 ng/ml |
96 x 01 |
EQ 6411-9601 | |
| ELISA |
Intact-PTH ELISA |
antibody-coated microplate wells |
Recombinant human parathormone (1-84) |
0-500 pg/ml |
96 x 01 |
EQ 6421-9601 | |
| ChLIA | IDS 25 VitD S | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-2500N1 | ||
| ChLIA | IDS 25 VitD S Calibrator Set | 1 x 1.0 ml Calibrator 1/2/3/4/5/6 | 25-hydroxyvitamin D |
6 concentration levels |
IS-2520N1 | ||
| ChLIA | IDS 25 VitD S Control Set | 3 x 2.5 ml Control 1/2 | 25-hydroxyvitamin D |
2 concentration levels |
IS-2530N1 | ||
| ChLIA | IDS Intact PTH Control Set | 6 x 1.0 ml Control 1/2/3 | Parathyroid hormone (PTH), intact |
3 concentration levels |
IS-32301 | ||
| ChLIA | IDS Intact PTH | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-32001 | ||
| ELISA |
calprotectin determination in stool |
Antibody-coated microplate wells |
0/15/60/240/960/2100 µg/g |
96 x 01 |
EQ 6831-9601 W | ||
| ChLIA |
Faecal Calprotectin ChLIA Sample type: Stool |
Antibody-coated magnetic particles |
quantitative |
01 x 00 |
LQ 6831-0100 W | ||
| ChLIA | Control set Faecal Calprotectin ChLIA | 2 x 0.5 ml control 1/2 |
02 x 02 |
LR 6831-0160 W | |||
| NUL |
IDS Calprotectin Extraction Device Use in combination with IS-AI26000 |
Use in combination with IS-AI26000 |
01 x 01 |
IS-AI260401 | |||
| NUL |
Stool Dosage Tubes, unfilled Use in combination with EQ / LQ 6831 W |
Use in combination with EQ / LQ 6831 W |
100 x 01 |
ZE 6010-0100-3 | |||
| NUL |
Stool Dosage Tubes, ready for use Use in combination with EQ / LQ 6831 W |
Use in combination with EQ / LQ 6831 W |
45 x 01 |
ZE 6010-4501-2 | |||
| ELISA | Anti-Saccharomyces cerevisiae ELISA (IgA) |
antigen-coated microplate wells |
mannan of S. cerevisiae |
2/20/200 RU/ml | IgA |
96 x 01 |
EV 2841-9601 A |
| ELISA | Anti-Saccharomyces cerevisiae ELISA (IgG) |
antigen-coated microplate wells |
mannan of S. cerevisiae |
2/20/200 RU/ml | IgG |
96 x 01 |
EV 2841-9601 G |
| IIFT |
antibodies against Saccharomyces cerevisiae IgA positive control |
fungal smear |
Saccharomyces cerevisiae |
IgA |
05 x 02 |
CV 2841-0502 A | |
| IIFT |
antibodies against Saccharomyces cerevisiae IgG positive control |
fungal smear |
Saccharomyces cerevisiae |
IgG |
05 x 02 |
CV 2841-0502 G | |
| IIFT |
Saccharomyces cerevisiae negative control |
IgA, IgG, IgM |
05 x 02 |
CV 2841-0502 Z | |||
| IIFT | Saccharomyces cerevisiae |
fungal smear |
Saccharomyces cerevisiae |
IgA IgG IgA IgG IgA IgG |
10 x 05 10 x 10 20 x 05 10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 |
FX 2841-1005 FX 2841-1010 FX 2841-2005 FV 2841-1005 A FV 2841-1005 G FV 2841-1010 A FV 2841-1010 G FV 2841-2005 A FV 2841-2005 G |
|
| ELISA | Anti-Gliadin (GAF-3X) ELISA (IgA) |
antigen-coated microplate wells |
gliadin-analogue fusion peptide (GAF-3X) |
2/25/200 RU/ml | IgA |
96 x 01 |
EV 3011-9601 A |
| ELISA | Anti-Gliadin (GAF-3X) ELISA (IgG) |
antigen-coated microplate wells |
gliadin-analogue fusion peptide (GAF-3X) |
2/25/200 RU/ml | IgG |
96 x 01 |
EV 3011-9601 G |
| ChLIA | IDS Total Testosterone | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-50001 | ||
| ChLIA | IDS Total Testosterone Control Set | 2 x 1.0 ml Control 1/2/3 | Testosterone |
3 concentration levels |
IS-50301 | ||
| ELISA |
Androstenedione ELISA |
antibody-coated microplate wells | 0/0.1/0.3/1/3/10 ng/ml |
96 x 01 |
EQ 6153-9601 | ||
| ChLIA | IDS Androstenedione | Antibody-coated magnetic particles |
quantitative |
100 x 01 |
IS-54001 | ||
| ChLIA | IDS Androstenedione Calibrator Set | 1 x 1.0 ml Calibrator 1/2/3/4/5/6 | Androstenedione |
6 concentration levels |
IS-54201 | ||
| ChLIA | IDS Androstenedione Control Set | 2 x 1.0 ml Control 1/2 | Androstenedione |
2 concentration levels |
IS-54301 | ||
| ELISA |
Dehydroepiandrosterone (DHEA) ELISA |
antibody-coated mircoplate wells | quantitative |
96 x 01 |
EQ 6154-9601-1 | ||
| ELISA |
CXCL13 determination in CSF |
antibody-coated microplate wells |
recombinant human CXCL13, expression in E. coli |
0-500 pg/ml |
96 x 01 |
EQ 6811-9601-L | |
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | 5/25/50/100/175/230 U/ml | IgG |
96 x 01 |
EI 2661-9601-2L G |
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgM |
96 x 01 |
EI 2661-9601-2L M | |
| ELISA |
CSQ pair of controls anti-Cytomegalovirus (IgG) |
IgG |
02 x 20 |
CK 2570-0220-L G | |||
| ELISA |
CSQ pair of controls anti-EBV-CA (IgG) |
IgG |
02 x 20 |
CK 2791-0220-L G | |||
| ELISA |
CSF: Anti-CMV ELISA (IgG) cytomegalovirus Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens from CMV |
5/25/50/100 U | IgG |
96 x 01 |
EI 2570-9601-L G |
| ELISA |
CSF: Anti-EBV-CA-ELISA (IgG) Epstein-Barr virus capsid antigen Sample type: CSF/serum pair |
antigen-coated microplate wells |
native, mixture of several viral capsid antigens |
5/25/50/100 U | IgG |
96 x 01 |
EI 2791-9601-L G |
| ELISA |
CSQ pair of controls anti-HSV-1/2 Pool (IgG) |
IgG |
02 x 20 |
CK 2531-0220-1 L G | |||
| ELISA |
CSF: Anti-HSV-1/2 Pool ELISA (IgG) herpes simplex virus Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens from HSV-1 and HSV-2 |
5/25/50/100/175/230 U/ml | IgG |
96 x 01 |
EI 2531-9601-1 L G |
| ELISA |
CSQ pair of controls anti-VZV (IgG) |
IgG |
02 x 20 |
CK 2650-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Toxoplasma gondii (IgG) |
IgG |
02 x 20 |
CK 2410-0220-L G | |||
| ELISA |
CSF: Anti-Toxoplasma gondii ELISA (IgG ) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens of Toxoplasma gondii |
5/25/50/100 U | IgG |
96 x 01 |
EI 2410-9601-L G |
| ELISA |
CSQ pair of controls anti-Treponema pallidum (IgG) |
IgG |
02 x 20 |
CK 2111-0220-L G | |||
| ELISA |
CSF: Anti-Treponema pallidum ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
recombinant antigens 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
5/25/50/100 U | IgG |
96 x 01 |
EI 2111-9601-L G |
| ELISA |
CSQ pair of controls anti-Borrelia (IgG) |
IgG |
02 x 20 |
CK 2132-0220-L G | |||
| ELISA | Anti-Borrelia CSF ELISA 2.0 (IgM) |
antigen-coated microplate wells |
TBE viral proteins | IgM |
96 x 01 |
EI 2132-9601-2L M | |
| ELISA |
CSF: Anti-Borrelia plus VlsE ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
whole antigen, detergent extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii PLUS recombinant VlsE from Borrelia burgdorferi sensu stricto |
5/25/50/100/175/230 U | IgG |
96 x 01 |
EI 2132-9601-L G |
| EUROLINE |
Anti-Borrelia EUROLINE-RN-AT (IgG) (p18, p19, p20, p21, p58, OspC (p25), p39, p83, LBb, LBa, VlsE Bg, VlsE Bb, VlsE Ba separately) |
EUROLINE | IgG IgG IgG |
240 x 01 32 x 01 50 x 01 |
DN 2131-24001 G DN 2131-3201 G DN 2131-5001 G |
||
| EUROLINE |
Anti-Borrelia EUROLINE-RN-AT (IgM) (OspC Bg native, OspC Bb native, OspC Ba native, p39, VlsE Bb separately) |
EUROLINE | IgM IgM IgM |
240 x 01 32 x 01 50 x 01 |
DN 2131-24001 M DN 2131-3201 M DN 2131-5001 M |
||
| ELISA |
CSQ pair of controls anti-Rubella virus (IgG) |
IgG |
02 x 20 |
CK 2590-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Measles virus (IgG) |
IgG |
02 x 20 |
CK 2610-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Mumps virus (IgG) |
IgG |
02 x 20 |
CK 2630-0220-L G | |||
| ELISA |
CSF: Anti-Rubella Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens, strain "HPV-77" |
5/25/50/100/175/230 U | IgG |
96 x 01 |
EI 2590-9601-L G |
| ELISA |
CSF: Anti-Measles Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens from Measles virus |
5/25/50/100/175/230 U | IgG |
96 x 01 |
EI 2610-9601-L G |
| ELISA |
CSF: Anti-Mumps Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
5/25/50/100 U | IgG |
96 x 01 |
EI 2630-9601-L G |
| IIFT |
Bornavirus (BoDV) |
infected and uninfected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgG |
10 x 05 10 x 10 |
FI 2620-1005 G* FI 2620-1010 G* |
|
| IIFT |
Arbovirus Mosaic Australia 2 Murray Valley encephalitis virus (MVEV) Ross River virus (RRV) Barmah forest virus (BFV) |
4 BIOCHIPs per field: infected cells infected cells infected cells non-infected cells |
EU 14 EU 14 EU 14 EU 14 |
IgG IgM |
10 x 05 10 x 05 |
FI 2666-1005-2 G* FI 2666-1005-2 M* |
|
| IIFT |
Crimean Congo fever virus Mosaic 2 CCHFV-GPC CCHFV-N |
3 BIOCHIPs per field: transfected cells transfected cells control transfection |
EU 90 EU 90 EU 90 |
IgG EB IgM EB IgG EB IgM EB IgG EB IgM EB |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 10 20 x 10 |
FI 279a-1005-2 G* FI 279a-1005-2 M* FI 279a-1010-2 G* FI 279a-1010-2 M* FI 279a-2010-2 G* FI 279a-2010-2 M* |
|
| IIFT | Rift Valley fever virus (RVFV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 280a-1005 G* FI 280a-1005 M* FI 280a-1010 G* FI 280a-1010 M* |
|
| IIFT |
Venezuelan equine encephalitis virus (VEEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG |
10 x 10 |
FI 290a-1010 G* | |
| IIFT | Sindbis virus (SINV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgM IgG IgM |
10 x 05 10 x 10 10 x 10 |
FI 291a-1005 M* FI 291a-1010 G* FI 291a-1010 M* |
|
| IIFT | West Nile virus (WNV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2662-1005 G FI 2662-1005 M FI 2662-1010 G FI 2662-1010 M |
|
| IIFT | Japanese encephalitis virus (JEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM |
10 x 05 10 x 05 |
FI 2663-1005 G FI 2663-1005 M |
|
| IIFT | Yellow fever virus (YFV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2665-1005 G FI 2665-1005 M FI 2665-1010 G FI 2665-1010 M |
|
| IIFT |
Mosaic Dengue virus types 1 - 4 (DENV) |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 |
FI 266a-1005-1 G FI 266a-1005-1 M FI 266a-1010-1 G FI 266a-1010-1 M FI 266a-2005-1 G FI 266a-2005-1 M |
|
| IIFT |
Sandfly fever virus Mosaic 1 types Sicilian, Naples, Toscana, Cyprus |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 277a-1005-1 G FI 277a-1005-1 M FI 277a-1010-1 G FI 277a-1010-1 M |
|
| IIFT |
Hantavirus Mosaic 1 types Hantaan (HTNV), Sin Nombre (SNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 278h-1005-1 G FI 278h-1005-1 M FI 278h-1010-1 G FI 278h-1010-1 M |
|
| IIFT |
Hantavirus Mosaic 2 Eurasia types Hantaan (HTNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected and non- infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 278h-1005-2 G FI 278h-1005-2 M FI 278h-1010-2 G FI 278h-1010-2 M |
|
| IIFT |
Hantavirus Mosaic 3: America types Sin Nombre (SNV), Andes (ANDV) |
2 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM |
10 x 05 10 x 05 |
FI 278m-1005-3 G FI 278m-1005-3 M |
|
| IIFT | Chikungunya virus (CHIKV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 |
FI 293a-1005 G FI 293a-1005 M FI 293a-1010 G FI 293a-1010 M FI 293a-2005 G FI 293a-2005 M |
|
| IIFT |
Arbovirus Fever Mosaic 1 Chikungunya virus (CHIKV) Japanese encephalitis virus (JEV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 293a-1005-1 G FI 293a-1005-1 M FI 293a-1010-1 G FI 293a-1010-1 M |
|
| IIFT | Yellow fever virus (YFV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI |
10 x 05 10 x 05 |
FR 2665-1005 G FR 2665-1005 M |
|
| IIFT |
Mosaic Dengue virus types 1 - 4 (DENV) EUROPattern |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 266a-1005-1 G FR 266a-1005-1 M FR 266a-1010-1 G FR 266a-1010-1 M |
|
| IIFT |
Sandfly fever virus Mosaic 1 EUROPattern types Sicilian, Naples, Toscana, Cyprus |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 277a-1005-1 G FR 277a-1005-1 M |
|
| IIFT |
Hantavirus Mosaic 1 EUROPattern types Hantaan (HTNV), Sin Nombre (SNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 278h-1005-1 G FR 278h-1005-1 M |
|
| IIFT |
Hantavirus Mosaic 3: America EUROPattern types Sin Nombre (SNV), Andes (ANDV) |
2 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 278m-1005-3 G FR 278m-1005-3 M |
|
| IIFT | Chikungunya virus (CHIKV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 293a-1005 G FR 293a-1005 M FR 293a-1010 G FR 293a-1010 M |
|
| ELISA |
Anti-West Nile Virus ELISA (IgG) WNV |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2662-9601 G |
| ELISA |
Anti-West Nile Virus ELISA (IgM) WNV |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
semi-quantitative | IgM |
96 x 01 |
EI 2662-9601 M |
| ELISA |
Avidity: Anti-West Nile Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2662-9601-1 G |
| ELISA |
Anti-JEV ELISA (IgG) Japanese encephalitis virus |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2663-9601 G |
| ELISA |
Anti-JEV ELISA (IgM) Japanese encephalitis virus |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
semi-quantitative | IgM |
96 x 01 |
EI 2663-9601 M |
| ELISA | Anti-Usutu Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant glycoprotein E of Usutu virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2667-9601 G |
| ELISA | Anti-Dengue Virus Type 1-4 ELISA (IgG) |
antigen-coated microplate wells |
preparation of Dengue virus particles and recombinant glycoprotein E of types 1-4 |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 266a-9601-1 G |
| ELISA | Anti-Dengue Virus Type 1-4 ELISA (IgM) |
antigen-coated microplate wells |
preparation of Dengue virus particles and recombinant glycoprotein E of types 1-4 |
semi-quantitative | IgM |
96 x 01 |
EI 266a-9601-1 M |
| ELISA | Anti-Dengue Virus NS1 ELISA 2.0 (IgG) |
antigen-coated microplate wells |
recombinant NS1 antigen from Dengue virus |
IgG |
96 x 01 |
EI 266a-9601-3 G | |
| ELISA | Anti-Oropouche Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant Oropouche-nucleocapsid protein |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2771-9601 G |
| ELISA | Anti-Oropouche Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant Oropouche-nucleocapsid protein |
semi-quantitative | IgM |
96 x 01 |
EI 2771-9601 M |
| ELISA | Anti-Toscana virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant N-protein from Toscana virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 277c-9601 G |
| ELISA | Anti-Hanta Virus Pool 1 "Eurasia" ELISA (IgG) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Hantaan HTNV, Dobrava DOBV, Puumala PUUV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 278h-9601-1 G |
| ELISA | Anti-Hanta Virus Pool 1 "Eurasia" ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Hantaan HTNV, Dobrava DOBV, Puumala PUUV |
semi-quantitative | IgM |
96 x 01 |
EI 278h-9601-1 M |
| ELISA | Anti-Hanta Virus Pool 2 "America" ELISA (IgG) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Andes ANDV and Sin Nombre SNV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 278h-9601-2 G |
| ELISA | Anti-Hanta Virus Pool 2 "America" ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Andes ANDV and Sin Nombre SNV |
semi-quantitative | IgM |
96 x 01 |
EI 278h-9601-2 M |
| ELISA | Anti-Chikungunya Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant structural protein from Chikungunya virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 293a-9601 G |
| ELISA | Anti-Chikungunya Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant structural protein from Chikungunya virus |
semi-quantitative | IgM |
96 x 01 |
EI 293a-9601 M |
| ELISA | Anti-Mayaro Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant structural protein from Mayaro virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 295c-9601 G |
| ELISA | Anti-Mayaro Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant structural protein from Mayaro virus |
semi-quantitative | IgM |
96 x 01 |
EI 295c-9601 M |
| ELISA |
Dengue virus NS1 antigen detection (DENV) |
antibody-coated microplate wells |
Dengue virus NS1 (type 1-4) | 1/10/100 RU/ml |
96 x 01 |
EQ 266a-9601-1 | |
| IIFT | Zika virus (ZIKV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2668-1005 G FI 2668-1005 M FI 2668-1010 G FI 2668-1010 M |
|
| IIFT |
Arbovirus Fever Mosaic 2 Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2668-1005-1 G FI 2668-1005-1 M FI 2668-1010-1 G FI 2668-1010-1 M |
|
| IIFT |
Arbovirus Profile 3 upper row : Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) bottom row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
infected cells infected cells infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 EU 14 EU 14 |
IgG IgM |
10 x 05 10 x 05 |
FI 2668-1005-3 G FI 2668-1005-3 M |
|
| IIFT | Zika virus (ZIKV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 2668-1005 G FR 2668-1005 M FR 2668-1010 G FR 2668-1010 M |
|
| IIFT |
Arbovirus Fever Mosaic 2 EUROPattern Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 2668-1005-1 G FR 2668-1005-1 M FR 2668-1010-1 G FR 2668-1010-1 M |
|
| ELISA | Anti-Zika Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant NS1 antigen from Zika virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2668-9601 G |
| ELISA | Anti-Zika Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant NS1 antigen from Zika virus |
semi-quantitative | IgM |
96 x 01 |
EI 2668-9601 M |
| ELISA | Anti-Zika Virus ELISA (IgAM) |
antigen-coated microplate wells |
specific NS1 antigen from Zika virus |
semi-quantitative | IgAM |
96 x 01 |
EI 2668-9601 Q |
| ELISA |
Anti-MERS-CoV ELISA (IgG) Middle east respiratory syndrome coronavirus |
antigen-coated microplate wells |
recombinant S1 antigen of MERS coronavirus (MERS-CoV S1) |
semi-quantitative | IgG |
96 x 01 |
EI 2604-9601 G |
| ELISA |
Anti-SARS-CoV-2 ELISA (IgA) Severe acute respiratory syndrome coronavirus 2 |
antigen-coated microplate wells |
recombinant S1 antigen of SARS-CoV-2 |
semi-quantitative | IgA |
96 x 01 |
EI 2606-9601 A |
| ELISA |
Anti-SARS-CoV-2 ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 |
antigen-coated microplate wells |
recombinant S1 antigen of SARS-CoV-2 |
semi-quantitative | IgG |
96 x 01 |
EI 2606-9601 G |
| ELISA |
Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 |
1/10/20/40/80/120 RU/mL | IgG |
96 x 01 |
EI 2606-9601-10 G | ||
| ELISA |
Anti-SARS-CoV-2 NCP ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 nucleocapsid protein |
semi-quantitative | IgG |
96 x 01 |
EI 2606-9601-2 G | ||
| ChLIA | Anti-SARS-CoV-2 RBD ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
100 x 1 |
LI 2606-10010-1 G | |
| ChLIA | Control set Anti-SARS-CoV-2 RBD ChLIA (IgG) | 2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 2606-20210-1 G | ||
| ELISA | Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgG) |
antigen-coated microplate wells |
recombinant protein from CCHFV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 279a-9601 G |
| ELISA | Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgM) |
antigen-coated microplate wells |
recombinant protein from CCHFV |
semi-quantitative | IgM |
96 x 01 |
EI 279a-9601 M |
| IIFT | TBE virus (TBEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005 G FI 2661-1005 M FI 2661-1010 G FI 2661-1010 M |
|
| IIFT |
Flavivirus Mosaic 1 TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
4 BIOCHIPs per field: infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005-1 G FI 2661-1005-1 M FI 2661-1010-1 G FI 2661-1010-1 M |
|
| IIFT |
Flavivirus Profile 2 upper row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) bottom row: Dengue virus types 1 - 4 (DENV) |
infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 20 x 05 20 x 05 |
FI 2661-1005-2 G FI 2661-1005-2 M FI 2661-2005-2 G FI 2661-2005-2 M |
|
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgG |
96 x 01 |
EI 2661-9601-2 G | |
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
semi-quantitative | IgM |
96 x 01 |
EI 2661-9601-2 M | |
| ChLIA | IDS SHBG | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-56001 | ||
| ChLIA | IDS SHBG Control Set | 2 x 1.0 ml Control 1/2/3 | Sexual hormone-binding globulin (SHBG) |
3 concentration levels |
IS-56301 | ||
| ELISA |
Free Testosterone ELISA |
antibody-coated microplate wells | 0/0.1/1/5/20/60 pg/ml |
96 x 01 |
EQ 6151-9601 | ||
| ChLIA | IDS Free Testosterone | Streptavidin-coated magnetic particles |
quantitative |
100 x 01 |
IS-53001 | ||
| ChLIA | IDS Free Testosterone Control Set | 2 x 1.0 ml Control 1/2/3 | Testosterone, free |
3 concentration levels |
IS-53301 | ||
| ChLIA | IDS Prolactin | Antibody-coated magnetic particles |
quantitative |
100 x 01 |
IS-57001 | ||
| ChLIA | IDS Prolactin Calibrator Set |
2 x 1.0 ml calibrator 1/2/3/4/5 |
Prolactin |
5 concentration levels |
IS-57201 | ||
| ELISA |
Estrone ELISA |
antibody-coated microplate wells | 0/20/60/200/600/2000 pg/ml |
96 x01 |
EQ 6165-9601-1 | ||
| ELISA |
Total Estrogens ELISA |
antibody-coated microplate wells | 0-2500 pg/ml |
96 x 01 |
EQ 6160-9601-1 | ||
| ELISA | Mullerian duct repression hormone(MRH/AMH) | antibody-coated microplate wells |
Anti-Mullerian hormone, Mullerian duct repression hormone |
6 standards, variable 0-24 ng/ml |
96 x 01 |
EQ 6161-9601 | |
| ELISA |
Pregnenolone ELISA |
antibody-coated microplate wells | 0/0.1/0.4/1.6/6.4/25.6 ng/ml |
96 x 01 |
EQ 6164-9601 | ||
| ELISA |
Dihydrotestosterone (DHT) ELISA |
antibody-coated microplate wells | 0/25/100/250/500/1000/2500 pg/ml |
96 x 01 |
EQ 6152-9601-1 | ||
| ELISA |
sCD163 determination in urine |
antibody-coated microplate wells |
soluble CD163 | 0-12 ng/ml |
96 x 01 |
EQ 6851-9601-U | |
| ELISA |
uromodulin determination in serum |
antibody-coated microplate wells |
0/25/50/100/200/400 ng/ml |
96 x 01 |
EQ 6821-9601 | ||
| PCR | EntericBio C. difficile | Clostridioides difficile |
lyophilized |
MH 0001-012401 | |||
| PCR | EntericBio Gastro Panel 2 | Salmonella, Shigella spp./EIEC, Campylobacter, EHEC(Stx1/2), Cryptosporidium, Giardia |
lyophilized |
MH 0002-012401 | |||
| PCR | EntericBio Dx | Salmonella, Shigella spp./EIEC, Campylobacter, EHEC(Stx1/2), Yersinia, Vibrio, Cryptosporidium, Giardia, Entamoeba histolytica |
lyophilized |
MH 0003-012401 | |||
| PCR | EntericBio CPE | Carbapenemase-Resistances (OXA-48, KPC, NDM, VIM, IMP, GES) |
lyophilized |
MH 0004-012401 | |||
| PCR | EntericBio Viral Panel 1 | Adenovirus, Rotavirus, Sapovirus |
lyophilized |
MH 0005-011201 | |||
| PCR | EntericBio Viral Panel 2 | Astrovirus, Norovirus GI, Norovirus GII |
lyophilized |
MH 0006-011201 | |||
| PCR | EntericBio Viral Panel 3 | Adenovirus, Rotavirus, Sapovirus, Astrovirus, Norovirus GI, Norovirus GII |
lyophilized |
MH 0007-011201 | |||
| PCR | EntericBio Stool Preparation Solution V2 | MH 0008-012401 | |||||
| ELISA | Anti-Hepatitis E Virus (HEV) ELISA (IgG) |
antigen-coated microplate wells |
recombinant target antigens from Hepatitis E virus genotypes 1 and 3 |
0,2/1/10/25 IU/ml | IgG |
96 x 01 |
EI 2525-9601 G |
| ELISA | Anti-Hepatitis E Virus (HEV) ELISA (IgM) |
antigen-coated microplate wells |
recombinant target antigens from Hepatitis E virus genotypes 1 and 3 |
semi-quantitative | IgM |
96 x 01 |
EI 2525-9601 M |
| EUROLINE |
Positive control serum (IgA, 50x concentrated) for Hepatitis E Virus |
IgA |
05 x 07 |
CL 2525-0507 A | |||
| EUROLINE |
Positive control serum (IgG, 50x concentrated) for hepatitis E virus |
IgG |
05 x 07 |
CL 2525-0507 G | |||
| EUROLINE |
EUROLINE Anti-Hepatitis E Virus (IgA) (separat: GT1 ORF2, GT2 ORF2, GT3 ORF2, GT4 ORF2) |
EUROLINE | IgA IgA IgA |
05 x 10 16 x 01 64 x 01 |
DN 2525-0510 A DN 2525-1601 A DN 2525-6401 A |
||
| EUROLINE |
EUROLINE Anti-Hepatitis E Virus (IgG) (separat: GT1 ORF2, GT2 ORF2, GT3 ORF2, GT4 ORF2) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DN 2525-1601 G DN 2525-6401 G |
||
| IIFT |
Listeria monocytogenes 1/2a and 4b |
bacterial smears (2 BIOCHIPs per field) |
Listeria monocytogenes 1/2a and 4b |
IgG IgG |
10 x 05 10 x 10 |
FI 2141-1005-1 G FI 2141-1010-1 G |
|
| ELISA | Anti-Helicobacter pylori ELISA (IgA) |
antigen-coated microplate wells |
detergent extract from Helicobacter pylori |
semi-quantitative | IgA |
96 x 01 |
EI 2080-9601 A |
| ELISA | Anti-Helicobacter pylori ELISA (IgG) |
antigen-coated microplate wells |
detergent extract from Helicobacter pylori |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2080-9601 G |
| ELISA | Anti-Helicobacter pylori CagA ELISA (IgA) |
antigen-coated microplate wells |
recombinant CagA, expression in E. coli |
semi-quantitative | IgA |
96 x 01 |
EI 2081-9601 A |
| ELISA | Anti-Campylobacter jejuni ELISA (IgA) |
antigen-coated microplate wells |
detergent extract from Campylobacter jejuni |
semi-quantitative | IgA |
96 x 01 |
EI 2091-9601 A |
| ELISA | Anti-Campylobacter jejuni ELISA (IgG) |
antigen-coated microplate wells |
detergent extract from Campylobacter jejuni |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2091-9601 G |
| ELISA | Anti-Yersinia enterocolitica ELISA (IgA) |
antigen-coated microplate wells |
recombinant Yop D of Yersinia enterocolitica |
semi-quantitative | IgA |
96 x 01 |
EI 2173-9601 A |
| ELISA | Anti-Yersinia enterocolitica ELISA (IgG) |
antigen-coated microplate wells |
native isolated virulence factors (release proteins, Yop) of Yersinia enterocolitica |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2173-9601 G |
| EUROLINE |
positive control serum: IgA, human, 50x concentrated for Yersinia enterocolitica IgA EUROLINE |
IgA |
05 x 07 |
CL 2173-0507 A | |||
| EUROLINE |
positive control serum: IgG, human, 50x concentrated for Yersinia enterocolitica IgG EUROLINE |
IgG |
05 x 07 |
CL 2173-0507 G | |||
| EUROLINE |
EUROLINE Anti-Yersinia enterocolitica (IgA) Detection of antibodies against virulence factors of the Yersinia enterocolitica pathogen in human serum (for diagnosing various forms of arthritis). |
EUROLINE | IgA IgA |
16 x 01 64 x 01 |
DN 2173-1601 A DN 2173-6401 A |
||
| EUROLINE |
EUROLINE Anti-Yersinia enterocolitica (IgG) Detection of antibodies against virulence factors of the Yersinia enterocolitica pathogen in human serum (for diagnosing various forms of arthritis). |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DN 2173-1601 G DN 2173-6401 G |
||
| WESTERNBLOT |
antibodies against Helicobacter pylori IgA positive control |
IgA |
50 x 05 |
CW 2080-5005 A | |||
| WESTERNBLOT |
antibodies against Helicobacter pylori IgG positive control |
IgG |
50 x 05 |
CW 2080-5005 G | |||
| WESTERNBLOT |
antibodies against Yersinia enterocolitica IgA positive control (for diagnosing various forms of arthritis) |
IgA |
50 x 05 |
CW 2173-5005 A | |||
| WESTERNBLOT |
antibodies against Yersinia enterocolitica IgG positive control (for diagnosing various forms of arthritis) |
IgG |
50 x 05 |
CW 2173-5005 G | |||
| WESTERNBLOT | Anti-Helicobacter pylori EUROLINE-Westernblot (IgA) | Westernblot |
whole antigen of H. pylori, plus recombinant VacA and CagA antigen |
IgA IgA |
16 x 01 30 x 01 |
DY 2080-1601-1 A DY 2080-3001-1 A |
|
| WESTERNBLOT | Anti-Helicobacter pylori EUROLINE-Westernblot (IgG) | Westernblot |
whole antigen of H. pylori, plus recombinant VacA and CagA antigen |
IgG IgG |
16 x 01 30 x 01 |
DY 2080-1601-1 G DY 2080-3001-1 G |
|
| WESTERNBLOT |
Anti-Yersinia enterocolitica WESTERNBLOT (IgA) Detection of antibodies against virulence factors of the Yersinia enterocolitica pathogen in human serum (for diagnosing various forms of arthritis). |
Westernblot |
isolated virulence factors (release proteins, Yop) of Yersinia enterocolitica |
IgA IgA |
16 x 01 30 x 01 |
DY 2173-1601 A DY 2173-3001 A |
|
| WESTERNBLOT |
Anti-Yersinia enterocolitica WESTERNBLOT (IgG) Detection of antibodies against virulence factors of the Yersinia enterocolitica pathogen in human serum (for diagnosing various forms of arthritis). |
Westernblot |
isolated virulence factors (release proteins, Yop) of Yersinia enterocolitica |
IgG IgG |
16 x 01 30 x 01 |
DY 2173-1601 G DY 2173-3001 G |
|
| IIFT |
Schistosoma mansoni |
frozen sections |
Schistosoma mansoni, adult |
IgG IgM |
10 x 05 10 x 05 |
FI 2300-1005 G FI 2300-1005 M |
|
| ELISA | Anti-Strongyloides ELISA (IgG) |
antigen-coated microplate wells |
native antigens from Strongyloides larvae |
semi-quantitative | IgG |
96 x 01 |
EI 2290-9601 G |
| ELISA | Anti-Schistosoma ELISA (IgG) |
antigen-coated microplate wells |
soluble egg-protein, purifiied from Schistosoma mansoni eggs"soluble egg antigen" |
semi-quantitative | IgG |
96 x 01 |
EI 2300-9601 G |
| ELISA | Anti-Schistosoma ELISA (IgM) |
antigen-coated microplate wells |
purified antigen from adult Schistosoma mansoni "adult worm antigen" |
semi-quantitative | IgM |
96 x 01 |
EI 2300-9601 M |
| ELISA | Anti-Adenovirus ELISA (IgA) |
antigen-coated microplate wells |
native antigens from Adenovirus |
semi-quantitative | IgA |
96 x 01 |
EI 2680-9601 A |
| ELISA | Anti-Adenovirus ELISA (IgG) |
antigen-coated microplate wells |
native antigens from Adenovirus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2680-9601 G |
| ELISA | Anti-Adenovirus ELISA (IgM) |
antigen-coated microplate wells |
native antigens from Adenovirus |
semi-quantitative | IgM |
96 x 01 |
EI 2680-9601 M |
| PCR | GeneProof Adenovirus PCR Kit |
Adenovirus respiratory species A–D, G and gastrointestinal species E-F |
01 x 100 01 x 25 |
MH 0011-01001 MH 0011-01251 |
|||
| PCR | GeneProof Aspergillus PCR Kit |
Aspergillus spp. (A. fumigatus, A. flavus, A. niger, A. oryzae, A. candidus, A. foetidus, A. nidulans, A. ustus, A. versicolor, A. wentii, A. clavatus, A. niveus) (ASPspp), 100 % Aspergillus terreus (ASPT), 100 % |
01 x 100 01 x 25 |
MH 0013-01001 MH 0013-01251 |
|||
| PCR | GeneProof Parvovirus B19 PCR Kit |
Parvovirus B19 |
01 x 100 01 x 25 |
MH 0015-01001 MH 0015-01251 |
|||
| PCR | GeneProof BK/JC Virus (BK/JC) PCR Kit |
BK Virus and JC Virus |
01 x 100 01 x 25 |
MH 0017-01001 MH 0017-01251 |
|||
| PCR | GeneProof BK Virus (BKV) PCR Kit |
BK Virus |
01 x 100 01 x 25 |
MH 0019-01001 MH 0019-01251 |
|||
| PCR | GeneProof Cytomegalovirus (CMV) PCR Kit |
Cytomegalovirus |
01 x 100 01 x 25 |
MH 0021-01001 MH 0021-01251 |
|||
| PCR | GeneProof Epstein-Barr Virus (EBV) PCR Kit |
Epstein-Barr Virus |
01 x 100 01 x 25 |
MH 0023-01001 MH 0023-01251 |
|||
| PCR | GeneProof Enterovirus PCR Kit |
Enterovirus species A-D including Coxsackievirus, Echovirus, Enterovirus, Poliovirus and the newly discovered Enterovirus group EV-C104 |
01 x 100 01 x 25 |
MH 0025-01001 MH 0025-01251 |
|||
| PCR | GeneProof Human Herpesvirus 6/7 /(HHV-6/7) PCR Kit |
human Herpesvirus 6 and 7 |
01 x 100 01 x 25 |
MH 0027-01001 MH 0027-01251 |
|||
| PCR | GeneProof Human Herpesvirus 8 (HHV-8) PCR Kit |
Humanes Herpesvirus 8 |
01 x 100 01 x 25 |
MH 0029-01001 MH 0029-01251 |
|||
| PCR | GeneProof Herpes Simplex Virus (HSV-1/2) PCR Kit |
Herpes Simplex Virus 1 / 2 |
01 x 100 01 x 25 |
MH 0031-01001 MH 0031-01251 |
|||
| PCR | GeneProof JC Virus (JCV) PCR Kit |
JC Virus |
01 x 100 01 x 25 |
MH 0033-01001 MH 0033-01251 |
|||
| PCR | GeneProof Varicella- Zoster Virus (VZV) PCR Kit |
Varicella-Zoster Virus |
01 x 100 01 x 25 |
MH 0035-01001 MH 0035-01251 |
|||
| PCR | GeneProof Borrelia PCR Kit |
Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, B. andersonii, B. bissettii, B. valaisiana, B. lusitaniae, B. japonica, B. tanukii, B. turdi, B. sinica, B. mayonii, B. spielmanii, B. bavariensis, B. kurtenbachii, B. miyamotoi (Asian genotype), 100 % |
01 x 100 01 x 25 |
MH 0037-01001 MH 0037-01251 |
|||
| PCR | GeneProof Bordetella pertussis/parapertussis PCR Kit |
Bordetella pertussis / Bordetella parapertussis |
01 x 100 01 x 25 |
MH 0039-01001 MH 0039-01251 |
|||
| PCR | GeneProof Chlamydia pneumoniae PCR Kit |
Chalmydia pneumoniae |
01 x 100 01 x 25 |
MH 0041-01001 MH 0041-01251 |
|||
| PCR | GeneProof Legionella pneumophila PCR Kit |
Legionella pneumoniae |
01 x 100 01 x 25 |
MH 0043-01001 MH 0043-01251 |
|||
| PCR | GeneProof Mycoplasma pneumoniae PCR Kit |
Mycoplasma pneumoniae |
01 x 100 01 x 25 |
MH 0046-01001 MH 0046-01251 |
|||
| PCR | GeneProof SARS-CoV-2 Advanced PCR kit |
SARS-CoV-2, three targets (RdRp/E/N), single callout for RdRp |
01 x 100 01 x 25 |
MH 0047-01001 MH 0047-01251 |
|||
| PCR | GeneProof SARS-CoV-2 Screening PCR kit |
SARS-CoV-2 three targets (RdRp/E/N), in one channel |
01 x 100 01 x 25 |
MH 0049-01001 MH 0049-01251 |
|||
| PCR | GeneProof Flu Multiplex PCR Kit |
Detects all currently known Influenza A serotypes including H1N1, H1N1pdm09, H3N2, H5N8 and H7N Detects both Influenza B lineages Victoria and Yamagata Detects RSV A and RSV B" |
01 x 100 01 x 25 |
MH 0051-01001 MH 0051-01251 |
|||
| PCR | GeneProof Human Papillomavirus (HPV) Screening PCR Kit |
differentiation of HR types 16, 18, 45 + unique detection of 24 HR HPV types |
01 x 100 01 x 25 |
MH 0053-01001 MH 0053-01251 |
|||
| PCR | GeneProof Chlamydia trachomatis PCR Kit |
Chlamydia trachomatis |
01 x 100 01 x 25 |
MH 0055-01001 MH 0055-01251 |
|||
| PCR | GeneProof CT/NG/MG Multiplex PCR Kit |
Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium |
01 x 100 01 x 25 |
MH 0057-01001 MH 0057-01251 |
|||
| PCR | GeneProof Gardnerella vaginalis PCR Kit |
Gardnerella vaginalis |
01 x 100 01 x 25 |
MH 0059-01001 MH 0059-01251 |
|||
| PCR | GeneProof Mycoplasma genitalium/hominis PCR Kit |
Mycoplasma genitalium / Mycoplasma hominis |
01 x 100 01 x 25 |
MH 0061-01001 MH 0061-01251 |
|||
| PCR | GeneProof MH/UU/UP Multiplex PCR Kit |
Mycoplasma hominis / Ureaplasma urealyticum / Ureaplasma parvum |
01 x 100 01 x 25 |
MH 0063-01001 MH 0063-01251 |
|||
| PCR | GeneProof Neisseria gonorrhoeae PCR Kit |
Neisseria gonorrhoeae |
01 x 100 01 x 25 |
MH 0065-01001 MH 0065-01251 |
|||
| PCR | GeneProof Treponema pallidum PCR Kit |
Treponema pallidum |
01 x 100 01 x 25 |
MH 0067-01001 MH 0067-01251 |
|||
| PCR | GeneProof Trichomonas vaginalis PCR Kit |
Trichomonas vaginalis |
01 x 100 01 x 25 |
MH 0069-01001 MH 0069-01251 |
|||
| PCR | GeneProof Ureaplasma PCR Kit |
Ureaplasma urealyticum / Ureaplasma parvum |
01 x 100 01 x 25 |
MH 0071-01001 MH 0071-01251 |
|||
| PCR | GeneProof Hepatitis B Virus (HBV) PCR Kit |
Hepatitis B Virus |
01 x 100 01 x 25 |
MH 0074-01001 MH 0074-01251 |
|||
| PCR | GeneProof Hepatitis C Virus (HCV) Diagnostic PCR Kit |
Hepatitis C Virus |
01 x 100 01 x 25 |
MH 0076-01001 MH 0076-01251 |
|||
| PCR | GeneProof HIV type 1 (HIV-1) Diagnostic PCR Kit |
Humanes Immundefizienz-Virus |
01 x 100 01 x 25 |
MH 0078-01001 MH 0078-01251 |
|||
| PCR | GeneProof VRE PCR Kit |
Vancomycin-resistant Enterococcus, vanA, vanB Gene (e. g. Enterococcus faecalis, Enterococcus faecium, Enterococcus gallinarium, etc.) |
01 x 100 01 x 25 |
MH 0079-01001 MH 0079-01251 |
|||
| PCR | GeneProof Mycobacterium tuberculosis PCR Kit |
Mycobacterium pneumoniae |
01 x 100 01 x 25 |
MH 0081-01001 MH 0081-01251 |
|||
| PCR | GeneProof Factor II Prothrombin PCR Kit |
Faktor II |
01 x 100 01 x 25 |
MH 0083-01001 MH 0083-01251 |
|||
| PCR | GeneProof Factor V Leiden PCR Kit |
Polymorphism of factor V Leiden |
01 x 100 01 x 25 |
MH 0085-01001 MH 0085-01251 |
|||
| PCR | GeneProof Factor XIII V34L PCR Kit |
Faktor XIII |
01 x 100 01 X 25 |
MH 0087-01001 MH 0087-01251 |
|||
| PCR | GeneProof MTHFR A1298C PCR Kit |
polymorphism in the gene for methylenetetrahydrofolate reductase |
01 x 100 01 x 25 |
MH 0089-01001 MH 0089-01251 |
|||
| PCR | GeneProof MTHFR C677T PCR Kit |
polymorphism in the gene for methylenetetrahydrofolate reductase |
01 x 100 01 x 25 |
MH 0091-01001 MH 0091-01251 |
|||
| PCR | GeneProof PAI - 1 Genotyping PCR Kit |
Polymorphism in promoter of the PAI-1 gene in site 675 |
01 x 100 01 x 25 |
MH 0093-01001 MH 0093-01251 |
|||
| PCR | GeneProof Universal Internal Control |
01 x 100 |
MH 0095-01001 | ||||
| PCR | GeneProof PathogenFree DNA Isolation Kit |
01 x 50 |
MH 0096-01501 | ||||
| PCR | GeneProof PathogenFree RNA Isolation Kit |
01 x 50 |
MH 0097-01501 | ||||
| IIFT | HHV-6 | infected cells | EU 30 | IgG IgM IgG IgM IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 20 x 10 20 x 10 |
FI 2536-1005 G FI 2536-1005 M FI 2536-1010 G FI 2536-1010 M FI 2536-2005 G FI 2536-2005 M FI 2536-2010 G FI 2536-2010 M |
|
| IIFT |
Epstein-Barr virus capsid antigen (EBV-CA) |
expressing cells | P3HR1 | IgG EB IgM EB IgG EB IgM EB IgM EB IgG EB |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 10 |
FI 2791-1005 G FI 2791-1005 M FI 2791-1010 G FI 2791-1010 M FI 2791-2005 M FI 2791-2010 G |
|
| IIFT |
Epstein-Barr virus nuclear antigen (EBNA, complement-fixing antibodies) |
expressing cells | Raji | C3c EB |
10 x 10 |
FI 2793-1010 C | |
| IIFT |
Epstein-Barr virus early antigen (EBV-EA) |
expressing cells | EU 33 | IgG EB IgG EB |
10 x 05 10 x 10 |
FI 2795-1005 G FI 2795-1010 G |
|
| IIFT |
BIOCHIP Sequence EBV fields A and B: EBV-CA (IgG) field C: EBV-CA (IgM) field D: EBV-EA field E: EBNA |
expressing cells expressing cells expressing cells expressing cells |
P3HR1 P3HR1 EU 33 Raji |
Aviditätsbestimmung Aviditätsbestimmung Aviditätsbestimmung Aviditätsbestimmung |
10 x 01 10 x 02 20 x 01 20 x 02 |
FI 2799-1001-1 X FI 2799-1002-1 X FI 2799-2001-1 X FI 2799-2002-1 X |
|
| IIFT |
EUROPLUS BIOCHIP Sequence EBV field A: EBV-CA (IgG), gp125 ag, p19 ag field B: EBV-CA (IgG) field C: EBV-CA (IgM), gp125 ag, p19 ag field D: EBV-EA field E: EBNA |
expr. cells, gp125/p19/ ag-free BIOCHIP expressing cells expressing cells expr. cells, gp125/p19/ ag-free BIOCHIP expressing cells |
P3HR1, native/rec. EU 120 P3HR1 P3HR1, native/rec. EU 120 EU 33 Raji |
Aviditätsbestimmung Aviditätsbestimmung Aviditätsbestimmung Aviditätsbestimmung |
10 x 01 10 x 02 20 x 01 20 x 02 |
FI 2799-1001-21 X FI 2799-1002-21 X FI 2799-2001-21 X FI 2799-2002-21 X |
|
| IIFT | HHV-6 EUROPattern | infected cells | EU 30 | IgG EB IgM EB IgG EB IgM EB IgG EB IgM EB IgG EB IgM EB |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 20 x 10 20 x 10 |
FR 2536-1005 G FR 2536-1005 M FR 2536-1010 G FR 2536-1010 M FR 2536-2005 G FR 2536-2005 M FR 2536-2010 G FR 2536-2010 M |
|
| ELISA |
Anti-EBV-CA ELISA (IgA) Epstein-Barr virus capsid antigen |
antigen-coated microplate wells |
native, mixture of several viral capsid antigens |
semi-quantitative | IgA |
96 x 01 |
EI 2791-9601 A |
| ELISA |
Anti-EBV-CA ELISA (IgG) Epstein-Barr virus capsid antigen |
antigen-coated microplate wells |
native, mixture of several viral capsid antigens |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2791-9601 G |
| ELISA |
Anti-EBV-CA ELISA (IgM) Epstein-Barr virus capsid antigen |
antigen-coated microplate wells |
native gp125 of EBV |
semi-quantitative | IgM |
96 x 01 |
EI 2791-9601 M |
| ELISA |
Avidity: Anti-EBV-CA-ELISA (IgG) Epstein-Barr virus capsid antigen avidity determination |
antigen-coated microplate wells |
native, mixture of several viral capsid antigens |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2791-9601-1 G |
| ELISA |
Anti-EBNA-1 ELISA (IgG) Epstein-Barr virus nuclear antigen |
antigen-coated microplate wells |
recombinant EBNA-1 from EBV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2793-9601 G |
| ELISA |
Anti-EBV-EA-D ELISA (IgA) Epstein-Barr virus early antigen |
antigen-coated microplate wells |
recombinant early antigen D from EBV |
semi-quantitative | IgA |
96 x 01 |
EI 2795-9601 A |
| ELISA |
Anti-EBV-EA-D ELISA (IgG) Epstein-Barr virus early antigen |
antigen-coated microplate wells |
recombinant early antigen D from EBV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2795-9601 G |
| ELISA |
Anti-EBV-EA-D ELISA (IgM) Epstein-Barr virus early antigen |
antigen-coated microplate wells |
recombinant early antigen D from EBV |
semi-quantitative | IgM |
96 x 01 |
EI 2795-9601 M |
| EUROLINE |
positive control serum: IgG, human, 50x concentrated for EBV-Profil 2 G |
IgG |
05 x 07 |
CL 2790-0507-12 G | |||
| EUROLINE |
positive control serum: IgM, human, 50x concentrated for EBV-Profil 2 M |
IgM |
05 x 07 |
CL 2790-0507-12 M | |||
| EUROLINE |
EUROLINE Anti-EBV Profile 2 (IgM) (VCA gp125, VCA p19, EBNA-1, p22, EA-D separately) |
EUROLINE | IgM IgM IgM |
05 x 10 16 x 01 64 x 01 |
DN 2790-0510-2 M DN 2790-1601-2 M DN 2790-6401-2 M |
||
| EUROLINE |
EUROLINE Anti-EBV (IgM) (VCA gp125, VCA p19, EA-D separately) |
EUROLINE | IgM IgM IgM |
05 x 10 16 x 01 64 x 01 |
DN 2790-0510-4 M DN 2790-1601-4 M DN 2790-6401-4 M |
||
| EUROLINE |
EUROLINE Anti-EBV Profile 2 (IgG) (VCA gp125, VCA p19, EBNA-1, p22, EA-D separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DN 2790-1601-2 G DN 2790-5001-2 G DN 2790-6401-2 G |
||
| EUROLINE |
EUROLINE Anti-EBV (IgG) (VCA gp125, VCA p19, EBNA-1, p22. EA-D separately) |
EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DN 2790-1601-4 G DN 2790-5001-4 G DN 2790-6401-4 G |
||
| ChLIA | IDS EBV VCA IgG | antigenic coated magnetic particles | Capsid antigen |
quantitative |
100 x 01 |
IS-ID58011 | |
| ChLIA | IDS EBV VCA IgM | antigenic coated magnetic particles | Capsid antigen |
quantitative |
100 x 01 |
IS-ID58021 | |
| ChLIA | IDS EBV EBNA-1 IgG | antigenic coated magnetic particles | EBNA-1 |
quantitative |
100 x 01 |
IS-ID58031 | |
| ChLIA | IDS EBV EA IgG | antigenic coated magnetic particles | EA-D antigen |
quantitative |
50 x 01 |
IS-ID58041 | |
| ChLIA | IDS EBV Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID58301 | ||
| ChLIA |
Anti-EBV-CA ChLIA (IgG) Epstein-Barr virus capsid antigen |
Antigen-coated magnetic particles |
recombinant p18, p23, gp125 |
quantitative | IgG |
100 x 1 |
LI 2791-10010 G |
| ChLIA |
Anti-EBV-CA ChLIA (IgM) Epstein-Barr virus capsid antigen |
Antigen-coated magnetic particles |
recombinant p18, gp125 |
quantitative | IgM |
100 x 1 |
LI 2791-10010 M |
| ChLIA |
Anti-EBNA-1 ChLIA (IgG) Epstein-Barr virus nuclear antigen |
Antigen-coated magnetic particles |
recombinant EBNA-1 |
quantitative | IgG |
100 x 1 |
LI 2793-10010 G |
| ChLIA |
Control set Anti-EBV-CA ChLIA (IgG) Epstein-Barr virus capsid antigen |
2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 2791-20210 G | ||
| ChLIA |
Control set Anti-EBV-CA ChLIA (IgM) Epstein-Barr virus capsid antigen |
2 x 0.5 ml control 1/2 | IgM |
02 x 02 |
LR 2791-20210 M | ||
| ChLIA |
Control set Anti-EBNA-1 ChLIA (IgG) Epstein-Barr virus nuclear antigen |
2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 2793-20210 G | ||
| MICROBLOT | EUROMicroblot Anti-EBV (IgG) | IgG |
96 x 01 |
KN 2790-9601 G | |||
| MICROBLOT | EUROMicroblot Anti-EBV (IgM) | IgM |
96 x 01 |
KN 2790-9601 M | |||
| ELISA |
Anti-CMV ELISA (IgG) cytomegalovirus |
antigen-coated microplate wells |
native antigens from CMV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2570-9601 G |
| ELISA |
Anti-CMV ELISA (IgM) cytomegalovirus |
antigen-coated microplate wells |
native antigens from CMV |
semi-quantitative | IgM |
96 x 01 |
EI 2570-9601 M |
| ELISA |
Avidity: Anti-CMV ELISA (IgG) cytomegalovirus avidity determination |
antigen-coated microplate wells |
native antigens from CMV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2570-9601-1 G |
| ELISA |
Anti-CMV p52 ELISA (IgM) cytomegalovirus p52 antigen from CMV |
antigen-coated microplate wells |
native antigens from CMV |
semi-quantitative | IgM |
96 x 01 |
EI 2570-9601-2 M |
| ELISA |
Anti-CMV gB ELISA (IgG) cytomegalovirus glycoprotein B glycoprotein B antigen from CMV |
antigen-coated microplate wells |
recombinant glycoprotein B antigen from CMV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2570-9601-3 G |
| EUROLINE |
positive control serum: IgG, human, 50x concentrated for CMV |
IgG |
05 x 07 |
CL 2570-0507 G | |||
| EUROLINE |
positive control serum: IgM, human, 50x concentrated for CMV |
IgM |
05 x 07 |
CL 2570-0507 M | |||
| EUROLINE | EUROLINE Anti-CMV (IgG) | EUROLINE | IgG IgG IgG |
16 x 01 50 x 01 64 x 01 |
DN 2570-1601-2 G DN 2570-5001-2 G DN 2570-6401-2 G |
||
| EUROLINE | EUROLINE Anti-CMV (IgM) | EUROLINE | IgM IgM IgM |
16 x 01 50 x 01 64 x 01 |
DN 2570-1601-2 M DN 2570-5001-2 M DN 2570-6401-2 M |
||
| ChLIA | IDS CMV IgG | antigenic coated magnetic particles | CMV antigen |
qualitative |
100 x 01 |
IS-ID54011 | |
| ChLIA | IDS CMV IgM | antigenic coated magnetic particles | CMV antigen |
qualitative |
100 x 01 |
IS-ID54021 | |
| ChLIA | IDS CMV Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID54301 | ||
| ChLIA | IDS CMV IgG Avidity | antigenic coated magnetic particles | CMV antigen |
qualitative |
50 x 01 |
IS-ID55011 | |
| ChLIA | IDS CMV Avidity Control Set | 3 x 1.0 ml Control 1/2 | human serum |
2 concentrations |
IS-ID55301 | ||
| ELISA |
Anti-HSV-1/2 Pool ELISA (IgG) herpes simplex virus native antigens from HSV-1 and HSV-2 |
antigen-coated microplate wells |
native antigens from HSV-1 and HSV-2 |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2531-9601-1 G |
| ELISA |
Anti-HSV-1/2 Pool ELISA (IgM) herpes simplex virus native antigens from HSV-1 and HSV-2 |
antigen-coated microplate wells |
native antigens from HSV-1 and HSV-2 |
semi-quantitative | IgM |
96 x 01 |
EI 2531-9601-1 M |
| ELISA |
Anti-HSV-1 (gC1) ELISA (IgG) herpes simplex virus 1 recombinant glycoprotein C1 from HSV-1 |
antigen-coated microplate wells |
recombinant glycoprotein C1 |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2531-9601-2 G |
| ELISA |
Anti-HSV-2 (gG2) ELISA (IgG) herpes simplex virus 2 recombinant glycoprotein G2 from HSV-2 |
antigen-coated microplate wells |
recombinant glycoprotein G2 |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2532-9601-2 G |
| WESTERNBLOT |
antibodies against Herpes simplex virus (HSV) IgG positive control |
IgG |
50 x 05 |
CW 2531-5005 G | |||
| WESTERNBLOT |
Anti-HSV-1 / HSV-2 gG-2 EUROLINE-WB (IgG) Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2 |
Westernblot |
whole antigen, SDS extract of HSV-1 plus purified gG2 |
IgG |
16 x 01 |
DY 2531-1601-1 G | |
| WESTERNBLOT |
Anti-HSV-1 / HSV-2 gG-2 EUROLINE-WB (IgM) Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2 |
Westernblot |
whole antigen, SDS extract of HSV-1 plus purified gG2 |
IgM |
16 x 01 |
DY 2531-1601-1 M | |
| ChLIA | IDS HSV-1 IgG | antigenic coated magnetic particles | gG1 antigen |
quantitative |
100 x 01 |
IS-ID56011 | |
| ChLIA | IDS HSV-2 IgG | antigenic coated magnetic particles | gG2 antigen |
quantitative |
100 x 01 |
IS-ID56021 | |
| ChLIA | IDS HSV 1/2 IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID56301 | ||
| ChLIA | IDS HSV 1/2 IgM | antigenic coated magnetic particles | gG1 and gG2 antigens |
quantitative |
100 x 01 |
IS-ID57011 | |
| ChLIA | IDS HSV 1/2 IgM Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID57301 | ||
| ChLIA | Anti-Herpes simplex virus 1 ChLIA (IgG) | Antigen-coated magnetic particles | recombinant gG1 | quantitative | IgG |
100 x 1 |
LI 2531-10010 G |
| ChLIA | Anti-Herpes simplex virus 2 ChLIA (IgG) | Antigen-coated magnetic particles | rekombinant gG2 | quantitative | IgG |
100 x 1 |
LI 2532-10010 G |
| ChLIA | Control set Anti-HSV 1 ChLIA (IgG) | 2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 2531-20210 G | ||
| ChLIA | Control set Anti-HSV 2 ChLIA (IgG) | 2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 2532-20210 G | ||
| IIFT |
Varicella zoster virus (VZV) |
infected cells | EU 168 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2650-1005 G FI 2650-1005 M FI 2650-1010 G FI 2650-1010 M |
|
| ELISA |
Anti-VZV ELISA (IgA) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
semi-quantitative | IgA |
96 x 01 |
EI 2650-9601 A |
| ELISA |
Anti-VZV ELISA (IgG) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
10/100/500/5000 IU/l | IgG |
96 x 01 |
EI 2650-9601 G |
| ELISA |
Anti-VZV ELISA (IgM) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
semi-quantitative | IgM |
96 x 01 |
EI 2650-9601 M |
| ELISA |
Avidity: Anti-VZV ELISA (IgG) Varicella zoster virus avidity determination |
antigen-coated microplate wells |
native antigens from VZV |
10/100/500/5000 IU/l | IgG |
96 x 01 |
EI 2650-9601-1 G |
| ELISA |
Anti-VZV ELISA 2.0 (IgG) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV | IgG |
96 x 01 |
EI 2650-9601-2 G | |
| ELISA |
Anti-VZV Glycoprotein ELISA (IgM) Varicella zoster virus |
antigen-coated microplate wells |
native glycoproteins from VZV |
semi-quantitative | IgM |
96 x 01 |
EI 2650-9601-2 M |
| ChLIA | IDS VZV IgG | antigenic coated magnetic particles | VZV virus antigen |
quantitative |
50 x 01 |
IS-ID59031 | |
| ChLIA | IDS MMV IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID59301 | ||
| ChLIA | IDS VZV IgM | antigenic coated magnetic particles | VZV virus antigen |
quantitative |
50 x 01 |
IS-ID60031 | |
| ChLIA | IDS MMV IgM Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID60301 | ||
| EUROArray | EUROArray Dermatomycosis |
MN 2850-0505 MN 2850-0803 MN 2850-1005 MN 2850-2005 |
|||||
| EUROArray | EUROArray STI - 11 |
MN 2830-0505 MN 2830-0803 MN 2830-1005 MN 2830-2005 |
|||||
| EUROArray | EUROArray HPV |
MN 2540-0505 MN 2540-0803 MN 2540-1005 MN 2540-2005 |
|||||
| IIFT | Chlamydia pneumoniae |
elementary bodies (MIF) non-infected cells (2 BIOCHIPs per field) |
EU 40 EU 40 |
IgA EB IgG EB IgM EB |
10 x 05 10 x 05 10 x 05 |
FI 2192-1005-80 A FI 2192-1005-80 G FI 2192-1005-80 M |
|
| IIFT |
Bartonella henselae |
infected cells | EU 70 | IgG IgG |
10 x 05 10 x 10 |
FI 219b-1005 G FI 219b-1010 G |
|
| IIFT |
Bartonella henselae |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 70 | IgM EB IgM EB |
10 x 05 10 x 10 |
FI 219b-1005 M FI 219b-1010 M |
|
| IIFT |
Bartonella henselae Bartonella quintana |
infected cells infected cells (2 BIOCHIPs per field) |
EU 70 EU 70 |
IgG IgG |
10 x 05 10 x 10 |
FI 219b-1005-1 G FI 219b-1010-1 G |
|
| IIFT |
Bartonella henselae Bartonella quintana |
infected and non- infected cells (4 BIOCHIPs per field) |
EU 70 EU 38 |
IgM EB IgM EB |
10 x 05 10 x 10 |
FI 219b-1005-1 M FI 219b-1010-1 M |
|
| IIFT |
Mosaic Coxsackie virus types A7, A9, A16, A24, B1, B2, B3, B4, B5 |
9 BIOCHIPs per field: infected cells |
EU 38 |
IgG IgM |
10 x 05 10 x 05 |
FI 2730-1005-1 G FI 2730-1005-1 M |
|
| IIFT |
Mosaic Coxsackie virus A types types A7, A9, A16, A24 |
4 BIOCHIPs per field: infected cells |
EU 38 |
IgG IgM IgG IgM IgG IgM |
10 x 05 10 x 05 20 x 05 20 x 05 20 x 10 20 x 10 |
FI 2730-1005-2 G FI 2730-1005-2 M FI 2730-2005-2 G FI 2730-2005-2 M FI 2730-2010-2 G FI 2730-2010-2 M |
|
| IIFT |
Mosaic Coxsackie virus B types types B1, B2, B3, B4, B5, B6 |
6 BIOCHIPs per field: infected cells |
EU 38 |
IgG IgM IgG IgM |
10 x 05 10 x 05 20 x 05 20 x 05 |
FI 2730-1005-3 G FI 2730-1005-3 M FI 2730-2005-3 G FI 2730-2005-3 M |
|
| IIFT |
Coxsackie virus type A7 Coxsackie virus type B1 |
infected cells infected cells (2 BIOCHIPs per field) |
EU 38 EU 38 |
IgA IgG |
10 x 05 10 x 05 |
FI 2730-1005-4 A FI 2730-1005-4 G |
|
| IIFT | Chlamydia pneumoniae EUROPattern |
elementary bodies (MIF) non-infected cells (2 BIOCHIPs per field) |
EU 40 EU 40 |
IgA EB IgG EB IgM EB |
10 x 05 10 x 05 10 x 05 |
FR 2192-1005-80 A FR 2192-1005-80 G FR 2192-1005-80 M |
|
| IIFT |
Bartonella henselae EUROPattern Bartonella quintana EUROPattern |
infected cells infected cells (2 BIOCHIPs per field) |
EU 70 EU 70 |
IgG PI IgG PI |
10 x 05 10 x 10 |
FR 219b-1005-1 G FR 219b-1010-1 G |
|
| IIFT |
Bartonella henselae EUROPattern Bartonella quintana EUROPattern |
infected and non- infected cells (4 BIOCHIPs per field) |
EU 70 EU 38 |
IgM EB |
20 x 10 |
FR 219b-2010-1 M | |
| IIFT |
Coxsackie virus screen (types A) EUROPattern types A7, A9, A16, A24 |
4 BIOCHIPs per field: infected cells |
EU 38 |
IgG PI IgM PI |
20 x 10 20 x 10 |
FR 2730-2010-2 G FR 2730-2010-2 M |
|
| IIFT |
Coxsackie virus screen (types B) EUROPattern types B1, B2, B3, B4, B5, B6 |
6 BIOCHIPs per field: infected cells |
EU 38 |
IgG PI IgM PI |
20 x 10 20 x 10 |
FR 2730-2010-3 G FR 2730-2010-3 M |
|
| ELISA | Anti-Brucella abortus ELISA (IgG) |
antigen-coated microplate wells |
bacterial lysate from Brucella abortus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2189-9601 G |
| ELISA | Anti-Brucella abortus ELISA (IgM) |
antigen-coated microplate wells |
bacterial lysate from Brucella abortus |
semi-quantitative | IgM |
96 x 01 |
EI 2189-9601 M |
| ELISA | Anti-Chlamydia pneumoniae ELISA (IgA) |
antigen-coated microplate wells |
native antigens, from C. pneumoniae |
semi-quantitative | IgA |
96 x 01 |
EI 2192-9601 A |
| ELISA | Anti-Chlamydia pneumoniae ELISA (IgG) |
antigen-coated microplate wells |
native antigens, from C. pneumoniae |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2192-9601 G |
| ELISA | Anti-Chlamydia pneumoniae ELISA (IgM) |
antigen-coated microplate wells |
native antigens, from C. pneumoniae |
semi-quantitative | IgM |
96 x 01 |
EI 2192-9601 M |
| ELISA | Anti-Enterovirus ELISA (IgA) |
antigen-coated microplate wells |
recombinant VP1 of ECHO 6 / Coxsackie B5 virus |
semi-quantitative | IgA |
96 x 01 |
EI 2730-9601-1 A |
| ELISA | Anti-Enterovirus ELISA (IgG) |
antigen-coated microplate wells |
recombinant VP1 of ECHO 6 / Coxsackie B5 virus |
semi-quantitative | IgG |
96 x 01 |
EI 2730-9601-1 G |
| ELISA | Anti-Enterovirus ELISA (IgM) |
antigen-coated microplate wells |
recombinant VP1 of ECHO 6 / Coxsackie B5 virus |
semi-quantitative | IgM |
96 x 01 |
EI 2730-9601-1 M |
| WESTERNBLOT |
negative control for infectious serology blot systems (IgA) |
IgA |
00 x 05 |
CW 2000-0005 ZA | |||
| WESTERNBLOT |
negative control for infectious serology blot systems (IgG) |
IgG |
00 x 05 |
CW 2000-0005 ZG | |||
| WESTERNBLOT |
negative control for infectious serology blot systems (IgM) |
IgM |
00 x 05 |
CW 2000-0005 ZM | |||
| ELISA | Aspergillus antigen |
antibody-coated microplate wells |
Aspergillus fumigatus extract | 0/20/50/125/312.5/625 pg/ml |
96 x 01 |
EQ 6911-9601 | |
| IIFT |
Leishmania donovani (promastigote) |
protozoan smear |
Leishmania donovani |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2231-1005 G FI 2231-1005 M FI 2231-1010 G FI 2231-1010 M |
|
| ELISA | Anti-Trypanosoma cruzi ELISA (IgG) |
antigen-coated microplate wells |
recombinant fusion protein of antigen epitopes from Trypanosoma cruzi |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2212-9601 G |
| ELISA | Anti-Leishmania ELISA (IgG) |
antigen-coated microplate wells |
antigen combination of specific recombinant L. donovani antigens and purified native antigens from L. infantum |
200-50-20-2 RU/ml | IgG |
96 x 01 |
EI 2232-9601 G |
| ELISA | Anti-Plasmodium ELISA (IgG) |
antigen-coated microplate wells |
optimized mixture of rec. antigens from 5 human pathogeneous species |
semi-quantitative | IgG |
96 x 01 |
EI 2260-9601 G |
| ELISA | Anti-Toxocara ELISA (IgG) |
antigen-coated microplate wells |
semi-quantitative | IgG |
96 x 01 |
EI 2311-9601 G | |
| ELISA | Anti-Echinococcus ELISA (IgG) |
antigen-coated microplate wells |
native Echinococcus multilocularis antigen EmVF |
semi-quantitative | IgG |
96 x 01 |
EI 2320-9601-1 G |
| ELISA | Anti-Trichinella ELISA (IgG) |
antigen-coated microplate wells |
antigens from Trichinella muscle larvae |
semi-quantitative | IgG |
96 x 01 |
EI 2360-9601 G |
| WESTERNBLOT |
antibodies against Echinococcus IgG positive control |
IgG |
50 x 05 |
CW 2321-5005 G | |||
| WESTERNBLOT | Anti-Toxocara Westernblot (IgG) | Westernblot | Toxocara whole lysate | IgG |
16 x 01 |
DY 2311-1601 G | |
| WESTERNBLOT |
EUROLINE-WB Anti-Echinococcus (IgG) Echinococcus multilocularis and Echinococcus granulosus |
Westernblot |
Echinococcus multilocularis and Echinococcus granulosus |
IgG IgG |
16 x 01 48 x 01 |
DY 2321-1601-2 G DY 2321-4801-2 G |
|
| IIFT |
Toxoplasma gondii |
protozoan smear |
Toxoplasma gondii |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2410-1005 G FI 2410-1005 M FI 2410-1010 G FI 2410-1010 M |
|
| ELISA | Anti-Toxoplasma gondii ELISA (IgA) |
antigen-coated microplate wells |
native antigens of Toxoplasma gondii |
semi-quantitative | IgA |
96 x 01 |
EI 2410-9601 A |
| ELISA | Anti-Toxoplasma gondii ELISA (IgM) |
antigen-coated microplate wells |
native antigens of Toxoplasma gondii |
semi-quantitative | IgM |
96 x 01 |
EI 2410-9601 M |
| ELISA |
Avidity: Anti-Toxoplasma gondii ELISA (IgG) avidity determination |
antigen-coated microplate wells |
native antigens of Toxoplasma gondii |
1/10/200 IU/ml | IgG |
96 x 01 |
EI 2410-9601-1 G |
| ELISA | Anti-Toxoplasma gondii ELISA 2.0 (IgG) |
antigen-coated microplate wells |
native antigens of Toxoplasma gondii |
IgG |
96 x 01 |
EI 2410-9601-2 G | |
| ChLIA | IDS TOXO IgG | antigenic coated magnetic particles | Toxoplasma gondii antigens |
quantitative |
100 x 01 |
IS-ID50011 | |
| ChLIA | IDS TOXO IgM | Anti-IgM-coated magnetic particles | Conjugate: Toxoplasma gondii antigens |
quantitative |
100 x 01 |
IS-ID50021 | |
| ChLIA | IDS TOXO Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID50301 | ||
| ChLIA | IDS TOXO IgG Avidity | antigenic coated magnetic particles | Toxoplasma gondii antigens |
semi-quantitative |
50 x 01 |
IS-ID51011 | |
| ChLIA | IDS TOXO Avidity Control Set | 3 x 1.0 ml Control 1/2 | human serum |
2 concentrations |
IS-ID51301 | ||
| PCR | EURORealTime Toxoplasma gondii |
01 x 100 01 x 25 |
MP 2410-0100 MP 2410-0125 |
||||
| ELISA | Anti-Parvovirus B19 ELISA (IgG) |
antigen-coated microplate wells |
recombinant viral structural protein expressed in eukaryotic cells |
1/5/25/100 IU/ml | IgG |
96 x 01 |
EI 2580-9601 G |
| ELISA | Anti-Parvovirus B19 ELISA (IgM) |
antigen-coated microplate wells |
recombinant viral structural protein expressed in eukaryotic cells |
semi-quantitative | IgM |
96 x 01 |
EI 2580-9601 M |
| ChLIA | IDS Parvovirus B19 IgG | antigenic coated magnetic particles | Structural proteins of Parvovirus B19 |
semi-quantitative |
50 x 01 |
IS-ID63011 | |
| ChLIA | IDS Parvovirus B19 IgM | Anti-IgM-coated magnetic particles | Conjugate: structural proteins of Parvovirus B19 |
quantitative |
50 x 01 |
IS-ID63021 | |
| ChLIA | IDS Parvovirus B19 Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID63301 | ||
| ELISA | Anti-Chlamydia trachomatis Advanced ELISA (IgA) | semi-quantitative | IgA |
96 x 01 |
EI 2191-9601-1 A | ||
| ELISA | Anti-Chlamydia trachomatis Advanced ELISA (IgG) | quantitative | IgG |
96 x 01 |
EI 2191-9601-1 G | ||
| IIFT |
Treponema pallidum (FTA-ABS) |
bacterial smear verification BIOCHIP (2 BIOCHIPs per field) |
T. pallidum | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2111-1005 G FI 2111-1005 M FI 2111-1010 G FI 2111-1010 M |
|
| IIFT |
Treponema pallidum (FTA-ABS) |
bacterial smears verification BIOCHIP (3 BIOCHIPs per field) |
T. pallidum T. phagedenis |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2112-1005 G FI 2112-1005 M FI 2112-1010 G FI 2112-1010 M |
|
| IIFT |
Anti-Chlamydia MIF Chlamydia trachomatis Chlamydia pneumoniae Chlamydia psittaci |
4 BIOCHIPs per field: elementary bodies and non-infected cells |
EU 40 EU 40 EU 40 |
IgA EB IgG EB IgM EB IgA EB IgG EB IgM EB |
10 x 05 10 x 05 10 x 05 10 x 10 10 x 10 10 x 10 |
FI 2191-1005-3 A FI 2191-1005-3 G FI 2191-1005-3 M FI 2191-1010-3 A FI 2191-1010-3 G FI 2191-1010-3 M |
|
| IIFT | Chlamydia trachomatis |
elementary bodies (MIF) non-infected cells (2 BIOCHIPs per field) |
EU 40 EU 40 |
IgA EB IgG EB IgM EB |
10 x 05 10 x 05 10 x 05 |
FI 2191-1005-80 A FI 2191-1005-80 G FI 2191-1005-80 M |
|
| IIFT |
Anti-Chlamydia MIF EUROPattern Chlamydia trachomatis Chlamydia pneumoniae Chlamydia psittaci |
4 BIOCHIPs per field: elementary bodies and non-infected cells |
EU 40 EU 40 EU 40 |
IgA EB IgG EB IgM EB IgA EB IgG EB IgM EB |
10 x 05 10 x 05 10 x 05 10 x 10 10 x 10 10 x 10 |
FR 2191-1005-3 A FR 2191-1005-3 G FR 2191-1005-3 M FR 2191-1010-3 A FR 2191-1010-3 G FR 2191-1010-3 M |
|
| ELISA | Anti-Treponema pallidum ELISA (IgG) |
antigen-coated microplate wells |
recombinant antigens 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2111-9601 G |
| ELISA | Anti-Treponema pallidum ELISA (IgM) |
antigen-coated microplate wells |
recombinant antigens 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
semi-quantitative | IgM |
96 x 01 |
EI 2111-9601 M |
| ELISA | Anti-Treponema pallidum ELISA 2.0 (IgGM) | 200/50/20/2 RU/ml | IgGM |
96 x 01 |
EI 2111-9601-2 O | ||
| ELISA | Anti-Chlamydia trachomatis ELISA (IgA) |
antigen-coated microplate wells |
native MOMP antigen from C. trachomatis |
semi-quantitative | IgA |
96 x 01 |
EI 2191-9601 A |
| ELISA | Anti-Chlamydia trachomatis ELISA (IgG) |
antigen-coated microplate wells |
native MOMP antigen from C. trachomatis |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2191-9601 G |
| ELISA | Anti-Chlamydia trachomatis ELISA (IgM) |
antigen-coated microplate wells |
native MOMP antigen from C. trachomatis |
semi-quantitative | IgM |
96 x 01 |
EI 2191-9601 M |
| EUROLINE |
positive control serum: IgG, human, 50x concentrated for Treponema pallidum |
IgG |
05 x 07 |
CL 2111-0507 G | |||
| EUROLINE |
positive control serum: IgM, human, 50x concentrated for Treponema pallidum |
IgM |
05 x 07 |
CL 2111-0507 M | |||
| EUROLINE |
EUROLINE Anti-Treponema pallidum (IgG) (TpN15, TpN17, TmpA, TpN47 separately) |
EUROLINE | IgG IgG |
16 x 01 64 x 01 |
DN 2111-1601 G DN 2111-6401 G |
||
| EUROLINE |
EUROLINE Anti-Treponema pallidum (IgM) (TpN15, TpN17, TmpA, TpN47 separately) |
EUROLINE | IgM IgM |
16 x 01 64 x 01 |
DN 2111-1601 M DN 2111-6401 M |
||
| WESTERNBLOT |
antibodies against Treponema pallidum IgG positive control |
IgG |
50 x 05 |
CW 2111-5005 G | |||
| WESTERNBLOT |
antibodies against Treponema pallidum IgM positive control |
IgM |
50 x 05 |
CW 2111-5005 M | |||
| WESTERNBLOT | Anti-Treponema pallidum WESTERNBLOT (IgG) | Westernblot |
15 kDa, 17 kDa, 45 kDa (tmpA), 47 kDa |
IgG IgG |
16 x 01 24 x 01 |
DY 2111-1601 G DY 2111-2401 G |
|
| WESTERNBLOT | Anti-Treponema pallidum WESTERNBLOT (IgM) | Westernblot |
15 kDa, 17 kDa, 45 kDa (tmpA), 47 kDa |
IgM IgM |
16 x 01 24 x 01 |
DY 2111-1601 M DY 2111-2401 M |
|
| ELISA |
Avidity: Anti-Rubella Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
native antigens, strain "HPV-77" |
1/10/50/200 IU/ml | IgG |
96 x 01 |
EI 2590-9601-1 G |
| ELISA | Anti-Rubella Virus Glycoprotein ELISA (IgM) |
antigen-coated microplate wells |
native glycoproteins, strain "HPV-77" |
semi-quantitative | IgM |
96 x 01 |
EI 2590-9601-2 M |
| ELISA | Anti-Rubella Virus ELISA 2.0 (IgG) |
antigen-coated microplate wells |
Recombinant Rubella virus antigens |
IgG |
96 x 01 |
EI 2590-9601-3 G | |
| ChLIA | IDS Rubella IgG | antigenic coated magnetic particles | Rubella antigen |
quantitative |
100 x 01 |
IS-ID52011 | |
| ChLIA | IDS Rubella IgM | Anti-IgM-coated magnetic particles | Conjugate: Rubella antigen |
quantitative |
100 x 01 |
IS-ID52021 | |
| ChLIA | IDS Rubella Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID52301 | ||
| ChLIA | IDS Rubella IgG Avidity | antigenic coated magnetic particles | Rubella antigen |
quantitative |
50 x 01 |
IS-ID53011 | |
| ChLIA | IDS Rubella Avidity Control Set | 3 x 1.0 ml Control 1/2 | human serum |
2 concentrations |
IS-ID53301 | ||
| IIFT |
Legionella Mosaic 8 Legionella pneumophila mixture 5 Legionella longbeachae |
3 BIOCHIPs per field: bacterial smear bacterial smear verification BIOCHIP |
L. pneumophila L. longbeachae |
IgAGM |
10 x 05 |
FI 2150-1005-8 P | |
| IIFT |
Legionella pneumophila serotype 1 |
bacterial smear verification BIOCHIP (2 BIOCHIPs per field) |
Legionella pneumophila |
IgAGM IgAGM |
10 x 05 10 x 10 |
FI 2151-1005 P FI 2151-1010 P |
|
| IIFT |
Legionella pneumophila mixture 5 (serotype 1 - 7) |
bacterial smear functional BIOCHIP |
Legionella pneumophila | IgAGM IgAGM |
10 x 05 10 x 10 |
FI 215k-1005-1 P FI 215k-1010-1 P |
|
| ELISA | Anti-Legionella pneumophila ELISA (IgG) |
antigen-coated microplate wells |
suspension of Legionella pneumophila serotypes 1-7 |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2150-9601 G |
| ELISA | Anti-Legionella pneumophila ELISA (IgM) |
antigen-coated microplate wells |
suspension of Legionella pneumophila serotypes 1-7 |
semi-quantitative | IgM |
96 x 01 |
EI 2150-9601 M |
| ELISA | Anti-Mycoplasma pneumoniae ELISA (IgA) |
antigen-coated microplate wells |
detergent extract from Mycoplasma pneumoniae |
semi-quantitative | IgA |
96 x 01 |
EI 2202-9601 A |
| ELISA | Anti-Mycoplasma pneumoniae ELISA (IgG) |
antigen-coated microplate wells |
detergent extract from Mycoplasma pneumoniae |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2202-9601 G |
| ELISA | Anti-Mycoplasma pneumoniae ELISA (IgM) |
antigen-coated microplate wells |
detergent extract from Mycoplasma pneumoniae |
semi-quantitative | IgM |
96 x 01 |
EI 2202-9601 M |
| ELISA |
Anti-RSV ELISA (IgA) Respiratory syncytial virus |
antigen-coated microplate wells |
native antigens from RSV |
semi-quantitative | IgA |
96 x 01 |
EI 2670-9601 A |
| ELISA |
Anti-RSV ELISA (IgG) Respiratory syncytial virus |
antigen-coated microplate wells |
native antigens from RSV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2670-9601 G |
| ELISA |
Anti-RSV ELISA (IgM) Respiratory syncytial virus |
antigen-coated microplate wells |
native antigens from RSV |
semi-quantitative | IgM |
96 x 01 |
EI 2670-9601 M |
| ELISA |
Anti-Parainfluenza Viruses Pool ELISA (IgA) (Pool) |
antigen-coated microplate wells |
native antigens from Parainfluenza virus types 1 - 4 |
semi-quantitative | IgA |
96 x 01 |
EI 2721-9601-1 A |
| ELISA |
Anti-Parainfluenza Viruses Pool ELISA (IgG) (Pool) |
antigen-coated microplate wells |
native antigens from Parainfluenza virus types 1 - 4 |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2721-9601-1 G |
| ELISA | Anti-Bordetella pertussis toxin ELISA (IgA) |
antigen-coated microplate wells |
natives Bordetella pertussis toxin |
2/10/25/50 IU/ml | IgA |
96 x 01 |
EI 2050-9601 A |
| ELISA | Anti-Bordetella pertussis toxin ELISA (IgG) |
antigen-coated microplate wells |
natives Bordetella pertussis toxin |
5/25/100/200 IU/ml | IgG |
96 x 01 |
EI 2050-9601 G |
| ELISA | Anti-Bordetella pertussis ELISA (IgM) |
antigen-coated microplate wells |
inactivated Bordetella pertussis lysate |
semi-quantitative | IgM |
96 x 01 |
EI 2050-9601 M |
| ELISA | Anti-Bordetella FHA ELISA (IgA) |
antigen-coated microplate wells |
native Bordetella pertussis filamentous haemagglutinin |
2/10/25/50 IU/ml | IgA |
96 x 01 |
EI 2050-9601-3 A |
| ELISA | Anti-Bordetella FHA ELISA (IgG) |
antigen-coated microplate wells |
native Bordetella pertussis filamentous haemagglutinin |
5/25/100/200 IU/ml | IgG |
96 x 01 |
EI 2050-9601-3 G |
| ELISA | Anti-Influenza A Virus ELISA (IgA) |
antigen-coated microplate wells |
strains "Texas" (H3N2), "California" (H1N1) and "Singapore" (H1N1) |
semi-quantitative | IgA |
96 x 01 |
EI 2691-9601 A |
| ELISA | Anti-Influenza A Virus ELISA (IgG) |
antigen-coated microplate wells |
strains "Texas" (H3N2), "California" (H1N1) and "Singapore" (H1N1) |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2691-9601 G |
| ELISA | Anti-Influenza B Virus ELISA (IgA) |
antigen-coated microplate wells |
strain"Hong Kong 5/72" | semi-quantitative | IgA |
96 x 01 |
EI 2692-9601 A |
| ELISA | Anti-Influenza B Virus ELISA (IgG) |
antigen-coated microplate wells |
strain"Hong Kong 5/72" | 2/20/200 RU/ml | IgG |
96 x 01 |
EI 2692-9601 G |
| EUROLINE |
positive control serum: IgA, human, 50x concentrated for Bordetella pertussis |
IgA |
05 x 07 |
CL 2050-0507 A | |||
| EUROLINE |
positive control serum: IgG, human, 50x concentrated for Bordetella pertussis |
IgG |
05 x 07 |
CL 2050-0507 G | |||
| EUROLINE |
EUROLINE Bordetella pertussis (IgA) (FHA, PT, ACT separately) |
EUROLINE | IgA IgA |
16 x 01 240 x 01 |
DN 2050-1601 A DN 2050-24001 A |
||
| EUROLINE |
EUROLINE Bordetella pertussis (IgG) (FHA, PT, ACT separately) |
EUROLINE | IgG IgG |
16 x 01 240 x 01 |
DN 2050-1601 G DN 2050-24001 G |
||
| IIFT |
EUROPLUS Borrelia afzelii Borrelia burgdorferi (USA) OspC antigen VlsE antigen |
4 BIOCHIPs per field: bacterial smear bacterial smear OspC BIOCHIPs VlsE BIOCHIPs |
B. afzelii B. burgd. (USA) B. burgdorferi recombinant |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2136-1005-1 G FI 2136-1005-1 M FI 2136-1010-1 G FI 2136-1010-1 M |
|
| ELISA |
Anti-Borrelia ELISA (IgM) whole antigen extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii |
antigen-coated microplate wells |
whole antigen, detergent extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii |
2/20/200 RU/ml | IgM |
96 x 01 |
EI 2132-9601 M |
| ELISA |
Anti-Borrelia plus VlsE ELISA (IgG) whole antigen extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii plus recombinant VlsE |
antigen-coated microplate wells |
whole antigen, detergent extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii plus recombinant VlsE from Borrelia burgdorferi sensu stricto |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2132-9601-2 G |
| ELISA | Anti-Coxiella burnetii Phase 1 ELISA (IgG) |
antigen-coated microplate wells |
native antigens from Coxiella burnetii cells in the chronical phase |
semi-quantitative | IgG |
96 x 01 |
EI 217a-9601-1 G |
| ELISA | Anti-Coxiella burnetii Phase 2 ELISA (IgG) |
antigen-coated microplate wells |
native antigens from Coxiella burnetii cells in the acute phase |
semi-quantitative | IgG |
96 x 01 |
EI 217a-9601-2 G |
| ELISA | Anti-Coxiella burnetii Phase 2 ELISA (IgM) |
antigen-coated microplate wells |
native antigens from Coxiella burnetii cells in the acute phase |
semi-quantitative | IgM |
96 x 01 |
EI 217a-9601-2 M |
| EUROLINE |
positive control serum: IgG, human, 50x concentrated for Borrelia |
IgG |
05 x 07 |
CL 2131-0507 G | |||
| EUROLINE |
positive control serum: IgM, human, 50x concentrated for Borrelia |
IgM |
05 x 07 |
CL 2131-0507 M | |||
| EUROLINE |
Anti-Borrelia EUROLINE-RN-AT-adv (IgM) (OspC-adv Bsp, OspC-adv Bg, OspC-adv Bb, OspC-adv Ba, p39, VlsE Bb separately) |
EUROLINE | IgM IgM IgM |
240 x 01 32 x 01 50 x 01 |
DN 2131-24001-2 M DN 2131-3201-2 M DN 2131-5001-2 M |
||
| WESTERNBLOT |
antibodies against Borrelia afzelii IgG positive control (Westernblot/EUROLINE-WB) |
IgG |
50 x 05 |
CW 2131-5005 G | |||
| WESTERNBLOT |
antibodies against Borrelia afzelii IgM positive control (Westernblot/EUROLINE-WB) |
IgM |
50 x 05 |
CW 2131-5005 M | |||
| WESTERNBLOT |
antibodies against Borrelia burgdorferi IgG positive control |
IgG |
50 x 05 |
CW 2132-5005 G | |||
| WESTERNBLOT |
antibodies against Borrelia burgdorferi IgM positive control |
IgM |
50 x 05 |
CW 2132-5005 M | |||
| WESTERNBLOT |
antibodies against Borrelia garinii IgG positive control |
IgG |
50 x 05 |
CW 2134-5005 G | |||
| WESTERNBLOT |
antibodies against Borrelia garinii IgM positive control |
IgM |
50 x 05 |
CW 2134-5005 M | |||
| WESTERNBLOT | Anti-Borrelia EUROLINE-WB (IgG) | Westernblot |
whole antigen, SDS extract of Borrelia afzelii plus VlsE |
IgG IgG IgG IgG |
16 x 01 240 x 01 30 x 01 48 x 01 |
DY 2131-1601-1 G DY 2131-24001-1 G DY 2131-3001-1 G DY 2131-4801-1 G |
|
| WESTERNBLOT | Anti-Borrelia EUROLINE-WB (IgM) | Westernblot |
whole antigen, SDS extract of Borrelia afzelii plus VlsE |
IgM IgM IgM IgM |
16 x 01 240 x 01 30 x 01 48 x 01 |
DY 2131-1601-1 M DY 2131-24001-1 M DY 2131-3001-1 M DY 2131-4801-1 M |
|
| WESTERNBLOT | Anti-Borrelia afzelii-WESTERNBLOT (IgG) | Westernblot |
whole antigen, SDS extract of Borrelia afzelii |
IgG IgG |
240 x 01 30 x 01 |
DY 2131-24001 G DY 2131-3001 G |
|
| WESTERNBLOT | Anti-Borrelia afzelii-WESTERNBLOT (IgM) | Westernblot |
whole antigen, SDS extract of Borrelia afzelii |
IgM IgM |
240 x 01 30 x 01 |
DY 2131-24001 M DY 2131-3001 M |
|
| WESTERNBLOT | Anti-Borrelia burgdorferi-WESTERNBLOT (IgG) | Westernblot |
whole antigen, SDS extract of Borrelia burgdorferi sensu stricto |
IgG |
30 x 01 |
DY 2132-3001 G | |
| WESTERNBLOT | Anti-Borrelia burgdorferi-WESTERNBLOT (IgM) | Westernblot |
whole antigen, SDS extract of Borrelia burgdorferi sensu stricto |
IgM |
30 x 01 |
DY 2132-3001 M | |
| WESTERNBLOT | Anti-Borrelia garinii-WESTERNBLOT (IgG) | Westernblot |
whole antigen, SDS extract of Borrelia garinii |
IgG |
30 x 01 |
DY 2134-3001 G | |
| WESTERNBLOT | Anti-Borrelia garinii-WESTERNBLOT (IgM) | Westernblot |
whole antigen, SDS extract of Borrelia garinii |
IgM |
30 x 01 |
DY 2134-3001 M | |
| ChLIA | IDS Borrelia IgG | antigenic coated magnetic particles | Borrelia burgdorferi VlsE antigen |
semi-quantitative |
100 x 01 |
IS-ID62011 | |
| ChLIA | IDS Borrelia IgM | antigenic coated magnetic particles | B. afzelii, B. burgdorferi, B. garinii, B. spielmani OspC and B. burgdorferi VlsE antigen |
semi-quantitative |
100 x 01 |
IS-ID62021 | |
| ChLIA | IDS Borrelia Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID62301 | ||
| ChLIA | Anti-Borrelia ChLIA (IgG) | Antigen-coated magnetic particles |
recombinant VlsE, recombinant DbpA |
quantitative | IgG |
100 x 1 |
LI 2132-10010 G |
| ChLIA | Anti-Borrelia ChLIA (IgM) | Antigen-coated magnetic particles | recombinant OspC | quantitative | IgM |
100 x 1 |
LI 2132-10010 M |
| ChLIA | Control set Anti-Borrelia ChLIA (IgG) | 2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 2132-20210 G | ||
| ChLIA | Control set Anti-Borrelia ChLIA (IgM) | 2 x 0.5 ml control 1/2 | IgM |
02 x 02 |
LR 2132-20210 M | ||
| MICROBLOT | EUROMicroblot Anti Borrelia (IgG) | IgG |
96 x 01 |
KN 2131-9601 G | |||
| MICROBLOT | EUROMicroblot Anti Borrelia (IgM) | IgM |
96 x 01 |
KN 2131-9601 M | |||
| ELISA | Anti-Diphtheria Toxoid ELISA (IgG) |
antigen-coated microplate wells |
inactivated diphtheria toxin |
0.01/0.1/1/2 IU/ml | IgG |
96 x 01 |
EI 2040-9601 G |
| ELISA | Anti-Tetanus Toxoid ELISA (IgG) |
antigen-coated microplate wells |
inactivated tetanus toxin |
0,01/0,1/1/2/5 IU/ml | IgG |
96 x 01 |
EI 2060-9601 G |
| ELISA | Anti-Measles Virus ELISA (IgG) |
antigen-coated microplate wells |
native antigens from Measles virus |
50/250/1000/5000 IU/l | IgG |
96 x 01 |
EI 2610-9601 G |
| ELISA | Anti-Measles Virus ELISA (IgM) |
antigen-coated microplate wells |
native antigens from Measles virus |
semi-quantitative | IgM |
96 x 01 |
EI 2610-9601 M |
| ELISA |
Avidity: Anti-Measles Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
native antigens from Measles virus |
50/250/1000/5000/5000 IU/l | IgG |
96 x 01 |
EI 2610-9601-1 G |
| ELISA | Anti-Measles Virus ELISA 2.0 (IgG) |
antigen-coated microplate wells |
native antigens from Measles virus |
quantitative | IgG |
96 x 01 |
EI 2610-9601-2 G |
| ELISA | Anti-Measles Virus NP ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleoprotein from Measles virus |
semi-quantitative | IgM |
96 x 01 |
EI 2610-9601-4 M |
| ELISA | Anti-Mumps Virus ELISA (IgG) |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2630-9601 G |
| ELISA | Anti-Mumps Virus ELISA (IgM) |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
semi-quantitative | IgM |
96 x 01 |
EI 2630-9601 M |
| ELISA |
Anti-Mumps Virus AT ELISA (IgG) strains "Enders" and "Jeryl Lynn" |
antigen-coated microplate wells |
native antigens, strains "Enders" (ATCC VR-106) and "Jeryl Lynn" |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2630-9601-3 G |
| ELISA | Anti-Mumps Virus ELISA (G5) (IgM) |
antigen-coated microplate wells |
native antigens, genotype "G5" |
semi-quantitative | IgM |
96 x 01 |
EI 2630-9601-5 M |
| ChLIA | IDS Measles IgG | antigenic coated magnetic particles | Measles virus antigen |
quantitative |
50 x 01 |
IS-ID59011 | |
| ChLIA | IDS Mumps IgG | antigenic coated magnetic particles | Mumps virus antigen |
quantitative |
50 x 01 |
IS-ID59021 | |
| ChLIA | IDS Measles IgM | antigenic coated magnetic particles | Measles virus antigen |
quantitative |
50 x 01 |
IS-ID60011 | |
| ChLIA | IDS Mumps IgM | antigenic coated magnetic particles | Mumps virus antigen |
quantitative |
50 x 01 |
IS-ID60021 | |
| ChLIA | IDS Tetanus IgG | antigenic coated magnetic particles | Tetanus toxoid antigen |
quantitative |
100 x 01 |
IS-ID61011 | |
| ChLIA | IDS Tetanus IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID61301 | ||
| ChLIA | IDS Specific IgE (G001) Sweet vernal grass | allergen |
quantitative |
50 x 01 |
IS-1G0011 | ||
| IIFT | CV2/CRMP5 |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG |
10 x 10 |
FA 1119-1010-51* | |
| IIFT | Myelin-associated glycoprotein (MAG/HNK-1) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgM IgM |
10 x 05 10 x 10 |
FA 1123-1005-50* FA 1123-1010-50* |
|
| IIFT |
Autoimmune Encephalitis Mosaic 1 glutamate receptor (type NMDA) glutamate receptor (type AMPA1) glutamate receptor (type AMPA2) contactin-associated protein 2 (CASPR2) leucine-rich glioma-inactivated protein 1 (LGI1) GABA B receptor |
6 BIOCHIPs per field: transfected cells transfected cells transfected cells transfected cells transfected cells transfected cells |
EU 90 EU 90 EU 90 EU 90 EU 90 EU 90 |
IgG |
10 x 05 |
FA 112d-1005-1* | |
| IIFT | Seizure 6-like protein 2 (SEZ6L2) |
transfected cells control transfection (2 BIOCHIPs per field) |
EU 90 EU 90 |
IgG IgG |
10 x 05 10 x 10 |
FA 112p-1005-50* FA 112p-1010-50* |
|
| ELISA | LISA-TRACKER Adalimumab | Anti-Adalimumab-coated microplate wells |
48 x 01 |
LTA 002-481 | |||
| ELISA | LISA-TRACKER anti-Adalimumab | Adalimumab-coated microplate wells |
48 x 01 |
LTA 003-481 | |||
| ELISA | LISA-TRACKER Duo Adalimumab | Anti-Adalimumab- and Adalimumab-coated microplate wells |
48 x 02 |
LTA 0051 | |||
| ELISA | LISA-TRACKER Bevacizumab | Anti-Bevacizumab-coated microplate wells |
48 x 01 |
LTB 002-481 | |||
| ELISA | LISA-TRACKER anti-Bevacizumab | Bevacizumab-coated microplate wells |
48 x 01 |
LTB 003-481 | |||
| ELISA | LISA-TRACKER Certolizumab | Anti-Certolizumab-coated microplate wells |
48 x 01 |
LTC 002-481 | |||
| ELISA | LISA-TRACKER anti-Certolizumab | Certolizumab-coated microplate wells |
48 x 01 |
LTC 003-481 | |||
| ELISA | LISA-TRACKER Duo Certolizumab | Anti-Certolizumab- and Certolizumab-coated microplate wells |
48 x 02 |
LTC 0051 | |||
| ELISA | LISA-TRACKER Etanercept | Anti-Etanercept-coated microplate wells |
48 x 01 |
LTE 002-481 | |||
| ELISA | LISA-TRACKER anti-Etanercept | Etanercept-coated microplate wells |
48 x 01 |
LTE 003-481 | |||
| ELISA | LISA-TRACKER Golimumab | Anti-Golimumab-coated microplate wells |
48 x 01 |
LTG 002-481 | |||
| ELISA | LISA-TRACKER anti-Golimumab | Golimumab-coated microplate wells |
48 x 01 |
LTG 003-481 | |||
| ELISA | LISA-TRACKER Duo Golimumab | Anti-Golimumab- and Golimumab-coated microplate wells |
48 x 02 |
LTG 0051 | |||
| ELISA | LISA-TRACKER Infliximab | Anti-Infliximab-coated microplate wells |
48 x 01 |
LTI 002-481 | |||
| ELISA | LISA-TRACKER anti-Infliximab | Infliximab-coated microplate wells |
48 x 01 |
LTI 003-481 | |||
| ELISA | LISA-TRACKER Duo Infliximab | Anti-Infliximab- and Infliximab-coated microplate wells |
48 x 02 |
LTI 0051 | |||
| ELISA | LISA-TRACKER Rituximab | Anti-Rituximab-coated microplate wells |
48 x 01 |
LTR 002-481 | |||
| ELISA | LISA-TRACKER anti-Rituximab | Rituximab-coated microplate wells |
48 x 01 |
LTR 003-481 | |||
| ELISA | LISA-TRACKER Duo Rituximab | Anti-Rituximab- and Rituximab-coated microplate wells |
48 x 02 |
LTR 005 1 | |||
| ELISA | LISA-TRACKER Secukinumab | Anti-Secukinumab-coated microplate wells |
48 x 01 |
LTS 002-481 | |||
| ELISA | LISA-TRACKER anti-Secukinumab | Secukinumab-coated microplate wells |
48 x 01 |
LTS 003-481 | |||
| ELISA | LISA-TRACKER Tocilizumab | Anti-Tocilizumab-coated microplate wells |
48 x 01 |
LTT 002-481 | |||
| ELISA | LISA-TRACKER anti-Tocilizumab | Tocilizumab-coated microplate wells |
48 x 01 |
LTT 003-481 | |||
| ELISA | LISA-TRACKER TNF | Anti-TNFα-coated microplate wells |
96 x 01 |
LTT 004-96 1 | |||
| ELISA | LISA-TRACKER Duo Tocilizumab | Anti-Tocilizumab- and Tocilizumab-coated microplate wells |
48 x 02 |
LTT 0051 | |||
| ELISA | LISA-TRACKER Trastuzumab | Anti-Trastuzumab-coated microplate wells |
48 x 01 |
LTTR 002-481 | |||
| ELISA | LISA-TRACKER anti-Trastuzumab | Trastuzumab-coated microplate wells |
48 x 01 |
LTTR 003-481 | |||
| ELISA | LISA-TRACKER Ustekinumab | Anti-Ustekinumab-coated microplate wells |
48 x 01 |
LTU 002-481 | |||
| ELISA | LISA-TRACKER anti-Ustekinumab | Ustekinumab-coated microplate wells |
48 x 01 |
LTU 003-481 | |||
| ELISA | LISA-TRACKER Duo Ustekinumab | Anti-Ustekinumab- and Ustekinumab-coated microplate wells |
48 x 02 |
LTU 0051 | |||
| ELISA | LISA-TRACKER Vedolizumab | Anti-Vedolizumab-coated microplate wells |
48 x 01 |
LTV 002-481 | |||
| ELISA | LISA-TRACKER anti-Vedolizumab | Vedolizumab-coated microplate wells |
48 x 01 |
LTV 003-481 | |||
| ELISA | LISA-TRACKER Duo Vedolizumab | Anti-Vedolizumab- and Vedolizumab-coated microplate wells |
48 x 02 |
LTV 0051 | |||
| ChLIA | i-Tracker Adalimumab | Anti-Adalimumab-coated magnetic particles | quantitative |
100 x 01 |
CTA 002-1001 | ||
| ChLIA | i-Tracker Anti-Adalimumab | Adalimumab-coated magnetic particles | recombinant Adalimumab |
quantitative |
100 x 01 |
CTA 003-1001 | |
| ChLIA | i-Tracker Anti-Adalimumab Total Ab | Adalimumab-coated magnetic particles |
50 x 01 |
CTA 003T-501 | |||
| ChLIA | i-Tracker Certolizumab |
Anti-Certolizumab-coated magnetic particles |
quantitative |
50 x 01 |
CTC 002-501 | ||
| ChLIA | i-Tracker Anti-Certolizumab | Certolizumab-coated magnetic particles | recombinant Certolizumab |
quantitative |
50 x 01 |
CTC 003-501 | |
| ChLIA | i-Tracker Etanercept | Anti-Etanercept-coated magnetic particles |
50 x 01 |
CTE 002-501 | |||
| ChLIA | i-Tracker Anti-Etanercept | Etanercept-coated magnetic particles |
50 x 01 |
CTE 003-501 | |||
| ChLIA | i-Tracker Golimumab | Anti-Golimumab-coated magnetic particles |
quantitative |
50 x 01 |
CTG 002-501 | ||
| ChLIA | i-Tracker Anti-Golimumab | Golimumab-coated magnetic particles | recombinant Golimumab |
quantitative |
50 x 01 |
CTG 003-501 | |
| ChLIA | i-Tracker Infliximab | Anti-Infliximab-coated magnetic particles |
quantitative |
100 x 01 |
CTI 002-1001 | ||
| ChLIA | i-Tracker Anti-Infliximab | Infliximab-coated magnetic particles | recombinant Infliximab |
quantitative |
10 x 001 |
CTI 003-1001 | |
| ChLIA | i-Tracker Anti-Infliximab Total Ab | Infliximab-coated magnetic particles |
50 x 01 |
CTI 003T-501 | |||
| ChLIA | i-Tracker Ocrelizumab | Anti-Ocrelizumab-coated magnetic particles |
50 x 01 |
CTO 002-501 | |||
| ChLIA | i-Tracker Anti-Ocrelizumab | Ocrelizumab-coated magnet particles |
50 x 01 |
CTO 003-501 | |||
| ChLIA | i-Tracker Rituximab | Anti-Rituximab-coated magnetic particles |
quantitative |
50 x 01 |
CTR 002-501 | ||
| ChLIA | i-Tracker Anti-Rituximab | Rituximab-coated magnetic particles | recombinant Rituximab |
quantitative |
50 x 01 |
CTR 003-501 | |
| ChLIA | i-Tracker Risankizumab | Anti-Risankizumab coated magnetic particles |
50 x 01 |
CTRZ 002-501 | |||
| ChLIA | i-Tracker Anti-Risankizumab | Risankizumab coated magnetic particles |
50 x 01 |
CTRZ 003-501 | |||
| ChLIA | i-Tracker Ustekinumab | Anti-Ustekinumab-coated magnetic particles |
quantitative |
50 x 01 |
CTU 002-501 | ||
| ChLIA | i-Tracker Anti-Ustekinumab | Ustekinumab-coated magnetic particles | recombinant Ustekinumab |
quantitative |
50 x 01 |
CTU 003-501 | |
| ChLIA | i-Tracker Vedolizumab | Anti-Vedolizumab-coated magnetic particles |
quantitative |
50 x 01 |
CTV 002-501 | ||
| ChLIA | i-Tracker Anti-Vedolizumab | Vedolizumab-coated magnetic particles | recombinant Vedolizumab |
quantitative |
50 x 01 |
CTV 003-501 | |
| IIFT |
FITC-labelled anti-human IgA (goat) |
IgA IgA |
05 x 40 05 x 46 |
AF 101-0540-R AF 101-0546-R |
|||
| IIFT |
FITC-labelled anti-human IgG (goat) |
IgG IgG |
05 x 40 05 x 46 |
AF 102-0540-R AF 102-0546-R |
|||
| IIFT |
FITC-labelled anti-human IgM (goat) |
IgM IgM |
05 x 40 05 x 46 |
AF 103-0540-R AF 103-0546-R |
|||
| IIFT |
FITC-labelled anti-human IgG+IgG4 (goat/mouse) |
IgG |
05 x 40 |
AF 104-0540-R | |||
| IIFT |
FITC-labelled anti-human IgAGM (IgA + IgG + IgM goat) |
IgAGM IgAGM |
05 x 40 05 x 46 |
AF 106-0540-R AF 106-0546-R |
|||
| IIFT |
FITC-labelled anti-human IgG (primate absorbed) (goat) |
IgG IgG |
05 x 40 05 x 46 |
AF 302-0540-R AF 302-0546-R |
|||
| IIFT |
biotin-labelled anti-human IgG (goat) |
IgG |
05 x 40 |
AF 402-0540-1-R | |||
| IIFT | FITC-labelled Avidin (biotin affine) | IgG |
05 x 40 |
AF 402-0540-2-R | |||
| IIFT |
FITC-labelled anti-human IgA with Evans Blue (goat) |
05 x 40 |
AF 601-0540-R | ||||
| IIFT |
FITC-labelled anti-human IgG with Evans Blue (goat) |
05 x 40 05 x 46 |
AF 602-0540-R AF 602-0546-R |
||||
| IIFT |
FITC-labelled anti-human IgM with Evans Blue (goat) |
05 x 40 |
AF 603-0540-R | ||||
| IIFT |
FITC-labelled anti-human C3c with Evans Blue (rabbit) |
05 x 40 |
AF 612-0540-R | ||||
| IIFT |
FITC-labelled anti-human IgG with propidium iodide for EUROPattern (goat) |
05 x 40 05 x 46 |
AF 702-0540-2-R AF 702-0546-2-R |
||||
| IIFT |
FITC-labelled anti-human IgM with propidium iodide for EUROPattern (goat) |
05 x 40 |
AF 703-0540-R | ||||
| IIFT |
Sample buffer 2, Crithidia luciliae sensitive (IIFT) (only for the Anti-dsDNA sensitive IIFT) |
04 x 25 05 x 30 |
ZF 1020-0425-2-R ZF 1020-0530-2-R |
||||
| IIFT | sample buffer (IIFT) |
04 x 25 05 x 30 05 x 45 |
ZF 1020-0425-R ZF 1020-0530-R ZF 1020-0545-R |
||||
| IIFT |
PBS (IIFT) salt for PBS, pH 7.2 |
04 x 10 10 x 01 |
ZF 1100-0410-R ZF 1100-1001-R |
||||
| IIFT | PBS-Tween (IIFT) |
05 x 100 |
ZF 1101-05100-R | ||||
| IIFT |
Tween 20 (IIFT) (2.0 ml as admixture for 1 liter of PBS) |
04 x 20 10 x 02 |
ZF 1110-0420-R ZF 1110-1002-R |
||||
| IIFT | Glycine urea buffer (IIFT) |
05 x 50 |
ZF 1140-0550-R | ||||
| IIFT |
Mounting medium (IIFT) (containing anti-bleaching reagent) |
04 x 30 06 x 500 10 x 03 |
ZF 1200-0430-R ZF 1200-06500-R ZF 1200-1003-R |
||||
| IIFT |
EUROSORB (IIFT) (liquid RF absorbent) |
05 x 45 |
ZF 1270-0545-R | ||||
| IIFT |
Human serum as complement source (IIFT) frozen, EBV antibody negative (lyophilized) |
10 x 02 |
ZF 9000-1002-R | ||||
| IIFT |
cuvette with insert for incubation of IFT (slides with 50 fields) |
01 x 01 |
ZZ 0017-0101 | ||||
| IIFT |
cuvette for incubation of IFT (slides with 50 fields, only to be used with ZZ 0019-0101) |
01 x 01 |
ZZ 0018-0101 | ||||
| IIFT |
insert for incubation of IFT (slides with 50 fields) |
01 x 01 |
ZZ 0019-0101 | ||||
| IIFT |
cuvette for incubation of IFT (slides with 5 or 10 fields) |
01 x 01 |
ZZ 9722-0101 | ||||
| IIFT |
incubated slide for demonstration purposes |
01 x 01 |
ZZ 9801-0101 | ||||
| IIFT |
slide tray for storage of incubated slides with 50 fields |
01 x 02 01 x 04 |
ZZ 9991-0102-1 ZZ 9991-0104-1 |
||||
| IIFT |
slide tray for storage of incubated slides with up to 10 fields |
01 x 10 01 x 20 |
ZZ 9991-0110 ZZ 9991-0120 |
||||
| IIFT |
box for packaging of incubated slides (demo slides) |
01 x 02 01 x 05 |
ZZ 9997-0102 ZZ 9997-0105 |
||||
| IIFT | TITERPLANE set for the incubation of slides with 10 fields |
01 x 01 |
ZZ 9999-0101-18-R | ||||
| IIFT | TITERPLANE set for the incubation of slides with 50 fields |
01 x 01 |
ZZ 9999-0101-19-R | ||||
| IIFT |
Coded reagent tray for slides with 5 fields with data matrix code |
01 x 05 |
ZZ 9999-0105-11-R | ||||
| IIFT | Reagent tray for incubation of slides |
01 x 05 01 x 10 |
ZZ 9999-0105-R ZZ 9999-0110-R |
||||
| IIFT |
Coded reagent tray for slides with 10 fields with data matrix code |
01 x 10 |
ZZ 9999-0110-12-R | ||||
| IIFT |
Coded reagent tray for slides with 50 fields with data matrix code |
01 x 50 |
ZZ 9999-0150-13-R | ||||
| IIFT | Reagent tray for the incubation of slides with 2 to 4 BIOCHIPs per field |
01 x 50 |
ZZ 9999-0150-2-R | ||||
| IIFT | Coded glass plate for the incubation of slides with 10 fields |
05 x 10 |
ZZ 9999-0510-15-R | ||||
| IIFT | Coded glass plate for the incubation of slides with 50 fields |
05 x 50 |
ZZ 9999-0550-16-R | ||||
| PCR | croBEE 201A Nucleic Acid Extraction Kit |
01 x 96 |
MH 0098-01961 | ||||
| PCR | Urethritis Gpack |
CNMX/GP/100 TV/GP/100 UNIC/GP/050 |
01 x 100 |
MH 0101-01001 | |||
| PCR | MGH/UUP/TV Diagnostic Gpack |
MGH/GP/100 UUP/GP/100 TV/GP/100 |
01 x 100 |
MH 0102-01001 | |||
| NUL | IDS-iSYS Cartridge Checking System CCS |
01 x 01 |
IS-60101 | ||||
| NUL | IDS-iSYS Cuvettes |
01 x 960 |
IS-CC1001 | ||||
| NUL | IDS-iSYS System Liquid (Syst.l) |
01 x 05 |
IS-CS1001 | ||||
| NUL | IDS-iSYS Trigger Set |
02 x 01 |
IS-CT1001 | ||||
| NUL | IDS-iSYS Wash Solution (Wash S) |
01 x 10 |
IS-CW1001 | ||||
| NUL | IDS-iSYS D-SORB Solution |
02 x 01 |
IS-DS2001 | ||||
| NUL | IDS Immunocleaner |
03 x 01 |
IS-IM1001 | ||||
| NUL | Green paper (EUROLineScan) |
01 x 500 |
ZD 9880-01500 | ||||
| NUL | adhesive foil |
01 x 16 01 x 30 |
ZD 9885-0116 ZD 9885-0130 |
||||
| NUL | incubation tray 30 channels (black) |
200 x 30 |
ZD 9895-20030-1 | ||||
| NUL | Incubation tray, volume-reduced |
120 x 44 200 x 30 |
ZD 9897-12044-1 ZD 9897-20030-1 |
||||
| NUL | incubation tray, white |
50 x 08 |
ZD 9899-10508 ZD 9899-5008 |
||||
| NUL | Setup Clean |
05 x 05 |
ZG 0009-0505 | ||||
| NUL | system liquid concentrate |
10 x 100 |
ZG 0862-10100 | ||||
| MDX | WASH REAGENT 1 |
100 x 50 |
ZM 0121-0050-R | ||||
| MDX | WASH REAGENT 2 |
100 x 12 |
ZM 0122-0012-R | ||||
| MDX | EUROArray wash buffer set |
01 x 01 |
ZM 0123-0101-R | ||||
| MDX | QIAamp DSP Blood Mini Kit |
01 x 50 |
ZM 0201-0150-Q | ||||
| MDX | QIAamp DNA Mini Kit |
01 x 50 |
ZM 0203-0150-Q | ||||
| MDX |
Copan regular FLOQSwabs with 1 ml eNAT transport and conservation medium (608CS01R) |
50 x 01 |
ZM 0281-5001 | ||||
| MDX |
Copan L-shape FLOQSwabs with 2 ml eNAT transport and conservation medium (606CS01L) |
50 x 01 |
ZM 0282-5002 | ||||
| MDX |
Buccal hDNAfree FLOQSwabs, Regular size tip, 20 mm Breaking Point, in tube with Active Drying System (50E010D01) |
50 x 01 |
ZM 0283-5001 | ||||
| MDX | TITERPLANE reagent tray for EUROArray slides |
01 x 05 |
ZM 9999-0105-R | ||||
|
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC. 1 Product manufactured by third party. Please contact your local Euroimmun representative for more information. | |||||||
Productfinder